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Trypanosomes are unicellular parasites of humans and livestock, characterised by a single 
mitochondrion and a highly complex mitochondrial DNA network, the kinetoplast. 
Trypanosoma brucei causes human African trypanosomiasis (HAT, or sleeping sickness) and 
Nagana in animals, often lethal diseases transmitted by tsetse flies in sub-Saharan Africa. The 
trypanosome mitochondrial respiratory system involved in energy production comprises of 
the five classical complexes (I-V); and in addition, a type 2 NADH:ubiquinone oxidoreductase, 
a glycerol-3-phosphate dehydrogenase and a trypanosome alternative oxidase. Some 
subunits for respiratory complexes I, III, IV and V are encoded in the kinetoplast DNA. T. brucei 
encodes genes for complex I; null mutants of complex I (cI) in monomorphic bloodstream form 
background and RNAi in procyclic cells have not shown any growth defects. Akinetoplastic 
stumpy cells have shorter life span which could be due to absence of mitochondrially encoded 
subunits and thus cannot express functional NADH dehydrogenase. Moreover, BF parasites in 
adipose tissue appear to upregulate pathway for beta-oxidation, which is expected to increase 
demand for NADH dehydrogenase activity. Little is known about the metabolism and 
bioenergetics of cI in stumpy forms. Mitochondrial activity changes across the life cycle stages 
of the parasite. The parasite life stages include slender and stumpy forms (found in the 
mammalian bloodstream) and procyclic form (found in the tsetse fly). The mammalian 
bloodstream stage parasite does not express respiratory complexes III and IV and generates 
most if not all ATP via glycolysis; the insect stage parasite generates most ATP mitochondrially. 
Thus, coordination of the expression patters for nuclearly and mitochondrially encoded 
respiratory chain subunits is essential for parasite life cycle progression. In organisms such as 
yeast, mammals and plants, ‘mitochondrial retrograde signalling’ pathways, including the 
‘unfolded protein response (UPRmt), convey information on the functional status of this 
organelle to the nucleus and modulate expression of nuclear genes accordingly. It is not 
known if similar signalling pathways exist in trypanosomes. 
This thesis investigated two questions: 




2. Does retrograde signalling pathway exists in T. brucei, lack of mitochondrial genome 
results in changes in nuclear gene expression?  
To address the first question, the goal was to generate genetic null mutants for key nuclearly 
encoded cI subunits (NUBM or NUKM) in pleomorphic (i.e. differentiation competent) 
Trypanosoma brucei brucei cell line EATRO 1125. Next, the ability of these knockout cell lines 
to differentiate and to reside in adipose issue would be monitored. Unfortunately, I could not 
generate a cI null mutant in pleomorphic background as I subsequently determined that the 
parental cell line used was not fully pleomorphic in mice. 
Even though the null mutant generated for complex I were not fully pleomorphic, I still 
investigated their survival in adipose tissue. Results showed that these null mutants were able 
to reside in adipose tissue. I further probed this by using pleomorphic cell lines devoid of 
mitochondrial DNA (akinetoplastic cell lines (AK)), which are also cI deficient as all seven 
mitochondrially encoded subunits of this complex are absent. These AK were able to 
differentiate in both blood and adipose tissue. The AK seems to present more in the adipose 
tissue when compared with the wild type. Coinfection with AK and WT together in mice 
showed that they both migrate from blood into adipose tissue. I observed that the ratio of 
WT/AK in blood is much higher than in adipose tissue. Moreover, blood/AT balance in AK is 
shifted towards AT, compared to WT. 
To explore potential retrograde signalling pathways in T. brucei, we compared the nuclear 
transcriptome of a wild type strain with an AK mutant, before and after differentiation from 
the slender to the stumpy form (a transitional stage on route to differentiation to the insect 
stage). This was done by RNA-sequencing. 
In WT and AK parasites, genes showed significant upregulation in stumpy forms (we 
considered a difference of  2-fold with a p-value  0.05 as significant) in comparison to WT. 
Most of these genes were hypothetical proteins. Genes involved in the glycolytic pathway 
were generally downregulated in stumpy cells. We also observed robust downregulation in 
stumpy cells of numerous histones and of two genes involved in kinetoplast maintenance, 
mitochondrial DNA ligase LIG k alpha (Tb927.7.610) and cysteine peptidase PNT1 
(Tb927.11.6550). Other changes in akinetoplastic stumpy cells concerned a hypothetical 
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protein (~3-fold upregulated) and a putative adenylosuccinate lyase (~3-fold downregulated), 
but overall, we observed only a limited number of robust changes (13 up, 9 down). 
This study suggests that the absence of the mitochondrial genome has a surprisingly limited 
effect on the levels of nuclearly encoded messenger RNA needed to make proteins in 
bloodstream stage of T. brucei. 
In summary, this will provide a comprehensive view of the potential effects of mitochondrial 
dysfunction on nuclear gene expression in these parasites. Also, my work will give 



















Trypanosomes are protozoan (single-cell) parasites of humans and livestock. They have a 
single mitochondrion called the kinetoplast, which is the cell component responsible for 
energy production. Trypanosoma brucei causes human African trypanosomiasis (sleeping 
sickness) and Nagana in animals, often lethal diseases transmitted by tsetse flies in sub-
Saharan Africa. The fly bites its host and sucks blood, and in the process, the trypanosome 
parasite within the fly’s saliva swims out and enters either the human or animal host. These 
parasites then swim into the host bloodstream, survive, grow and divide to produce many of 
its kind. Some of them are then taken up by a fly during feeding and transferred to a new host. 
This is the mechanism of spreading the disease. It has been difficult to cure this disease and 
stop its spread because there are only few drugs available to treat affected people. Moreover, 
there has been high rates of drug resistance which is very worrying.  
Mitochondrial respiratory complex comprises of five sub-complexes (I-V) which are involved 
in energy production. Some subunits for respiratory complexes I, III, IV and V are encoded in 
the kinetoplast DNA. T. brucei encodes genes for complex I; null mutants of complex I (cI) in 
monomorphic bloodstream form (BF) background and RNAi in procyclic cells have not shown 
any growth defects.  Akinetoplastic stumpy cells have shorter life span which could be due to 
absence of mitochondrially encoded subunits and thus cannot express functional NADH 
dehydrogenase. Moreover, BF parasites in adipose tissue appear to upregulate pathway for 
beta-oxidation, which is expected to increase demand for NADH dehydrogenase activity. Little 
is known about the metabolism and energy relationships and transformation of cI in stumpy 
forms. Mitochondrial activity changes across the life cycle stages of the parasite. The parasite 
life stages include slender and stumpy forms (found in the mammalian bloodstream) and 
procyclic form (found in the tsetse fly). The mammalian bloodstream stage parasite does not 
express complexes III and IV so generates most, if not all, its energy through the glycolysis (i.e. 
breakdown of food into energy). In organisms such as yeast, mammals and plants, 
‘mitochondrial retrograde signalling’ pathways convey information on the functional status of 
mitochondrion to the nucleus and modulate expression of nuclear genes accordingly. It is not 
known if similar signalling pathways exist in trypanosomes. 
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My thesis investigates how lack of a mitochondrial genome results in changes in nuclear gene 
expression to know whether retrograde signalling pathways exists in T. brucei. I compared the 
nuclear transcriptome of a wild type strain with strain without a kinetoplast, (AK) before and 
after differentiation from the ‘slender’ to the ‘stumpy’ form using RNA sequencing. In WT and 
AK parasites, genes showed significant upregulation in stumpy forms (we considered a 
difference of  2-fold with a p-value  0.05 as significant) in comparison to WT. Most of these 
genes were hypothetical proteins. Genes involved in the glycolytic pathway were generally 
downregulated in stumpy cells. 
Subsequently, my research explored to know the role that complex I plays in stumpy forms 
and/or in cells residing in adipose tissue, two cI subunit genes were knocked in cell line that 
can differentiate from slender to stumpy. Unfortunately, I could not generate a complex I null 
mutant in pleomorphic background as I determined that the parental cell line used could not 
differentiate. Even though the null mutant generated for complex I were not fully 
pleomorphic, I still investigated their survival in adipose tissue. Results showed that these null 
mutants resided preferentially in adipose tissue. I further probed this by using pleomorphic 
cell lines without mitochondrial DNA (akinetoplastic cell lines (AK)), which are also complex I 
deficient as all seven mitochondrially encoded subunits of this complex are absent. These AK 
were able to differentiate in both blood and adipose tissue. 
In summary, my work will give a comprehensive view of the potential effects of mitochondrial 
dysfunction on nuclear gene expression in these parasites. Also, showing that AK cells are able 
to differentiate and reside in adipose tissue will be a platform for further studies to be done 
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 A6       Subunit a of T. brucei F1Fo ATPase  
 AAC   ATP/ADP carrier 
AAT    Animal African Trypanosomiasis 
AK    Akinetoplastic  
ATF    Adipose tissue form 
ATOM    Archaic translocase of the outer mitochondrial membrane  
ATP    Adenosine triphosphate 
BARP    Bloodstream alanine-rich proteins (misnomer) 
BBB    Blood-brain barrier 
BSD    Blasticidin 
BLE    Phleomycin 
 BSA    Bovine serum albumin  
BSF       Bloodstream form  
bZip    Basic-leucine zipper  
cAMP     Cyclic adenosine monophosphate 
CCA    Cis aconitate/citrate  
CDK    Cyclin dependent kinases 
CKO    Conditional knock-out 
Cl    Complex I 
COX    Cytochrome oxidase subunit 
DAPI    4’, 6-diamidino-2-phenylindole 
DHAP    Dihydroxyacetone phosphate 
DK       Dyskinetoplastic 
E. coli      Escherichia coli 
EP    Glutamate-proline repeat containing protein 
ES    Expression site 
EtBr    Ethidium bromide  
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ETC    Electron transport chain 
FACS    Fluorescence activated cell sorting 
FAD    Flavin adenine dinucleotide 
 FAZ    Flagellar attachment zone 
FC    Fold change 
FCS    Fetal calf serum  
Fe/S    Iron sulfur centre  
FMN    Flavin mononucleotide 
G-3-P     Glyceraldehyde-3-phosphate  
G3PDH      Glycerol-3-phosphate dehydrogenase 
gDNA   Genomic DNA 
Gly-3-P      Glycerol-3-phosphate  
GPEET  Glycine-proline-glutamate threonine pentapeptide repeat-containing -
protein  
GPI    Glycosylphosphatidylinositol  
gRNA    Guide RNA  
HAT    Human African Trypanosomiasis  
HpHbR   Haptoglobin-haemoglobin receptor  
HPR    Haptoglobin-related protein 
Hyg    Hygromycin 
IFA    Immunofluorescence assay 
IM    Inner mitochondrial membrane 
kDNA     Kinetoplast DNA 
kDNA+   Cells retaining their kDNA 
L262P     Lysine to proline substitution at amino acid position 262 
LipDH     Lipoamide dehydrogenase  
MtDNA      Mitochondrial DNA 
NAD+     Nicotinamide adenine dinucleotide (oxidised)  
NADH     Nicotinamide adenine dinucleotide (reduced) 
NDH2     Alternative NADH dehydrogenase  
xii 
 
NECT     Nifurtimox-eflornithine combination therapy 
Neo    Neomycin 
OM    Outer membranes 
OSCP    Oligomycin sensitivity-conferring protein (misnomer) 
PAD1      Protein associated with differentiation 
PAGE    Polyacrylamide gel electrophoresis  
PCF       Procyclic form 
PCR    Polymerase chain reactions  
Puro    Puromycin 
PV    Proventriculus 
PVDF    Polyvinylidene fluoride 
qPCR    Quantitative polymerase chain reaction  
qRT-PCR     Quantitative reverse transcriptase-polymerase chain reaction 
RT-PCR   Reverse transcriptase Polymerase Chain Reaction 
RIT-seq   RNA interference target–sequencing  
RNAi    RNA interference  
S. cerevisiae   Saccharomyces cerevisiae 
SDS       Sodium dodecyl sulfate 
SIF    Stumpy induction factor 
SKO    Single knockout 
SL    Slender 
SS    Stumpy 
T.  b. gambiense  Trypanosoma brucei gambiense  
T. b. brucei   Trypanosoma brucei brucei  
T. b. equiperdum  Trypanosoma brucei equiperdum  
T. b. evansi   Trypanosoma brucei evansi  
T. b. rhodesiense  Trypanosoma brucei rhodesiense  
T. brucei   Trypanosoma brucei 
T. congolense  Trypanosoma congolense 
xiii 
 
T. vivax   Trypanosoma vivax  
TAC       Tripartite attachment complex 
TAO       Trypanosome alternative oxidase 
TCA    Tricarboxylic acid 
TLF    Trypanosome lytic factor 
TMD    Transmembrane domain 
UPRmt    Mitochondrial unfolded protein response  
UTR    Untranslated region  
VSG    Variable surface glycoprotein 
WHO    World Health Organisation 
WT    Wild type 
WTγ                                 Wild type with ATPase subunit γ  
γGS    Glutamate-γ-semialdehyde  
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1      Introduction 
1.1      Trypanosomes as a pathogen  
Trypanosomatid parasites cause several neglected tropical diseases globally, which put about 
half a billion people and over 60 million livestock at risk of infection (Fèvre et al., 2008a). 
These trypanosomatids include Leishmania spp., responsible for leishmaniasis; Trypanosoma 
cruzi, which causes Chagas disease mainly in Central and South America; salivarian 
Trypanosoma brucei, the cause of African trypanosomiasis in both humans and animals, 
including the subspecies T. brucei which cannot infect human but infects only livestock and 
wildlife; Trypanosoma vivax and Trypanosoma congolense, which causes disease in animals 
(Abdi et al., 2017; Meyer et al., 2016). It has been reported that T. vivax and T. congolense 
infections result in adverse effect on animal production and health deterioration in humans 
living in sub-Saharan Africa (Auty et al., 2015; Giordani et al., 2016; Morrison et al., 2016). 
These subspecies belong to the taxonomic order Kinetoplastida and phylum Euglenozoa. 
Moreover, they have a densely intercatenated network of circular DNA forming a major 
component of their mitochondrial genome which  characterises all kinetoplastids (Meyer and 
Porter, 1954; Steinert, 1960; Steverding, 2008).  
These organisms are biologically intriguing due to the vast differences in their molecular and 
cellular biology compared to other eukaryotes. In addition to its being an infectious pathogen, 
trypanosomes are intrinsically useful organisms for investigating many aspects of 
fundamental eukaryotic and kinetoplastid-specific cell biology. For example, T. brucei has 
become an attractive model to study the assembly and the functions of cilia and flagella 
(Santi-Rocca et al., 2015). Studying this parasite also helps to understand developmental 
regulation in trypanosomatids in general. T. brucei is amenable to reverse genetic 
approaches, such as gene knockout by homologous recombination, or RNA interference 
(RNAi)‐mediated downregulation of gene expression (Serricchio and Bütikofer, 2011). The 
energy metabolism of bloodstream of T .brucei serves as kinetic metabolic model in systems 







the GPI anchor, which were first discovered in African trypanosomes, has made these 
parasites an interesting model organism for these processes (Ferguson et al., 1988). 
 
1.1.1   Animal trypanosomiasis 
Animal African Trypanosomiasis (AAT) also known as Nagana, is spread by about 30 species 
of tsetse flies found in tropical Africa. Livestock breeders have indicated that the disease 
prevents sustainable farming in most parts of sub-Saharan Africa, thereby drastically reducing 
meat and milk production (http://www.fao.org) and necessitates constant administering of 
trypanocidal drugs. The disease causes US$4 billion in loss of crop and livestock production in 
sub-Saharan Africa (http://www.fao.org). Moreover, the disease retards usage of these 
animals for agricultural activities such as ploughing, thereby limiting food cultivation, local 
transport, and ultimately socio-economic development (Franco et al., 2014b; Meyer et al., 
2016). 
Nagana infection can either be acute or chronic, with the chronic infection being more 
common. The pathological symptoms associated with Nagana infection include: fever, 
emaciation, loss of hair, listlessness, discharge from the eyes, oedema, severe anaemia, and 
paralysis (Steverding, 2008). The reported incidence of Nagana may be affected by several 
factors such as accessibility of reservoir hosts, periodic seasons of the disease vector, flies’ 
behaviour in densely populated areas, the specificity and accuracy of analytical techniques, 
the infection phase, method of collecting specimen, and other human actions (Albert et al., 
2015; Majekodunmi et al., 2013; Odeniran and Ademola, 2018). For instance, Nagana 
infection is rampant in Nigeria because about 80% of the nation’s landforms are populated 
with tsetse flies (Anene et al., 1991; Odeniran and Ademola, 2018). Despite the disease 
prevalence in tropical Africa, the method of diagnosing Nagana infection is mostly 
rudimentary.  
Identification of the parasite using reliable diagnostic tools underpins efficient control of the 







parasites via the use of a microscope, even though the technique is extremely insensitive 
(Takeet et al., 2013).  
Currently, researchers have adopted the use of polymerase chain reaction, serological testing 
and immunodiagnostic techniques to improve diagnostic efficiency of the disease 
(Majekodunmi et al., 2013; Odeniran and Ademola, 2018). Efficient eradication of the disease 
could be boosted by adopting the use molecular methods to diagnose Nagana infection.  
Recently, the first-line drug for treatment of late-stage animal trypanosomiasis is organo-
arsenical tryparsamide combined with suramin (Steverding, 2008). Drugs originally used for 
treatment of Nagana infection were phenanthridines homidium bromide (also known as 
ethidium bromide), isometamidium chloride, quinapyramine and aromatic diamidine 
diminazene aceturate (Dolan et al., 1990; Kinabo, 1993). Resistance to these drugs have led 
to an extensive spread of the disease within sub- Saharan Africa (Chitanga et al., 2011). In 
addition to chemotherapy, control of the vector is another effective way of controlling the 
disease (subsection 1.1.3 of Chapter 1). 
 
1.1.2   Human African trypanosomiasis 
Human African trypanosomiasis (HAT) is recognized as a serious public health concern. It is 
classified by the WHO as a neglected tropical disease that is caused by two subspecies of the 
protozoan parasite T. brucei: T. b. rhodesiense and T. b. gambiense. The distribution of African 
trypanosomes is restricted to 36 countries in sub-Saharan Africa. The epidemiology of the 
disease is determined by the distribution of the vector (tsetse fly), with over 95% of cases 
attributed to T. b. gambiense infection and the remaining 5% to T. b. rhodesiense infection 
(Franco et al., 2014a). A number of epidemics of the disease have occurred during the 20th 
century, resulting in the death of approximately 700,000 natives of Africa. In response to 
these epidemics, surveillance of affected individuals and control of the disease vector have 







In 2017, the number of new cases of HAT reported to WHO was reduced to about 1500 (WHO, 
2017) compared with 11,382 cases reported in 2006 (Fèvre et al., 2008b). 
HAT is usually fatal when left untreated. The disease can be divided into two clinical stages, 
correlating with the location of the parasite and the associated symptoms: the early 
haemolymphatic stage and the later neurological stage. In the early stage of the disease, 
symptoms include intermittent fever, headache, severe itching of the skin (also known as 
pruritus), adenopathy, swollen lymph nodes and joint pain. The central nervous system (CNS) 
stage of the disease is accompanied by neurological symptoms including mental and sleep 
anomalies (Kennedy, 2004). The sleep anomalies indicate that sleeping sickness may be a 
circadian clock rhythm disorder (Rijo-Ferreira et al., 2018). Countries such as Uganda, Malawi, 
Nigeria, Cameroon, Kenya and Ghana have fewer cases of trypanosomiasis due to provision 
of funding for surveillance, drug donations by pharmaceutical companies and implementation 
of control programs (Simarro et al., 2008). In 2013, the World Health Organization and the Bill 
and Melinda Gates Foundation agreed to implement novel surveillance policies to reduce 
disease caused by T. b. gambiense (WHO, 2013). 
Previous studies have found that T. b. rhodesiense occurs in Southern and South-Eastern 
Africa and is associated with acute disease (as described in the haemolymphatic stage of the 
disease) in humans. T. b. gambiense is found in West and Central Africa and causes chronic 
disease, which is associated with persistent or otherwise long-lasting neurological disorder in 
humans (Goodhead et al., 2013; Pays and Vanhollebeke, 2009; Simarro et al., 2011). 
Trypanosomiasis occurs in humans when the host immune system is incapable of eliminating 
the parasite infection because of rapid parasite growth and parasite antigenic variation (Horn 
and McCulloch, 2010). In mouse models, trypanosomes have been shown to sequester in 
tissues or organs (Capewell et al., 2016; Trindade et al., 2016). 
Ultimately, these phenomena result in evasion of the host immune system by the parasite 
and concomitant parasitaemia waves, thereby serving as a vital survival strategy for the 







MacGregor et al., 2011). The mechanisms for parasite evasion and survival is described in 
section 1.2.1 of Chapter 1. 
 
1.1.3   Vector control 
Tsetse flies, of the genus Glossina, are the vectors that harbour and transmit the trypanosome 
parasite. A better comprehension of the complex biology and mitochondrial oxidative 
regulation processes within the parasite is essential for development of Trypanosomatid-
targeting chemotherapy (Menna-Barreto and de Castro, 2014). 
Tsetse flies are categorised into three main taxonomic groups: morsitans, palpalis and fusca, 
depending on their habitation, preference of host and morphology of external genitalia 
(Vreysen et al., 2013). Out of these groups, palpalis and morsitans are of economic 
importance since they transmit most cases of African animal and human trypanosomiasis 
(Esterhuizen et al., 2011; Vreysen et al., 2013). Flies belonging to the palpalis group transmit 
about 90% of HAT cases, whiles palpalis subspecies are known for transmission of animal 
trypanosomiasis in western and central Africa (Esterhuizen et al., 2011; Omolo et al., 2009). 
The morsitans group on the other hand transmits both HAT and AAT in southern and eastern 
Africa (Vreysen et al., 2013). These insects are expanding their geographical coverage in 
search for food, to boost reproduction, in search for a new niche to evade eradication, or 
migrating from treated regions to colonise an untreated area and migration driven by climate 
change (Cuisance et al., 1984; Getahun et al., 2014; Moore et al., 2012). 
Tsetse fly vector control is considered an appropriate way of controlling trypanosomiasis 
(Bouyer et al., 2010). The use of genetics techniques to understand and quantify gene flow 
among subpopulations of tsetse flies can be used to control fly population.  Techniques 
employed to control the vector include the use of biconical traps, targets impregnated with 
insecticide, progressive airborne spraying, and male insect sterility (Joja and Okoli, 2001; Kgori 
et al., 2006; Vreysen et al., 2000). Alternative approaches include the use of electric nets to 







2003). The latter technique attempts to reduce the competence of vectors to sustain and 
transmit disease by expressing parasite inhibitory molecules in the vector symbiont. Tsetse 
species belonging to the morsitans group are receptive to host odours, such that targets and 
traps treated with insecticide or baits containing artificial mixtures of these odours can 
control these tsetse populations (Vale et al., 1988). The chemicals used to attract morsitans-
group tsetse are ineffective when used on Palpalis-group species of tsetse (Green, 1994). 
 
1.1.4   Diagnosis and current therapy for HAT  
The HAT disease is diagnosed primarily through usage of the card agglutination test for 
trypanosomiasis (CATT), which is a serological screen for antibodies produced in response to 
one of the many trypanosome’s surface antigen types (Checchi et al., 2011). The sensitivity of 
CATT is highly variable, and complete diagnosis requires identification of parasites in either 
the lymph or blood using a compound microscope (Chappuis et al., 2005). The choice of drug 
for treatment of the disease is dependent on the stage of infection. Parasite identification via 
lumbar puncture is critical for diagnosing the second stage of the disease (Bonnet et al., 2015). 
T. b. rhodesiense and T. b. gambiense are morphologically identical to each other even though 
they have separate geographical locations.  
In case of suspected co-infection with both parasites, microscopy and other simple techniques 
are less efficient in diagnosis and more advance techniques are required. For example, the 
genes encoding serum resistance-associated (SRA) protein is present only in the genome of 
T. b. rhodesiense but not  T. b. gambiense and  T. b. brucei (Radwanska et al., 2002); thus 
detection of this gene by molecular techniques is the preferred diagnostic approach. There 
are only few available active drugs for the treatment of HAT.  
Pentamidine, Suramin, Eflornithine and Melarsoprol, although a fifth, Nifurtimox, is 
increasingly used in combination with Eflornithine. These drugs are associated with toxicity 









Figure 1.1  Drugs currently licensed for use against HAT. Figure generated from data gathered in 
(Blum et al., 2001; Burri and Blum, 1996; Coulaud et al., 1975). 
 
The nifurtimox-eflornithine combination therapy (NECT) was introduced in 2009. NECT is 
ineffective against T. b. rhodesiense infections (Stich et al., 2013). Despite the high risk 
associated with this drug, it is still used for treatment of HAT since the disease will always lead 
to death if left untreated. Therefore, there is an urgent need to discover new medications 










1.1.5   Drug resistance  
T. brucei is capable of developing resistance to drugs through genetic mutations. Resistance 
has been recorded against all available drugs, even though the mechanisms underlying 
resistance to all these drugs is yet to be fully understood.  Melarsoprol and pentamidine 
resistance is known to be caused by point mutations in TbAT1, a purine nucleoside 
transporter, and TbAQP2, an aquaporin. The loss of TbAT1 does not solely account for the 
high level of resistance to melarsoprol and pentamidine (Stewart et al., 2010). Moreover, 
deletion or rearrangements of TbAQP2 has been found to be present in strains resistant to 
both drugs (Munday et al., 2014). The AQP2 protein mediates high affinity drug uptake and is 
a genetic marker for predicting drug-resistant strains of trypanosomes (Fairlamb and 
Patterson, 2018). 
The loss of a single non-essential amino acid within the transporter gene, TbAAT6, in 
genetically modified cell lines was shown to be a consequence of eflornithine resistance 
(Vincent et al., 2010). TbAAT6, an amino acid transporter, controls the uptake of eflornithine. 
Gene deletion causes drug resistance, and re-expression of the gene causes restoration of 
sensitivity to eflornithine (Vincent et al., 2010). 
Due to the privatization of veterinary services in most parts of Africa, farmers can easily access 
these drugs; and hence misuse has led to drug resistance (Delespaux et al., 2008, 2002; Van 
den Bossche et al., 2000). Resistance to these drugs has been reported in many countries, 
especially within the endemic areas (Delespaux and de Koning, 2007; Tchamdja et al., 2017).  
Suramin resistance is linked to expression switch of one of the VSG (Wiedemar et al., 2018). 
The invariant surface glycoprotein, ISG75, shows reduction of T. brucei susceptibility to 
suramin when genome-scale RNA interference (RNAi) target sequencing (RIT-Seq) screen was 
performed (Alsford et al., 2013, 2012). 
New therapies that are safer and easier to administer is needed to minimise the side effect of 
drug toxicity of the current trypanocides. At present, there are no existing vaccines for the 







model organism for the study of trypanosomiasis (La Greca and Magez, 2011). The use of non-
pathogenic trypanosome species is also being explored as a possible vaccine. These non-
pathogenic trypanosomes are being manipulated to serve as vehicles for establishing an 
immune response to specific antigens, or as delivery vehicles for therapeutics (Mott et al., 
2011). The available drugs for treating the disease are associated with poor efficacy, major 
side effects and increasing levels of resistance (Fairlamb et al., 2016).  
Recently, West and colleagues reported three novel and versatile approaches for synthesizing 
ascofuranones, which together with the structure-activity relationship, resulted in improved 
yields compared to previous synthetic approaches. These novel synthetic methods also 
allowed late stage modification of the crucial aromatic head group of ascofuranone, which is 
responsible for enzyme-compound affinity and the non-drug-like functionality of the 
compound (West et al., 2017). From a library of oxaboroles, the benzoxaborole 6-
carboxamides were particularly active against T. brucei and following a lead optimization 
programme, SCYX-7158 was selected as a clinical candidate for HAT (Jacobs et al., 2011). 
Benzoxaboroles, which are boron-containing compounds, have been reported as potential 
drugs against several diseases caused by viruses, fungi, bacteria and parasites (Goldstein et 
al., 2013; Mahalingam et al., 2011; Markham, 2014; Zhang et al., 2015). In the case of HAT, 
the two compounds currently in clinical trials, fexinidazole and the oxaborole SCYX-7158, 
were both derived from phenotypic approaches (Field et al., 2017). In general, oxaboroles 
have demonstrated to be potent against all T. brucei subspecies, with low potential for 
cytochrome P450 CYP450 inhibition and high permeability (Nare et al., 2010). The oxaborole, 
SCYX-7158, which is an orally active benzoxaborole, is also effective, safe and active for 
treatment of stage 2 HAT (Jacobs et al., 2011). The phase I clinical study with SCYX-7158 for 
treatment of human African trypanosomiasis was completed in 2015, and the phase II/III trial 
started in 2016 (Carneiro et al., 2017). 
Extracts from plant sources are also sources of bioactive molecules with novel 
chemotherapeutic potentials against trypanosomes. Notably, extracts from plants which 







against the bloodstream form of T. brucei. Plants that have produced antitrypanosomal 
extracts include: Alnus rubra, Hoita macrostachya, Salvia spathacea, Sabal minor, 
Ribes montigenum, Quercus alba, Leea rubra, Coccoloba pubescens, Rhus integrifolia 
and Nuphar luteum. It is anticipated that further studies with these extracts would provide 
novel compounds that are useful for treatment of HAT (Jain et al., 2016). 
 
1.2   Cell biology of T. brucei 
The biology of trypanosomes is beginning to unveil the links between the structure 
of the genome and the understanding of the parasitology of trypanosomes (Daniels et al., 
2010). The  study of the various aspects of the parasite’s cell biology include structure and 
morphology of the cell, positioning of the organelles, cell division and transfer of protein 
across the cell to other organelles (Matthews, 2005). There are several examples of 









Figure 1.2. Schematic of the cellular architecture of T. brucei (Matthews, 2005). 
 
Trypanosomes use hydrodynamic flow to eliminate surface bound immunoglobulins in order 
to increase cell survival and disease transmission (Engstler et al., 2007). The surface of the 
parasite is covered by variant surface glycoproteins (VSG) that act as a blockade to the 
alternative pathway of complement (Ferrante and Allison, 1983) and also allows the parasite 
population to evade host immunoglobulins by antigenic variation (Schwede and Carrington, 
2010). This precludes the development of vaccines against HAT and thus chemotherapy 
remains the only option for disease intervention. It has been shown that the trypanosome 
surface coat proteins undergo antigenic variation via expression of only one of the pool of 







Trypanosomes also use the haptoglobin-haemoglobin receptor (HpHbR) protein, which binds 
haptoglobin-haemoglobin complexes, to acquire haem from their host  (Lane-Serff et al., 
2016). 
In human blood, two complexes of lipid-rich particles called trypanosome lytic factors (TLFs) 
1 and 2 contain a lipid-binding protein, apolipoprotein L1 (ApoL1) and haptoglobin-related 
protein (HPR), which binds haemoglobin (Raper et al., 1999; Thomson et al., 2009). According 
to Pays (2014), the uptake of TLF-1 into T. b. brucei via parasite haptoglobin-haemoglobin 
receptor (HpHbR) causes their lysosome to swell when ApoL1 is released into the lysosome 
and embeds in the membrane, ultimately leading to lysis of T. b. brucei. However, the 
mechanism of T. b. brucei death by TLFs is not clear at the molecular level. Trypanosoma 
brucei gambiense and Trypanosoma brucei rhodesiense are the only two subspecies that 
counteract the effect of trypanolytic factors, and hence can cause Human African 
Trypanosomiasis (Pays et al., 2014; Vanhamme et al., 2003). 
 
1.2.1   The life cycle of T. brucei 
T. brucei survives extracellularly, in the mammalian bloodstream, and within the tissues. The 
parasite is transmitted by tsetse flies. Vector-transmitted pathogens acclimatise to periodic 
changes in their environment in order to survive the drastic change in environmental 
conditions during their life cycle (Figure 1.3) (Silvester et al., 2017). Like other eukaryotic 
parasites, T. brucei encounters different surroundings as they migrate between the 
mammalian host and the tsetse fly. Therefore, these parasites undergo differentiation, when 
necessary, to facilitate survival and transmission. This involves modulation of gene 
expression, as well as immunological, metabolic and morphological changes that are 









Figure 1.3.  The life cycle of Trypanosoma brucei. The cyclic events of the T. brucei life cycle. (1) T. 
brucei stumpy forms ingested from an infected mammalian host differentiate to procyclic cells within 
the midgut of the tsetse fly. (2) Procyclic cell body and flagellum are continuously elongated further 
the midgut to assume the mesocyclic form. (3) Following differentiation, the mesocyclic forms migrate 
to the proventriculus. (4) The epimastigotes undergo further differentiation into metacyclic cells, 
which is the infective stage in the salivary gland. (5) Metacyclics are transferred to a mammalian host 
by the tsetse fly during a blood meal and differentiate to bloodstream forms in the new host. (6) The 
stumpy form of T. brucei must survive a reasonable duration of time in the bloodstream of the 
mammalian host in order to be transmitted. The parasite must also survive within the tsetse midgut 
to enable differentiation, which is essential for establishing infection. Image adapted from (Silvester 











1.2.2   Bloodstream form stages 
In the bloodstream of mammalian hosts, parasites are routinely attacked by the host immune 
system to control possible infection. Trypanosomes have various strategies of evading the 
host defence mechanisms. These include auto regulation of parasitaemia and antigenic 
variation. Antigenic variation involves consecutive expression of discrete VSGs, which are 
linked to the surface membrane of the parasite by a glycosylphosphatidylinositol (GPI) anchor 
(Pays et al., 2004). There are approximately 20 VSG expression sites in the genome of T. 
brucei (Gottesdiener et al., 1991). VSG is the main surface protein that protects other surface 
proteins from detection by the host’s immune system. This is due to a rapid turnover of the 
surface VSG, which is aided by motility of the parasites. 
Slender forms of the parasite evade the host immune response by switching the expression 
of VSG coat (Horn, 2014; MacGregor et al., 2011; Vickerman, 1978). Even though the 
repertoire of potential VSG genes and pseudogenes is over 1000 (Berriman et al., 2005), only 
one VSG is expressed, at any time per cell (Callejas et al., 2006; Hertz-Fowler et al., 2008), 
with antigenic variation occurring either by a new VSG gene recombining with the expressed 
VSG gene or by activation of another VSG expression site (ES) (Cross et al., 1998; Vanhamme 
et al., 2001). 
A switch in the expression of a specific VSG can be facilitated by either gene conversion, 
telomere exchange or dynamic expression site switching (Horn and Cross, 1997; Taylor and 
Rudenko, 2006). The frequency of occurrence of switches in the expression of VSG genes 
ranges from 2.2 × 10−7 to 2.6 × 10−6, in vitro, in T. brucei (Lamont et al., 1986). Recognition of 
antibodies by the VSG triggers a lytic response in the slender forms and stumpy forms, though 
stumpy forms are relatively resistant (Amiguet-Vercher et al., 2004).  
In the bloodstream of the mammalian host, the cell population cycles between proliferative 
slender bloodstream forms, the intermediate forms and the cell cycle-arrested (G0/G1) 







The slender forms respond to a signal molecule, known as the stumpy induction factor (SIF), 
which is released constantly by the parasite. SIF accumulates with increase in the population 
of the slender forms, thereby triggering differentiation of slender forms to stumpy cells 
(Vassella et al., 1997). 
Growth is halted in stumpy cells as parasitaemia peaks, and hence prolong infection by 
preventing further increase in parasitaemia. Stumpy forms dominate the late stage of 
infection and they do not switch their VSG. As a result, the host immune system can clear the 
infection since stumpy forms have a limited lifespan (Dewar et al., 2018). Because all the 
parasite population do not undergo differentiation, the few slender bloodstream forms that 
are able to switch their VSG evade immune clearance and proliferate to initiate repeat waves 
of infection.  
In the laboratory, the strains that can undergo differentiation from slender to stumpy forms 
are called pleomorphic. Monomorphic slender bloodstream forms are generated through a 
series of in vivo or in vitro passages, rendering them unable to differentiate to stumpy forms. 
These monomorphic cells are virulent and lethal to the host (Ashcroft, 1960; Turner, 1990). 
Unlike pleomorphic slender forms, monomorphic cells are unable to sense the presence of 
SIF (Vassella et al., 1997). 
Even though monomorphic trypanosomes respond ineffectively to SIF in vivo, they could be 
exposed to cell-permeable cAMP and AMP analogues, that bypass SIF signalling, to generate 
a ‘stumpy-like’ forms in vitro (Breidbach et al., 2002, 2002; Vassella et al., 1997). Surprisingly, 
the identity of SIF remains unknown (MacGregor et al., 2011; Vassella et al., 1997). As a 
consequence of the signal, mRNA expression of PAD proteins, encoding carboxylate 
transporters, increases once the parasites are committed to differentiation and have 
undergone cell cycle arrest (Dean et al., 2009). Genome-wide RNAi screening has been used 
to demonstrate that several RNA binding proteins, kinases and phosphatases are involved in 








1.2.3   The insect stages 
Following ingestion, the stumpy form of trypanosomes adapts and differentiates into an 
‘early’ procyclic form in the tsetse fly midgut (Vassella et al., 2000) (figure 1.3). Many factors 
can influence the success of transmission from the mammalian bloodstream to the midgut of 
the insect. These factors include the age of the fly, number of previous blood meals of the fly, 
the tsetse immune response and gut conditions (Dyer et al., 2013). Trypanosomes are 
exposed to different temperature conditions between the mammalian host and the tsetse fly 
vector. 
The temperature within the mammalian bloodstream is 37 °C, whereas tsetse flies survive at 
an optimum temperature of approximately 27 °C. In the evenings, and at dawn, flies are 
exposed to lower temperatures (approximately 20 °C) during the uptake of their blood meal 
(Makumi et al., 1998). The PAD1 protein is involved in citrate cis-aconitate (CCA)-mediated 
differentiation, which is upregulated in stumpy forms; the PAD2 protein is elevated at low 
temperatures and it potentially signals the initiation of differentiation stimulated by blood 
citrate (Dean et al., 2009). The addition of 6 mM citrate/cis-aconitate to SDM79 culture 
medium can also drive in vitro differentiation of stumpy to procyclic  forms at 27 °C (Brun and 
Schonenberger, 1981; M. Engstler and Boshart, 2004). 
The intracellular signalling pathway that responds to cis aconitate/citrate (CCA) has been 
deduced. TbPTP1, a protein phosphatase, acts downstream of PAD1 to prevent differentiation 
of stumpy forms to the procyclic form whilst in the bloodstreams (Szoor et al., 2006). In the 
presence of CCA, T. brucei phosphotyrosine phosphatase (TbPTP1) is inactivated, and leads to 
phosphorylation and activation of its substrate called PTP1-interacting protein (TbPIP39), 
which is trafficked to the glycosome to initiate differentiation.  
In addition to expression of PAD proteins, stumpy forms of T. brucei show upregulation of the 
nucleoside transporter 10 gene (TbNT10 ) (Sanchez et al., 2004). T. brucei is incapable of 
synthesizing purines de novo, and thus depends on transport of purine nucleosides across the 







of TbNT10 may promote transformation to procyclic forms in the tsetse fly (Sanchez et al., 
2004). Moreover, RNA-Seq analysis has shown upregulated expression of adenylate cyclases 
in stumpy forms (Naguleswaran et al., 2018), as well as 12 additional genes that encode 
components of the inositol metabolic pathway (Cordeiro et al., 2017). Lipoamide 
dehydrogenase (LipDH) also shows increased activity in the stumpy form (Tyler et al., 1997) 
and can be used to detect differentiation in stumpy form. Indeed, the stumpy surface 
receptor marker PAD1, which is expressed exclusively in stumpy forms (Dean et al., 2009), 
and a secretory protein called expression site associated genes (ESAG9) (Monk et al., 2013), 
are the markers used in this project to confirm differentiation from slender to stumpy forms. 
In addition to exposure to CCA, differentiation from stumpy forms to procyclic forms can be 
stimulated in various ways, in vivo. For instance, digestive proteases within the midgut of the 
fly have been shown to induce differentiation into the procyclic forms, in vitro (Aksoy et al., 
2003; Yabu and Takayanagi, 1988). Stumpy forms can tolerate a constant cytoplasmic pH of 
6.9, which is encountered within the protease-rich environment of the midgut. In Leishmania 
and T. cruzi, acidic stress can contribute to differentiation of promastigotes into amastigotes 
in vitro and in vivo (Bates et al., 1992). Similarly, mild acid treatment can stimulate the 
differentiation of stumpy forms to procyclic forms (Rolin et al., 1998) the signalling pathway 
underlying the acid-mediated differentiation of stumpy forms is shared with the CCA-based 
signalling (Szoor et al 2013).  
Within the third day of post infection, procyclic forms are found in the ectoperitrophic space, 
and by the sixth day, they migrate through the proventriculus (PV) to the anterior of the gut 
(Sharma et al., 2009).  
Subsequently, mesocyclic trypomastigotes emerge, and are usually mobile because they 
possess long flagella. In the lumen of the PV, the mesocyclic trypomastigotes initiate 
differentiation into epimastigotes, with a concomitant reversal of the positions of the 
kinetoplast and nucleus (Sharma et al., 2008). Long epimastigotes divide asymmetrically into 








The epimastigotes that are attached to the epithelium of the salivary glands undergo 
proliferation and colonise the salivary gland (Sharma et al., 2009). These epimastigotes 
undergo a subsequent division into trypomastigotes and finally to metacyclics (Rotureau et 
al., 2012). The cell cycle-arrested forms can be injected into the mammalian host upon a 
tsetse bite, where they differentiate to slender forms to complete the life cycle. 
The surface proteins of the forms found in the fly stages can be used as differentiation and 
stage-specific markers. For example, in procyclic forms the VSG-coat is substituted with the 
surface glycoproteins, glutamate-glutamate-threonine repeat containing protein (GPEET) and 
glutamate-proline repeat (EP) procyclin (Ruepp et al., 1997). Three forms of closely-related 
EP procyclin (EP1-1, EP1-2, EP1-3) exhibit similarity across their entire coding regions but have 
distinct 3′ UTRs (Vassella et al., 2001a). The EP procyclin is usually found in the midgut and 
the proventricular stages. ‘Early’ (which express GPEET predominantly) and ‘late’ (which 
express EP predominantly) procyclic forms can be sustained in culture, in vitro.  
Moreover, addition of glycerol to the culture medium extends GPEET expression, which upon 
removal, results in the cells undergoing a temporal growth arrest and suppression of GPEET 
expression (Vassella et al., 2000). GPEET-negative cells can re-express GPEET in glucose-
depleted culture medium, or spontaneously, without glycerol induction (Morris et al., 2002; 
Vassella et al., 2004). An alanine-rich protein (BARP) is expressed exclusively by epimastigotes 
in the salivary glands (Urwyler et al., 2007).  
VSG is expressed on the metacyclic forms which enables them to be resistant to existing 
humoral immunity to VSGs (Barry et al., 1998) and complement activated by the alternative 
pathway. 
 
1.2.4   The cell cycle of T. brucei 
The mitotic cell division cycle in eukaryotes is a conserved process whereby a cell duplicates 







and degradation, as well as activation and silencing of regulatory proteins, regulate the 
sequential events that must occur for cell division to proceed properly (Crozier et al., 2018). 
The trypanosome cell division cycle is divided into four sequential stages: Gap 1 (G1), where 
metabolic changes prepare the cell for division; DNA synthesis (S), where nuclear and 
kinetoplast DNA are replicated; Gap 2 (G2), where metabolic changes gathers cytoplasmic 
materials required for mitosis and cytokinesis; and mitotic (M) phase, where replicated DNA 
separates into the daughter cells. These events occur once per cell cycle in the described 
sequential order (Elledge, 1996). This requires coordination between the cell cycle and the 
parasite life cycle regulation (Matthews and Gull, 1994a) (section 1.3 of this thesis). 
Kinetoplast DNA replication initiates prior to nuclear DNA replication in S phase. Thus, at the 
onset of the G1 phase of the cell cycle, each  cell has a single kinetoplast and nucleus (1K1N) 
(Woodward and Gull, 1990).  
The cell cycle regulatory machinery of T. brucei has some similarities and differences with 
other eukaryotic organisms. The genome of T. brucei consist of genes encoding several cyclins 
and Cdc2-related kinases (CRKs) (Elledge, 1996), which are essential for the cellular changes 
occurring between the G1/S and G2/M-phases (Hammarton et al., 2004; Tu and Wang, 2004). 
The spindle assembly checkpoint, which is important for cell division in other eukaryotes, is 
yet to be identified in trypanosomatid species (Hammarton, 2007; Li, 2012).  
Since trypanosomes comprise several  single-copy organelles such as the basal body, the 
flagellum, the mitochondrion and the kinetoplast (mitochondrial DNA), organelle replication 
and segregation must be tightly regulated and integrated in the cell cycle (Steinert and Van 
Assel, 1967). 
During the G1 phase, eukaryotic cells respond to environmental cues, which determine 
whether to multiply, differentiate or go into quiescence. Current data suggest that 
trypanosomes regulate G1 phase progression through different mechanisms (Hammarton, 
2007). For example, T. brucei lacks receptor-linked tyrosine kinases and G-protein coupled 
receptors. Additionally, the organism has only one phosphoinositide 3-kinase (Vps34), which 







However, the CRKs (cyclin-related kinases) are required for progression through G1 phase in 
(Hall et al., 2006). 
During the nuclear S-phase, the replicated mitochondrial genomes segregate into two 
kinetoplasts (generating a 2 kinetoplast, 1 nucleus, ‘2K1N’, configuration of DNA containing 
organelles). The basal body extends and develops a new daughter basal body close to the 
existing basal body (Sherwin and Gull, 1989). A new flagellum also begins to obtrude from the 
daughter basal body, extending within the flagellar pocket (Lacomble et al., 2010) and then 
externally. Bloodstream forms have no flagellar connector (a structure in procyclic forms that 
tethers the flagellar tip along the cell body as it extends; Moreira-Leite et al., 2001), thereby 
allowing flexibility for growth to occur (Briggs et al., 2004). The binding of the flagellum 
attachment zone (FAZ) between the flagellar tip and the base of the flagellum causes a 
relocation of the daughter basal body to the posterior of the cell. 
The relocation event is also influenced by growth and movement of the daughter flagellum 
(Absalon et al., 2007). Segregation of the kinetoplast is aided by the connection of basal 
bodies to the kDNA by the tripartite attachment complex (TAC; Ogbadoyi et al., 2003); the 
movement is driven by migration of the basal body (Robinson and Gull 1991). 
Transition to the G2/M phase in T. brucei is controlled by the mitotic cyclin dependent kinases 
(CDK). This is performed by the cyclin related kinase (CRK3), which is homologous to the 
mammalian CDK1. Formation of a complex between CRK3 and the cyclin-like gene, CYC6, 
ensures initiation of mitosis (Li and Wang, 2003; Tu and Wang, 2004). Cells in G2 phase have 
2K1N due segregation of the replicated kinetoplast, but not the nuclear DNA. Progression to 
the M phase causes segregation of chromosomal DNA (Sharma et al., 2008). After mitosis, 
and just prior to cytokinesis, the cells  contain two kinetoplasts and two nuclei (2K2N; 
Woodward and Gull, 1990). 
Cytokinesis occurs following cleavage at the anterior end (Kohl et al., 2003), which progresses 
towards the posterior end between the two flagella (Vaughan and Gull, 2003). In the procyclic 







KKNN (Briggs et al., 2004). Cellular checkpoints exist in the bloodstream forms and procyclic 
forms to ensure that mitosis will only take place after the nucleus has undergone S phase; 
however, cytokinesis can occur in the absence of mitosis, generating anucleate cytoplasts 
(‘zoids’;) (Robinson et al., 1995). 
There does not, however, appear to be a mitosis-dependent cytokinesis checkpoint in 
trypanosomes, with cytokinesis progressing even if mitosis fails (Ploubidou et al., 1999; 
Robinson et al., 1995). The mechanism controlling coordination between DNA duplication and 
segregation is not well understood. Specifically, change in a single amino acid in the nuclearly 
encoded F1FO–ATPase subunit γ can compensate for complete loss of kDNA in the 
bloodstream form of T. brucei (Dean et al., 2013). The ATP synthase γ mutation that 
compensates for kDNA loss in bloodstream forms is not able to compensate for kDNA loss in 
procyclic forms.  
This observation precludes a potential kDNA replication checkpoint for cell cycle completion, 
suggested by (Ploubidou et al., 1999), but indicates that the checkpoint is DNA independent, 
perhaps being enacted at the level of the basal bodies. Pleomorphic T. brucei with and without 
kDNA (selected after expressing mutant γ in strain AnTat1.1 90:13) can also differentiate to 
stumpy forms. However, these akinetoplastic cells showed a decreased lifespan, suggesting a 
critical role for a kDNA-encoded product in stumpy form (Dewar et al., 2018). These 











Figure 1.4. Cell cycle showing the major morphological events of T. brucei procyclic forms. (a)The 
trypanosome cell cycle categorised under nuclear and kinetoplast components of DNA replication (S). 
Kinetoplast DNA replication initiates before nuclear DNA replication. The latter is relatively shorter 
and is followed by kinetoplast segregation (D), which preceed nuclear mitosis (M).  ‘A’ refers to the 
‘apportioning’ phase during which basal bodies move away from each other. (b) Schematic 
representations of the formation of daughter cells through the cell cycle. The black arrow indicates 
the direction and position of the cleavage groove (McKean, 2003). 
 
1.2.5   Glycosomes  
Glycosomes are peroxisome-like organelles found in trypanosomatids. They are responsible 
for sequestering enzymes needed for - oxidation of fatty acids, lipid biosynthesis and purine 
salvage. Also, most enzymes involved in the glycolytic pathway are found within the 
glycosome, even though other organisms have these enzymes localized within the cytosol 







T. brucei has a range of proteins which are used for preserving the glycosome population to 
maintain a well-organized energy production system (Furuya et al., 2002; Michels et al., 
2006). Glycosomes are indispensable for survival of the parasite. The composition of 
glycosome is dependent on the life cycle of the parasite. For the bloodstream form of the 
parasite, ATP is generated solely by glycolysis, the components of which comprise 
approximately 90% of glycosomal proteins (Haanstra et al., 2016). On the contrary, the 
procyclic forms of the parasite generate ATP via glycolysis in the presence of glucose, but 
switches to amino acid-based metabolism in the absence of glucose (Lamour et al., 2005). 
Unlike the bloodstream forms, procyclics have a fully functional mitochondrion and specific 
proteins which are involved in the production of ATP (details on ATP production by the 
mitochondrion is provided in section 1.3.5). Moreover, activation and upregulation of the 
mitochondrion in the procyclic form are relevant for metabolism of proline and threonine, 
the electron transport chain and the tricarboxylic acid (TCA) cycle (Haanstra et al., 2016; 
Misset et al., 1986). 
 
1.2.6   Gene Expression 
Gene expression is regulated at different stages, which includes transcription, mRNA stability, 
translation and protein stability (Jeacock et al., 2018). T. brucei is an interesting model 
organism for studying gene expression because of the presence of GT-rich RNA polymerase II 
(pol-II) promoters, which are responsible for driving constitutive polycistronic transcription. 
However, they lack regulators of RNA polymerase II promoters for protein-coding genes 
(Wedel et al., 2017).  
Unlike other eukaryotes, where RNA polymerase I solely transcribes ribosomal RNA (rRNA), 
in T. brucei this enzyme also transcribes genes encoding the variant surface proteins of the 
bloodstream forms and the procyclin genes of procyclin forms of the parasite (Günzl et al., 
2003). Most protein-encoding genes in kinetoplastids are arranged as polycistronic units of 







(Martínez-Calvillo et al., 2003). Mature mRNA is generated via post-transcriptional 
processing, including trans-splicing (Liang et al., 2003).  
 Trypanosomes have only two genes with known introns (Tb927.3.3160 and Tb927.8.1510 
(Koch et al., 2016), and each mRNA has an identical sequence trans-spliced onto the 5'-end 
(Clayton, 2016; Mair et al., 2000); the mature mRNA is obtained via post-transcriptional 
processing (Liang et al., 2003). However, the 3'-untranslated sequences are responsible for 
translational control, mRNA stability and interactions with RNA-binding proteins (Clayton, 
2013). In yeast, a single mRNA can generate 4000 protein molecules (Futcher et al., 1999). In 
contrast, the ratio of mRNA to protein in T. brucei procyclic forms is 1:550 (Kolev et al., 2010).  
 
1.3 Energy metabolism and mitochondrial biology of trypanosomes 
Trypanosomes have a single mitochondrion, unlike many other eukaryotes which usually have 
multiple mitochondria per cell. The trypanosome mitochondrial DNA contains an 
incompletely characterised genome that is organised into a single, discrete structure, called 
kinetoplast DNA (kDNA). The kDNA comprises giant genetic elements of thousands of 
concatenated circular DNA, classified as maxicircles and minicircles (Kolev et al., 2010). A cell 
of T. brucei contains 30-50 copies of maxicircles and about 200-400 copies of minicircles, 
which makes kDNA replication a complex process (Verner et al., 2015). The population of 
minicircles in T. brucei is heterogeneous, with each minicircle encoding between two to five 
guide RNAs (Pollard et al., 1990). These guide RNAs are responsible for RNA editing 
(Aphasizhev et al., 2016; Hajduk and Ochsenreiter, 2010).  
RNA editing is essential in T. brucei, and is currently being explored as a potential drug target 
(Schnaufer et al., 2001). RNA editing is performed by the 20S editosome (Mehta et al., 2015; 
Simpson et al., 2017). The process of RNA editing can either be repair of frameshifts, 
insertion of uridine at the 5’ end of the mRNA to generate a start codon, or formation of an 







a sequential process, which occurs in the 3’ - 5’ direction (Maslov and Simpson, 1992; 
Panigrahi et al., 2003). 
The maxicircles and minicircles are intertwined to form a large disc-shaped network that is 
connected to the basal body of the flagellum. Kinetoplast histone-like associated proteins 
(KAP1-KAP4) are involved in stabilizing the kDNA network to form a regular disk (Xu et al., 
1996). The kDNA is linked to the base of the flagella and the basal body by a membrane-
bound so-called tri-partite attachment complex (TAC). The TAC consist of three regions; the 
first region connects the kDNA network to the inner mitochondrial membrane (IM), the 
second region is a segment tightly enclosing a detergent-resistant differentiated IM and outer 
membranes (OM) and the third region comprise the final (exclusion zone) filaments that form 
a link between the OM and the basal body (Povelones, 2014; Robinson and Gull, 1991). 
Currently, the identified components of the TAC include the p166, which contains a single 
transmembrane domain (TMD) and is not essential for localization of the complex (Zhao et 
al., 2008). The TAC102 constitute unilateral filaments while p196 and TAC65 have been shown 
to localize to the exclusion zone filaments (Gheiratmand et al., 2013; Kaser et al., 2016; Trikin 
et al., 2016). TAC40, a β-barrel protein of the mitochondrial porin family was found to be 
confined to the TAC whiles the peripheral archaic translocase of the OM 36 protein 
(pATOM36) was detected throughout the OM (Käser et al., 2016).  
Procyclic and bloodstream form T. brucei depend on their mitochondrion and, normally, their 
kDNA for survival. However, as described above (section 1.2.4), some akinetoplastic (AK, cells 
without kDNA) and dyskinetoplastic (DK, cells that have lost functionally critical parts of 
kDNA) T. brucei bloodstream form mutants do exist (Schnaufer et al., 2001). Specific 
mutations in the nuclearly encoded subunit γ of the FOF1-ATPase enable AK or DK cells of the 
bloodstream form to survive (Dean et al., 2013), but viable AK or DK insect forms have not 
been reported (Schnaufer et al., 2002; Stuart, 1971). Loss of kDNA can be induced with kDNA-
intercalating drugs or by down-regulation of proteins required for kDNA replication or 







1.3.1 Structure and expression of trypanosome mitochondrial genome 
The mitochondrion is an indispensable organelle in most eukaryotes, though some organisms 
can survive without it. In addition to production of energy, the mitochondrion triggers 
signalling, cell death and cell proliferation (McBride et al., 2006). The mitochondrion possess 
its own genome, which is organized for transcription, replication and translation (Borst, 1972; 
Schatz et al., 1964), even though most proteins are encoded by the nuclear DNA, translated 
in the cytosol and imported into the mitochondrion (Chacinska et al., 2009).  
One of the characteristics of the T. brucei life cycle is the regulation of mitochondrial activity. 
Control of mitochondrial activity through the life cycle, in particular with respect to energy 
metabolism, is central to fulfilling the metabolic requirements of the trypanosome. 
Alternating between extreme niche environments requires vast morphological and metabolic 
adaptations. The slender bloodstream form of the parasite uses ATP generated by glycolysis, 
with oxidative phosphorylation absent. 
The mitochondrion of bloodstream forms does not have detectable cytochromes and lack 
several key enzymes of the citric acid cycle (such as pyruvate dehydrogenase, a-ketoglutarate 
dehydrogenase, citrate synthetase, and succinate dehydrogenase) that are required for 
oxidative phosphorylation. Hence the mitochondrion is not involved in energy production in 
the bloodstream forms (Priest and Hajduk, 1994; Vickerman Keith, 1965). However, the 
mitochondrion has roles in iron-sulphur centre (Fe/S) biogenesis (Kovarova et al., 2014), fatty 
acid biosynthesis (Clayton et al., 2011) and production of thymidine monophosphate (dTMP) 
(Roldan et al., 2011).  
Differentiation of stumpy form prepares the activation of mitochondrion for energy 
production in the procyclic form (Priest and Hajduk, 1994; Vickerman Keith, 1965). The 
mitochondrion is a single elongated and stretched tube (Tyler et al., 2001) as shown in Figure 
1.5. Activation of the mitochondrion involves expansion and remodeling of the inner 







entire organelle is enlarged and forms a complex network throughout the cell (Figure 1.5) 
(Priest and Hajduk, 1994). 
 
 
Figure 1.5. The life cycle of Trypanosoma brucei and mitochondrial function. The mitochondrial 
activity changes across the life cycle stages of T. brucei. Mitochondrion is inactive for oxidative 
phosphorylation in slender forms  (the mitochondrion is shown in pale pink). Differentiation from 
intermediate to stumpy forms causes upregulation of mitochondrion activity in preparation for 
oxidative phosphorylation (mitochondrion is shown in red). In the procyclic form, mitochondrion is 
active for oxidative phosphorylation. This image is adapted from Vickerman (1965) after modification 









The T. brucei ETC consists of five classic multi-subunit complexes (cI-cV) (Figure 1.6). Complex 
I is discussed in detail in section 1.3.6, whereas complexes II, III, IV and V are explained in this 
section. There are three additional enzymes that provide alternative pathways for the flow of 
electrons between UQ and UQH2. These enzymes are: (i) glycerol-3-phosphate oxidase (GPO, 
Figure 1.7), which oxidizes glycerol-3-phosphate (G-3-P) to dihydroxyacetone phosphate 
(DHAP) (Guerra et al., 2006); (ii) a rotenone-insensitive NADH:Q oxidoreductase (NDH2) (Fang 
and Beattie, 2002); (iii) the trypanosome alternative oxidase (TAO), which catalyzes the 
reduction of O2 to H2O (Chaudhuri et al., 2002). The TAO is absent in the mammalian host. 
None of these enzymes contribute to ΔΨm, as they do not pump protons. In the bloodstream 
form, these three complexes together with complexes I and V are present in the inner 
mitochondrial membrane (Surve et al., 2012). It has been hypothesized that cI activity can be 
fully replaced by NDH2 to regenerate NAD+ (Fang and Beattie, 2002). However, when NADH 
was applied externally to digitonin-permeabilised procyclic cells to ascertain whether the 
NADH binding site of NDH2 has the correct orientation to contribute to mitochondrial NAD+ 
regeneration, oxygen consumption was detected (Verner et al., 2013). The mitochondrial 
membrane is resistant to NADH, suggesting that NDH2 is oriented towards the cytosol in the 
mitochondrial membrane.  
In bloodstream forms, the first seven steps of glycolysis occur in the glycosome, which is 
associated with mitochondrial respiration through the glycerol-3-
phosphate:dihydroxyacetone phosphate shuttle (G3P:DHAP). The shuttle consists of two 
enzymes; GPO in the inner mitochondrial membrane (see above and Figure 1.7) and NAD-
dependent glycerol-3-phophate dehydrogenase (NAD-G3PDH), which is positioned within the 
glycosomes (Opperdoes et al., 1977). NAD+ is produced from the G3P:DHAP in bloodstream 
and procyclic forms. Alternatively  it can be generated from the succinate-producing 
glycosomal pathway in procyclic forms to maintain an NAD+/NADH balance in the glycosome 
(Michels et al., 2006). In bloodstream forms, GPO transfers electrons from G3P to ubiquinol 










Figure 1.6. Composition of the respiratory chain varies across the life cycle of T. b. brucei. Complexes 
I, III, IV and V contain kDNA-encoded subunits. These are labelled; black = never-edited, white = edited. 
Key: GPO = glycerol-3-phosphate oxidase, NDH2 = alternative NADH:ubiquinone dehydrogenase, TAO 











1.3.1.1  Complex II 
 
Complex II has been shown to be non-essential in procyclic forms in the presence of abundant 
glucose, but it is essential in glucose-depleted conditions (Coustou et al., 2008). In the absence 
of glucose, proline catabolism is used to generate ATP in the mitochondrion. Interestingly, the 
T. brucei complex II is larger than in other eukaryotes, having additional but non-canonical 
subunits (Acestor et al., 2011). Complex II may also be present in the stumpy bloodstream 
forms, although its activity or role is yet to be determined (Gunasekera et al., 2012). 
 
1.3.1.2  Complex III 
 
Complex III (cIII) is a multisubunit transmembrane protein encoded by both the mitochondrial 
(subunit apocytochrome b, CyB) and the nuclear genomes. In bloodstream forms, the levels 
of CyB transcript are very low (Michelotti and Hajduk, 1987). Translation of this subunit 
cannot occur in this parasitic stage, as unedited CyB mRNA lacks an AUG codon that is 
generated by the editing of the transcript only in procyclic forms (Feagin et al., 1987). Genetic 
knock-down of two nuclearly-encoded subunits of cIII (Rieske protein and subunit I) in 
procyclic forms (Horváth et al., 2005) resulted in retardation of cell growth, as well as in a 
decrease of cytochrome c reductase activity and Δψm. These observations are in accordance 
with complex III having a classical role in the procyclic respiratory chain. 
 
1.3.1.3  Complex IV 
 
Complex IV or cytochrome c oxidase (COX) has three mitochondrially and fifteen nuclearly-
encoded core subunits. Complex IV also has multiple accessory proteins whose functions are 
currently unknown (Zíková et al., 2008). Messenger RNAs for two of the mitochondrially-







Silencing of three novel subunits of complex IV by RNAi in procyclic forms showed no lethal 
growth defects, even though there was drastic decrease in RNA level as well as cytochrome c 
oxidase activity (Gnipova et al., 2012). Complex IV has a traditional role in the procyclic 
respiratory chain. Hence, knocking down subunits of the complex reduces the Δψm and the 
cytochrome c oxidase activity. In the bloodstream form, complex IV is absent (Figure 1.6) and 
is induced upon differentiation to the procyclic form (Mayho et al., 2006; Priest and Hajduk, 
1994). 
 
1.3.1.4  Complex V 
 
Complex V or ATP synthase (F1FO ATPase) uses transmembrane protonmotive force, which is 
generated via electron flow to O2, to synthesise ATP from ADP and inorganic phosphate in a 
process called oxidative phosphorylation (Boyer, 1997,  
Baradaran et al., 2013; Berrisford and Sazanov, 2009; Friedrich and Bottcher, 2004). The 
structure of ATP synthase consists of an extrinsic domain, F1, and an intrinsic membrane 
domain, FO, which are linked by two stalks (Boyer, 1997). A connecting central stalk contains 
subunits δ, ε, and γ; the latter subunit contacts both F1 and FO. The enzyme functions as a 
reversible H+-transporting ATPase via coupling of F1 and FO. In yeast, the mitochondrial ATP 
synthase consist of thirteen different subunits. 
The F1 segment comprises subunits      and  and the FO sector subunits 6, 8, 9,   f, 
h and OSCP (Spannagel et al., 1997). In T. brucei, complex V has a stoichiometry of 
α3β3γ1δ1ε1p181 for the F1 subunits. The FO complex is composed of one each of subunits 6 (a) 
and 4 (b) and a ring of multiple subunits 9 (c). The catalytic sites of ATP synthase are within 
the  subunits, with three active sites per complex. All three active sites need to be occupied 
for optimal catalysis (Amano et al., 1996). The subunits b OSCP, F6 and d make up the 
peripheral stalk. During ATP synthesis, the movement of protons across the concentration 







deprotonation of aspartate 6 in subunit c, thereby driving rotation of the c ring (Girvin and 
Fillingame, 1995; Kuruma et al., 2012). This causes rotation of γ within the α/β hexamer, 
which results in a conformational change within the β active sites to drive ATP synthesis 
(Rastogi and Girvin, 1999). A complete revolution of γ within the α3β3 core produces three 
ATP molecules (Stock et al., 1999).  
The A6 is a subunit of FO ATPAse subunit 6; it is encoded by the mitochondrion and is involved 
in proton translocation (Kuruma et al., 2012). The A6 transcript is pan-edited in both 
bloodstream and procyclic forms. Specific point mutations within the nuclearly-encoded γ 
subunit of the mitochondrial F1 FO - ATPase allow survival in the absence of kDNA in the 
slender bloodstream forms of T. brucei (Dean et al., 2013).  
In the bloodstream form of T. brucei, ATPase generates Δψm during ATP hydrolysis, and the 
ADP/ATP carrier (AAC) supplies the mitochondrion with ATP from glycolysis (Schnaufer et al., 
2005). The ADP/ATP carrier plays an essential role in sustaining the cellular ATP homeostasis 
by exchanging mitochondrial ATP for cytosolic ADP. The enzyme fuels the substrate level 
phosphorylation and oxidative phosphorylation in procyclic cells by providing the 
mitochondrion with ADP and the rest of the cell with mitochondrially-produced ATP. AAC 
activity in procyclic forms is driven by Δψm. This observation is supported by RNAi studies 
performed on TbMCP5 (Peña-Diaz et al., 2012). Moreover, the AAC inhibitor, 
carboxyatractyloside (CATR), strongly reduced mitochondrial ATP production, confirming that 
the exchange of mitochondrial ATP for cytoplasmic ADP is entirely aided by AAC activity 
(Peña-Diaz et al., 2012). 
 
1.3.2   Mitochondrial Protein Import in Trypanosomes 
In T. brucei, as in other eukaryotes, most mitochondrial proteins are encoded in the nucleus. 
These proteins must be imported into the mitochondrion to perform their functions. TOM40 
is a typical protein import channel within the mitochondrial outer membrane (Gabriel et al., 







The OM protein translocase of T. brucei called archaic translocase of the outer mitochondrial 
membrane (ATOM) has 7 subunits (ATOM40, ATOM19, ATOM14, ATOM12, ATOM11, 
ATOM69 and ATOM46) and also aid membrane translocation (Desy et al., 2016). Except for 
ATOM46, the remaining six subunits are essential for mitochondrion protein import (Harsman 
and Schneider, 2017).  
Only two ATOM subunits, ATOM40 and ATOM14, have been shown to be homologous to the 
yeast TOM subunits (Mani et al., 2016). Until now, no orthologues of the other five ATOM 
subunits have been found outside the kinetoplastid lineage. T. brucei contains a SAM complex 
within the mitochondrial OM, and the core subunit (Sam50/Tob55) is conserved (Sharma et 
al., 2010).  
 
1.3.3   Metabolism in slender bloodstream form  
In bloodstream form, ATP is mainly produced via glycolysis; pyruvate is generated as the end 
product (Creek et al., 2015), along with some production of succinate, acetate and alanine 
(Mazet et al., 2013). Trypanosomatids partially oxidize pyruvate, succinate, alanine and 
acetate, which are secreted as end products from energy metabolism (Mazet et al., 2013). All 
trypanosomatids studied so far generate acetate, which vary across their life cycle stages 
(Cazzulo, 1992; VanHellemond et al., 1997) and is dependent on the species and 
environmental conditions.  
Conversion of glucose to 3-phosphoglycerate occurs within the glycosome, with pyruvate 
conversion occurring in the cytosol. There is a fine balance between ATP production and 
usage, as well as NADH/NAD+ balance, which must be maintained within the glycosome under 
aerobic conditions for efficient ATP production. Aldolase generates two 3-carbon 
intermediates, DHAP and G3P. DHAP is converted to G3P within the glycosome, with 
glycosomal NAD+ maintaining the metabolism of G3P to pyruvate. (Figure 1.7). In the 
mitochondrion, pyruvate is converted by the pyruvate dehydrogenase complex into acetyl-







(Michels et al., 2006). Under anaerobic conditions, DHAP is metabolised to glycerol, thereby 
producing one ATP molecule within the glycosome (Figure 1.7). 
 
 
Figure 1.7 Glycolytic pathway in bloodstream form of T. brucei. This pathway shows the aerobic and 
anaerobic conditions, leading to pyruvate and glycerol production respectively. Key for abbreviations 
and enzymes involved in the pathways are listed: 1,3 BPGA = 1,3 bisphosphoglycerate, DHAP, 
dihydroxyacetone phosphate, F6P = fructose-6-phosphate, G3P = glyceraldehyde-3-phosphate, G6P = 
glucose-6-phosphate, Gly-3-P= glycerol-3-phosphate, PEP = phosphenolpyruvate, 3PGA = 3-
phosphoglycerate, Pi = inorganic phosphate, UQ = ubiquinone pool. Enzymes: 1. hexokinase, 2. G6P 
isomerase, 3. phosphofructokinase, 4. aldolase, 5. triosephosphate isomerase, 6. G3P dehydrogenase, 
7. glycerol kinase, 8. G3P dehydrogenase, 9. phosphoglycerate kinase, 10. phosphoglycerate mutase, 
11. enolase, 12. pyruvate kinase, 13. glycerol3-phosphate dehydrogenase, 14. alternative oxidase. The 









1.3.4   Metabolism in stumpy bloodstream form  
The stumpy forms adapt to the procyclic midgut upon entry into the tsetse fly. This adaptation 
also corresponds to metabolic changes occurring within the parasite during differentiation 
from slender to stumpy forms. Stumpy bloodstream form show increase in complex I, II and 
V activities, whilst complex III and IV activities attain their peak in the procyclic forms. Stable 
isotope labelling by amino acids in cell culture (SILAC), followed by quantitative proteomic 
analysis has been used to demonstrate that stumpy forms have abundant mitochondrial 
proteins compared to slender forms  when the fold change (log2) was analysed between the 
different life cycle stages (Gunasekera et al., 2012). The production of acetate from acetyl-
CoA is catalysed by either ASCT or acetyl coA thioesterase (Figure 1.8) (Mazet et al., 2013). 
Moreover, stumpy forms can utilise glucose and α-ketoglutarate as energy sources 
(Vickerman Keith, 1965). Complex V is believed to act in the directionality of ATP synthase in 
the stumpy form (Dewar et al., 2018). It has been reported that SCoAS and ASCT levels in 
stumpy forms and procyclic are similar (Gunasekera et al., 2012). 
 
1.3.5   Metabolism in procyclic forms 
The mitochondrion of procyclic forms can produce ATP through three different pathways 
(Besteiro et al., 2005) (Figure 1.9). Under conditions of glucose deficiency, the carbon sources 
that are used for ATP production are proline, an amino acid abundant in the fly midgut, and 
threonine. Metabolism of proline produces alanine, glutamate, CO2 and succinate in glucose-
deficient medium (van Weelden et al., 2005) whiles the end products of threonine 
metabolism are acetate and glycine (Linstead et al., 1977; van Weelden et al., 2005). 
A metabolic switch occurs as the stumpy forms in the mammalian bloodstream transit to the 
midgut of tsetse fly and differentiate into procyclic forms (Fenn and Matthews, 2007). 
Conversion of proline to glutamate is mediated by enzymatic and non-enzymatic steps. Firstly, 







dehydrogenase (TbProDH) (Lamour et al., 2005). The P5C ring opens to produce glutamate-γ-
semialdehyde (γGS) through a non-enzymatic process.  
Finally, the γGS carbonyl moiety is oxidized to glutamic acid by a P5C dehydrogenase 





Figure 1.8 Mitochondrial ATP production in procyclic forms of T. brucei. The three ATP production 
pathways are the respiratory chain, the citric acid cycle, and the ASCT cycle. The sites of ATP 








The acetate:succinate CoA-transferase/SCoAS cycle (ASCT cycle) produces ATP, coupling ATP 
generation with acetate formation (Bochud-Allemann and Schneider, 2002). It can function in 
anaerobic conditions, which is a possible adaptation to hypoxic conditions in the fly. 
Mitochondrial ATP can be generated by SUBPHOS in an aerobic condition where acetate is 
formed using the acetate:succinate coenzyme A (CoA) transferase/SCoAS cycle (ASCT cycle) 
(see Figure 1.8) (Van Hellemond et al., 1998). Proline metabolism generates α-ketoglutarate 
as an intermediate causes flux through this pathway (Bochud-Allemann and Schneider, 2002). 
This enzyme is essential in the presence of glucose; the interruption of SCoAS eliminates 
mitochondrial ATP production via the substrate level phosphorylation pathways (Figure 1.8). 
ASCT is expressed in procyclic forms but is not important in the presence of glucose because 
acetyl-CoA thioesterase is able to generate acetate (Zíková et al., 2017). Production of ATP 
using substrate level phosphorylation is approximately 3 times higher in glucose-rich media 
compared to glucose-depleted media, due to ASCT (Bringaud et al., 2006). The ASCT cycle 
occurs in the mitochondria of trypanosomatids and some helminths and is also present in 


















Figure 1.9 Proline-alanine cycle between T. brucei, tsetse tissue, fat body and flight muscles. Proline 
combustion produces alanine as the main end product in tsetse flight muscle (right panel). Alanine is 
conveyed to the fat body by the hemolymph (left panel). Alanine and lipids are the main sources for 
proline production in the fat body. Alanine amino group (-NH2) is transported to oxoglutarate to 
generate glutamate and pyruvate. Pyruvate can be carboxylated to form oxaloacetate and acetyl-CoA 
for β-oxidation of lipids. The fat body TCA cycle goes from citrate to oxoglutarate. Proline fuels the 
respiratory capacity to synthesize ATP driven by OxPHOS. Midgut procyclics depend on proline 
degradation for survival within tsetse fly. TbP5CDH (in red) is important for establishment within the 









1.3.6   Complex I of T. brucei  
The presence and role of complex I (NADH dehydrogenase) in energy metabolism in 
trypanosomatid has been debated (Opperdoes and Michels, 2008). Eukaryotic complex I 
consists of about 46 subunits; 14 of these subunits are bacterial core subunits and 21 subunits 
are eukaryotic core subunits. The Trypanosoma complex I has 19 subunits which are 
homologous to both eukaryotes and prokaryotes. Homology search of T. brucei indicates 12 
core homologues and 7 conserved accessory subunits within five members of the 
trypanosomatid family; these proteins are encoded by genes in the mitochondrial and nuclear 
genomes (Acestor et al., 2011; Panigrahi et al., 2009). The trypanosomatid complex I has four 
bacterial homologues and seven subunits encoded by the trypanosomatid mitochondrial 
genome, as well as six nuclearly-encoded subunits (Opperdoes and Michels, 2008). Aside  the 
core subunits of complex I in trypanosomatids, proteomic studies have identified other core 
components of complex I (Panigrahi et al., 2009). Two core subunits thought to be essential 
for proton pumping, NADH dehydrogenase subunits 4L (ND4L) and 6 (ND6), were not found 
using bioinformatic or proteomic analysis.  
This observation suggests that complex I does not participate in generation of Δψm 
(Opperdoes and Michels, 2008) or that the subunits could be present in diverged form. Thus, 
some of the mitochondrial ‘C-rich’ (CR) genes and unidentified reading framed (MURFs) may 
represent some of the ‘missing’ subunits. Indeed, one of these has since been tentatively 
identified as ND2 (Kannan and Burger, 2008). 
There has been much debate about the role of complex I in T. brucei even though NADH 
oxidation occurring within the mitochondrion of T. brucei is well known (Fang and Beattie, 
2003; Horváth et al., 2005). The function of complex I has been reported to be neither 
significant nor important in the bloodstream forms (Surve et al., 2012). Moreover, the impact 
of complex I in procyclic forms is still unclear. Individual knock-down of three complex I core 
subunits (NUBM, NUKM and NUEM) in procyclic forms via RNA interference suggested that 
complex I only contributes 20% of the total mitochondrial NADH:ubiquinone oxidoreductase 







that knockdown of the complex I core subunits had no effect on Δψm (Verner et al., 2011). 
Unlike procyclic forms, no reduction of NADH oxidation activity was seen in monomorphic 
bloodstream forms (Surve et al., 2012). This observation has also been reported for 
Phytomonas serpens, a pathogen of plants, which is devoid of complexes III and IV (Maslov et 
al., 2002) but has a complex I similar to T. brucei (Cermáková et al., 2007). 
Research on the role of complex I is complicated by the presence of a second ‘type 2’ 
NADH:ubiquinone oxidoreductase, NDH2, in T. brucei which contributes to respiration (Fang 
and Beattie, 2003). NDH2 is composed of a single subunit confined to the mitochondrion 
(Surve et al., 2017). Additionally, NDH2 is insensitive to rotenone, is nuclearly-encoded and 
contributes partially to rotenone-insensitive respiration (Fang and Beattie, 2003; Horváth et 
al., 2005). A previous report has indicated that rotenone-sensitive Δψm is present in the 
stumpy bloodstream form of T. brucei (Bienen et al., 1991).  
It has been hypothesized that NDH2 facilitates rapid growth of procyclic forms , and also 
facilitates NAD+ regeneration for other mitochondrial dehydrogenases, instead of complex I 
(Fang and Beattie, 2003). However, there is debate as to whether the NADH binding site of 
NDH2 is correctly-oriented for regenerating mitochondrial NAD+. When NADH was tested on 
digitonin-permeabilised procyclic cells, mitochondrial G3PDH activity was increased with a 
corresponding reduction in respiration (Verner et al., 2013). RNAi targeting NDH2 produced 
growth retardation and decreased ΔΨm in procyclic forms (Verner et al., 2013). However, 
there was no significant change in activity of NADH:Q2 oxidoreductase in NDH2 knockdown 
cells (Verner et al., 2013). 
 The mitochondrial membrane is not permeable to NADH and hence NDH2 could be oriented 
towards the cytosol from the mitochondrial membrane; it is not certain whether NDH2 would 
be able to compensate for complex I activity. Generation of an NDH2 mutant in slender 
bloodstream form of T. brucei lacking the NUBM gene showed strong defects in growth 
phenotype in parasites lacking cI function (Surve et al., 2017). Using proton nuclear magnetic 
resonance (H-NMR) spectrometry, the study also demonstrated that there was no difference 







mutants and in the uninduced NUBM NDH2 conditional knockout cell line (Surve et al., 2017). 
The reduction in the level of acetate also resulted in a shift in fatty acid composition of the 
cell line with NDH2 knockdown in the NUBM background. These data imply that NDH2 is 
present but non-essential for sustaining mitochondrial redox balance in slender bloodstream 
forms (Surve et al., 2017). Recent studies have shown that adipose tissue is a reservoir for T. 
brucei. The bloodstream form of T. brucei in the adipose tissue upregulate the pathway for 
beta-oxidation, which is expected to increase the demand for NADH dehydrogenase activity 
(Trindade et al., 2016). It was hypothesized in this study that NADH dehydrogenase is involved 
in the pathway for beta oxidation but not energy production. This hypothesis was tested in 
chapter 4 of this thesis. 
 
 
1.3.7   Compensation for mitochondrial DNA function in dyskinetoplastic T. 
brucei  
Balanced production of proteins and gene regulation is crucial to trypanosomes. During the 
life cycle stages, there are modulations of gene expression and metabolic adjustment to suit 
environmental changes and ensure progression of the life cycle (as discussed section 1.2.1). 
As previously reported, the developmental regulation of mitochondrial activity requires 
coordination between the nucleus and kinetoplast (Schneider, 2001). In this thesis, the 
nuclearly-encoded subunit of cytochrome oxidase COX VI, which has been extensively studied 
(Matthews and Gull, 1998), was used to investigate whether absence of the kinetoplast 
influences regulation of nuclear gene expression. 
Cytochrome oxidase has 10 nuclearly-encoded and 3 mitochondrially-encoded subunits. RNA 
interference of three subunits of cytochrome c oxidase (TbCOX VII, TbCOX X and TbCOX 6080) 
in procyclic forms caused reduced mitochondrial membrane potential and decreased 







III and IV, are not present in short stumpy forms but mRNA expression of their nuclearly-
encoded subunits was increased by approximately 2-fold (Priest and Hajduk, 1994). The 
cytochrome oxidase complex is developmentally regulated in T. brucei. COX VI expression 
has been shown to be enriched at the protein levels in procyclic forms (Tasker et al., 2001). 
Additionally, COX VI mRNA has been reported to be 2.5-fold higher in procyclic forms 
compared to bloodstream forms (Mayho et al., 2006). 
To investigate the potential crosstalk between the nuclear and mitochondrial genome during 
the events of differentiation, expression of a nuclear-encoded component of the cytochrome 
oxidase (COX) complex was disrupted by RNA interference in dyskinetoplastid cells lacking a 
mitochondrial genome. This allows the ablation of mRNA of the COX VI to turn off its 
expression. The result showed that dyskinetoplastic cells were able to express nuclear Cox VI 
and thus, the regulation of COX VI gene is independent of kinetoplast (Timms et al., 2002). 
Coordination between mitochondrion and nucleus have been studied in organisms like yeast 
and mammals. The mitochondrion communicates with the nucleus if there is a dysfunction of 
the mitochondrion; the process is termed retrograde signalling. Retrograde signalling was first 
observed by independent studies conducted by (Butow and Avadhani, 2004; Kirchman et al., 
1999; Laun et al., 2001). Retrograde regulation is triggered in response to changes in the 
functional state of the mitochondrion. An example is the existence of metabolic 
readjustments for the maintenance of glutamate supplies in respiratory-deficient yeast cells 
(Butow and Avadhani, 2004). Retrograde response has also been shown to account for 
longevity, as extension of life span was reversed by inactivation of retrograde target (RTG) 
genes (Butow and Avadhani, 2004). Mitochondrion dysfunction leads to a reduction in 










In yeast, the role of RTG genes in communication between mitochondria and the nucleus are 
also required for expression of genes encoding peroxisomal proteins. During mitochondrial 
dysfunction, there are  recruitment of  a series of signal transduction proteins that  induces a 
wide range of nuclear target genes (Jazwinski, 2013; Kirchman et al., 1999; Kotiadis et al., 
2014). This response plays a vital role in maintaining mitochondrial function and cell integrity. 
To date, there is no evidence of retrograde response in trypanosomes during stringent 
regulation of mitochondrial activity. Is T. brucei capable of sensing the absence of 
mitochondrial genome to relay information to the nucleus to compensate for the defect? In 
chapters 3 and 4 of this thesis, the effect of absence of mitochondrial genome on gene 
regulation during differentiation from slender to stumpy forms was investigated both in vitro 
and in vivo. A typical signalling response to mitochondrion misfolded proteins for eliciting 









Figure 1.10 Factors Involved in Mitochondrial Retrograde Signalling and UPRmt mitochondrion-
nuclear crosstalk is triggered under mitochondrial stress in yeast. Activation of the UPRmt signalling 
pathway occurs when proteins aggregate or  misfold and accumulate in the mitochondrial matrix. This 
two-step pathway involves activation of transcription factors, including the CCAAT-enhancer-binding 
protein homologous protein (CHOP). This leads to transcription of mitochondrial quality control genes 
including Hsp60/10. Retrograde signalling is activated by dysfunction of the mitochondrion and  
triggers activation of cytosolic signalling pathways which lead to activation of transcription factors 
including (RXRA, JNK2, CHOP, NKκB,) and transcription of nuclear genes that produce adaptive 












1.4   Aims  
The aims of this thesis are to investigate the consequences of mitochondrial dysfunction: 
(i) on temporal and spatial differentiation of bloodstream form of T. brucei  
(ii) on nuclear gene expression, to uncover potential retrograde signalling pathways in 
these parasites.  
Why will T. brucei invest energy in the biogenesis of complex I if it does not contribute to its 
growth in both bloodstream and procyclic forms? An akinetoplastic cell line that had 
spontaneously lost its mitochondrial DNA and expresses ATPase subunit γL262P, a WTγ cell 
line containing the complete kDNA but otherwise being isogenic, and complex I null mutant 
cell lines were used to address the following: 
1. Do retrograde signalling pathways exists in T. brucei? Does lack of a mitochondrial 
genome result in changes in nuclear gene expression? 
2. Does complex I play an important role in stumpy forms and/or in cells residing in 
adipose tissue? 
















2 Materials and methods 
2.1   Trypanosome cultures 
2.1.1   Cell lines 
All bloodstream form cell lines (see Table 2.1) were cultured in HMI-9 medium (Hirumi and 
Hirumi, 1989) and incubated at 37 °C with 5% CO2. Akinetoplastic cell line (WT/L262Pγ) and 
one wild type gamma mutant (WT/WTγ) strain of T. brucei EATRO 1125 AnTat1.1 90:13 were 
donated by Caroline Dewar and Sinclair Cooper, Schnaufer’s laboratory, University of 
Edinburgh. The mutant cell lines were generated by replacing one allele of the nuclear-
encoded F1FO-ATPase subunit γ with an L262P mutation (L262Pγ) to functionally uncouple the 
F1Fo synthase part in the pleomorphic cell line T. brucei EATRO 1125 (AnTat1.1 90:13). The 
isogenic control (WT/WTγ), otherwise referred to as WTγ was generated by introducing a wild 
type version of gamma ATPase subunit γ into the same parental cell line, thus controlling for 
changes associated with transfection and selection of transgenic parasites. These cell lines 
were cultivated in the presence of 2.5 μg/ml hygromycin and 1.25 μg/ml G418 to maintain 
expression of the T7-polymerase and the tetracycline repressor. Culture-adapted 
pleomorphic T. brucei EATRO 1125 AnTat1.1 (Markus Engstler and Boshart, 2004) (Table 2.1) 
was cultured in methylcellulose (Sigma-94378) containing HMI-9 medium supplemented with 
10% heat-inactivated foetal calf serum (FCS) (Invitrogen), prior to transfection (Hirumi and 
Hirumi, 1989). The AnTat 1.1 refers to serodeme/VSG. UBP1/2 RNAi cell lines (Hartmann et 
al., 2007) and PNT1 RNAi cells (courtesy of Dr Claudia Schaffner, Schnaufer lab) were induced 
by adding 100 ng/ml tetracycline to the cell cultures. Purite water that was used throughout 










Table 2.1 Cell lines used and /or generated in this study 








T. b. brucei Lister 427 with one ATPγ 
allele replaced with PURO and 
constitutively expressing an additional 
L262P mutant ATPγ gene replaced with 
WT ATPγ 
427 WT  
Lister 
427SM 






T. b. brucei Lister 427 with one ATPγ 
allele replaced with PURO and 






T. b. brucei Lister 427 with both alleles 
replaced with NEO and HYG and 
constitutively expressing NUKM- mutant 








T. b. brucei Lister 427 with both alleles 
replaced with NEO and HYG and 
constitutively expressing NUBM- mutant 





















T. b. brucei AnTat 1.1 90:13 with both 
ATPγ alleles replaced with NEO and HYG 
and constitutively expressing an 







 T. b. brucei AnTat 1.1 90:13 with both 
ATPγ alleles replaced with NEO and HYG 
and constitutively expressing an 
additional L262P mutant ATPγ. This cell 
line spontaneously lost mitochondrial 







 T. b. brucei AnTat 1.1 90:13 with both 
ATPγ alleles replaced with NEO and HYG 
and constitutively expressing an 







line treated with acriflavine to devoid it 
of kinetoplast  




 T. b. brucei AnTat 90:13 with one NUKM 
allele replaced with BSD  
NUKM SKO AnTat1.1 Δnukm/NUKM  
 T. b. brucei AnTat 1.1 with one NUKM 
allele replaced with NEO  
NUBM SKO  AnTat1.1 Δnubm/NUBM 
 T. b. brucei AnTat 1.1 with one NUBM 
allele replaced with NEO  
NUKM DKO  NUKM SKO  
Δnukm::NEO/Δnukm
::HYG  
T. b. brucei AnTat 1.1 with both alleles 
replaced with NEO and HYG and 
constitutively expressing NUKM- mutant 
complex I gene 
NUBM DKO NUBM SKO  
Δnubm::NEO/Δnubm
::HYG  
T. b. brucei AnTat 1.1 with both alleles 
replaced with NEO and HYG and 
constitutively expressing NUBM- mutant 






T. b. brucei AnTat 1.1 with both NUKM 
alleles deleted. The addback of NUKM  is 
inserted in β tubulin locus to 
constitutively express NUKM complex I 
gene 
NUBM PCF  NUBM DKO  
Δnubm::NEO/Δnubm
::HYG 
T. b. brucei AnTat 1.1 with NUBM alleles 
replaced with NEO and HYG and 
constitutively expressing NUBM- mutant 
complex I gene differentiated to 
procyclic using cis aconitate 
Systemic TriTrpDB IDs: NUBM (Tb927.5.450) 
                                         NUKM (Tb927.11.1320) 
                                        ATPase subunit γ (Tb927.10.180) 
 
 
2.1.2   Transfection of bloodstream form cells 
Bloodstream forms were transfected as described (Schumann Burkard et al., 2011). 10 µg 
plasmid DNA was used per transfection. DNA was linearized by restriction enzyme NotI. After 
confirming linearization via gel electrophoresis, DNA was ethanol precipitated and the final 
pellet was resuspended in 20 µl MilliQ water (Sigma). Cells in the logarithmic stage of growth 







Cell pellets were resuspended in 100 µl nucleofection solution (90 mM NaH2PO4, 5 mM KCl, 
0.15 M CaCl2, 50 mM HEPES, pH 7.3) (Schumann Burkard et al., 2011). Cells in methylcellulose 
were removed from the cultures by diluting the culture in 1:4 with sterile TDB and followed 
same protocol to transfect 5 x 107 trypanosomes with 10 μg of linearized plasmid DNA. 
A mock transfection of parental cells without DNA was done to serve as a control to confirm 
that the selective drugs inhibited growth of untransfected cells. For the transfection, the 
AMAXA Nucleofector® II was used with Program Z-001 (Schumann Burkard et al., 2011). After 
nucleofection, cells were recovered in a pre-warmed 25 ml culture medium supplemented 
with FCS for at least 6 hours at 37 °C, 5% CO2. After the 6-hour incubation, selective drugs 
were added, and the cells were plated in 24-well plates in 10-fold serial dilutions and in 48-
well plates in 1:30 and 1:100 dilutions.  
Drugs to maintain selection for transgenes were: G418 (2.5 μg/ml for bloodstream forms, 15 
μg/ml for procyclin forms) (Invitrogen), hygromycin (5 μg/ml for bloodstream forms, 50 μg/ml 
for procyclic forms) (Invitrogen), and puromycin (1 μg/ml for bloodstream forms and 
procyclic) (Sigma).  
The genomic DNA (gDNA) of these clones was extracted using GenElute Mammalian gDNA 
miniprep kit (Sigma) for downstream analyses (e.g. PCR) to allow direct Sanger sequencing of 
the selected clones.  
 
2.1.3   Differentiation to the stumpy stage 
For a generation of density-induced stumpy parasites, slender cells at a seeding density of 5 
x 105 cells/ml were cultivated without dilution for 48 hours in methylcellulose containing HMI-
9 medium supplemented with 10% v/v heat-inactivated FCS and 5% v/v serum plus (94378, 
Sigma). This allowed the accumulation of SIF that consequently developed into stumpy cells. 
Cultures were incubated at 37 °C and 5% CO2. To harvest the cells, methylcellulose was 
removed from the cultures by diluting the cultures at least 1:4 with sterile trypanosome 







20 mM glucose, pH 7.6). The diluted culture was filtered (MN 615 1/4, Macherey-Nagel, 
Germany) using sterile conditions and centrifuged (1500g, 15 min, RT) prior to differentiation 
to PCF. 
 
2.1.4   Differentiation to Procyclic Forms 
Bloodstream stage trypanosomes were induced to differentiate to procyclic forms by seeding 
1.5 × 107 cells into 5 ml of HMI-9 with 50 μl of 6 mM cis-aconitate and a shift in temperature 
from 37 °C to 27 °C and 5% CO2. After 24 hr incubation, the cells were washed from HMI-9 
and transferred into the SDM-79 medium (Brun and Schonenberger, 1981). The differentiated 
population was assessed by the expression of EP by immunoblotting (Section 2.12). 
 
2.2   Growth analysis in-vitro 
Cell lines were grown to measure the growth effect of the absence of cI NUBM in-vitro. Cells 
were grown in HMI-9 media (Invitrogen) (Hirumi and Hirumi, 1989) containing 10% v/v FCS. 
Cell counts were performed daily for 14 days using the Neubauer counting chamber; cells 
were diluted to starting concentration (2 x 106cells/ml) every 24 hours.  
 
2.3   Animal experiment and parasite purification 
Animal experiments were carried out according to the United Kingdom Animals Act (Scientific 
Procedures) under a licence PPL70/8734 issued by the United Kingdom Home Office and 
approved by the University of Edinburgh local ethics committee. Unless otherwise indicated, 
all infections were performed in wild-type male C57BL/6J mice, which were 6–10 weeks old 
(Charles River, France) and MF1 mice that were at least 10 weeks old (SCRM, Edinburgh) by 
intraperitoneal injection of 2,000 T. brucei AnTat 1.1 and EATRO 1125 AnTat 1.1 .90:13 
parasites without any immunosuppressants. Parasitaemia was monitored daily from day 







blood compressed under a cover slip on a microscope slide at the 40x objective. Cell numbers 
per field of view were estimated by examining at least 10 fields of view from the wet smears 
using the Herbert and Lumsden rapid matching method (Herbert and Lumsden, 1976). The 
cell morphology was also scored qualitatively from these wet smear slides. Slender cells are 
longer, thinner with a long flagellum at the posterior end whiles stumpy cells are shorter, 
wider, with an extremely short attached flagellum. Slender or stumpy cells depending on the 
experiment were harvested via a cardiac puncture to collect the infected blood in a 2 ml 
syringe containing 200 µl of 2% sodium citrate (anticoagulant). Trypanosome parasites were 
purified from blood using DEAE-cellulose DE52 (Whatman anionic exchange cellulose, 
Z742600) at pH 7.8 (Lanham, 1968) that were preincubated with phosphate saline glucose 
(PSG) (44 mM NaCl, 57 mM Na2HPO4, 3 mM KH2PO4, 55 mM glucose, pH 7.8) pre-warmed at 
37 °C. Blood was loaded onto the column, and the column was continuously topped up with 
warm PSG, and the eluate was collected. The density of the cells was measured using a 
Beckmann Z2 Coulter counter. 
 
 
2.3.1   Perfusion and parasite isolation from adipose tissue and solid 
organs 
Anesthetized mice were laid on their back on a dissecting board placed on the procedural 
stage. Forelimbs were spread to secure each paw to the rack with a pin. A pair of dissecting 
scissors was used to open the skin to expose the chest cavity. An incision with a scalpel was 
then made through the abdomen, along the length of the diaphragm, with a sharp scissor and 
cut through the connective tissue at the bottom of the diaphragm to access the rib cage. 
About 500 μl of blood was collected from the right ventricle using a 27G insulin syringe. 
Prewarmed (37 °C) heparinized saline (50 ml phosphate buffered saline (PBS) with 250 μl of 
5000 I.U./mL) was passed through the left ventricle using a syringe and needle. The right 
atrium was cut with a pair of sharp scissors, making sure solution was freely flowing through 







washed quickly in 1x PBS. The pre-weighed organs were transferred into 1.5 ml eppendorf 
tubes and snap froze in liquid nitrogen and then transferred to -80 °C. Adipose tissue form 
(ATF) parasites were collected from gonadal fat depot by agitated at 150 rpm in HMI-9 at 37 
°C for up to 1 hour to enable parasites to be harvested from the fat tissue. 
 
2.4   DNA Manipulation 
2.4.1   Polymerase chain reaction 
Polymerase chain reactions (PCR) were carried out in 0.2 ml PCR tubes (Axygen 321-10-051) 
in PeqSTAR 96 Universal Gradient thermo-cycler (95-96002, PeQLab Biotechnology). GoTaq® 
Flexi DNA polymerase (Promega) was used for routine PCR reactions to confirm the presence 
or absence of a gene or DNA fragment of interest. PCR primers were designed using Primer3 
Plus Design software (Untergasser et al., 2007) and all primers were manufactured by Sigma 
Aldrich (Appendix A). PCR reactions were performed on 50 ng T. b. brucei gDNA. A 50 μl 
reaction in sterile water consisted of 10 µl 5x reaction buffer, 3 µl 25 mM MgCl2, 2 µl 10 mM 
dNTP mix, 2 µl 10 µM Forward primer, 2 µl 10 µM Reverse primer, 0.5 µl Taq Polymerase (5 
units/µl) and 29.5 µl MilliQ water. The reaction was performed with the following condition: 
95 °C for 5 min and [95 °C 30 s, (Tm-5) °C 30 s, 72 °C 1 min/kb] for 35 cycles and 72 °C for 10 
min. 
 
2.4.2   Agarose gel electrophoresis 
Gel electrophoresis was used to visualise DNA as well as for separating different length DNA 
fragments by restriction digest, gel purification of fragments of interest and to assess the 
amplicons from PCR reactions. Gel electrophoresis was carried out at 80 V for 1 hour using 
1% (w/v) agarose gels in 1x TAE buffer (40 mM Tris-Acetate, 1 mM EDTA, pH 8). For the nucleic 
acid stain, ethidium bromide (10 mg/ml, Sigma) was added during the preparation of agarose 
gels to enable the visualisation of the separated DNA fragments in a dilution of 1:100, 000. 







size of the DNA fragments of interest was estimated using DNA ladders from New England 
Biolabs.  
 
2.4.3  Bacterial transformation 
For transformation, chemically competent laboratory stocks of XL-1 blue E. coli cells (C7373-
03) stored at -80 °C were used. One microliter of prepared plasmid was added to 100 µl of 
competent bacteria and the mixture incubated on ice for 30 min. The cells were heat shocked 
at 42 °C for 30 seconds in a water bath. To allow the cells to recover before selection, 800 µl 
of Luria broth (LB) broth was added to the cells and incubated at 37 °C for 45 min while 
shaking. The cells were then plated onto selective LB agar plates (1 mg/ml ampicillin or 1 
mg/ml kanamycin) and incubated at 37 °C overnight. All plasmids used in this thesis contain 
ampicillin or kanamycin resistance genes. Only cells with the plasmid with formed colonies 
were seen the following day. The colonies were then used to prepare DNA (Section 2.4.4) to 
confirm that they have obtained a plasmid and that plasmid contains the appropriate 
sequence.  
 
2.4.4   Preparation of plasmid DNA 
For plasmid DNA preparation, a mini-prep was carried out. A discrete colony of interest on an 
LB agar plate was picked with a sterile pipette tip and used to inoculate 5ml of LB broth. In 
all, Ampicillin or kanamycin drug (1 mg/ml) was added to the culture. The culture was grown 
overnight at 37 °C with shaking. On the following day, 2 ml of culture is transferred to a 2 ml 
eppendorf tube and centrifuged at 16,000 g for 5 min at room temperature. The extraction 
was done using the Monarch Plasmid Miniprep Kit (NEB T1010). The supernatant was 
removed and 200 µl of plasmid resuspension buffer (B1) was added to the pellet. The pellet 
was resuspended by rapping the eppendorf along a rack and 200 µl of plasmid lysis buffer 
(B2) added. The sample in the tube was mixed by inversion and 400 µl of pre-chilled plasmid 







incubated for 2 min at room temperature. The sample was then centrifuged at 16,000 g for 5 
min at room temperature.  
The supernatant was transferred to a spin column and centrifuged for 1 min. The flow through 
was discarded and column re-inserted column in the collection tube and added 200 µl of 
plasmid wash buffer 1 and centrifuged for 1 min.  
This was followed by adding 400 µl of plasmid wash buffer 2 and centrifuged for 1 min. The 
column was transferred into a clean 1.5 ml microfuge tube and added 30 µl of DNA Elution 
Buffer. After 1 min of incubation at room temperature, the sample was spun for 1 min to elute 
DNA. and stored at -20 °C. 
 
2.4.5   Plasmids and Constructs 
To generate knock-out constructs for complex I (cI) subunits NUBM and NUKM, about 500 bp 
of the 5′ and 3′ intergenic regions from NUKM and NUBM were amplified using NUBM 5’ and 
3’ UTR and NUKM 5’ and 3’ UTR forward and reverse primers listed in Appendix A and cloned 
into pGEM-T Easy (Promega). Knockout constructs using pLew 13 and pLew 90 were 
generated as described by (Ochatt et al., 1999). The constructs used in this study are listed in 
Table 2.2. The open reading frames of NUBM and NUKM (Tb927.5.450 and Tb927.11.1320 
respectively) were PCR amplified with forward and reverse primers for NUBM and NUKM 
(Appendix A). The amplified PCR products were cloned into expression vector pLew 79-3V5-
PAC as described (Surve et al., 2012) to generate expression vector for the two genes. An 
example of one of the many plasmids used is shown in figure 2.1. The remaining plasmid maps 
used in this thesis are shown in Appendix B. 
To generate the synthetic knockout construct for NUKM, about 200 bp proximal of the 5′ and 
3′ intergenic regions from NUKM gene with 3’ aldolase used as housekeeping gene. The 
selectable marker used here was phleomycin (KO_NUKM_proximal_phleo_3Aldo). For 
KO_NUKM_distal_blast_5Aldo construct, the 200 bp was distal to the 5′ and 3′ intergenic 







used as drug marker (Table 2.2). For plasmids used for making probes for northern analysis, 
COX VI (Tb927.10.280) coding sequence was inserted into the multiple cloning sites of 
pBluescript sk+ by in silico cloning using Seqbuilder software (version 14, DNASTAR). Direct 
integration of COX VI into the vector was confirmed using M13 forward and reverse primers 
(Appendix A) and COX VI PCR product used to prepare riboprobe for northern blot analysis. 
The Sanger sequencing reaction was set-up using the BigDye® Terminator v3.1 Cycle- 
Sequencing Kit (Applied Biosystems) using ABI 3730XL capillary sequencing instrument at the 









Figure 2.1 pLew 13 vector with T7 RNA polymerase and neomycin gene. The bacterial resistance is 
ampicillin and the target locus is tubulin. This plasmid served as the backbone to generate the 









Table 2.2 List of constructs used in this study 
Name of plasmid  Resistance Markers 
pTbNUBM-KO1 (pLew 13) Neomycin (NEO) 
pTbNUBM-KO2 (pLew 90) Hygromycin (HYG) 
pTbNUKM-KO1 (pLew 13) Neomycin (NEO) 
pTbNUKM-KO2 (pLew 90) Hygromycin (HYG) 
pHD1344-tubNUKM (pHD1344-tub) Puromycin (PAC) 
pEX-K4 NUKM- 1_ Blasticidin (BSD) 
pEX-K4 NUKM- 2 Phleomycin (BLE) 
COX VI pBluescript sk+  Ampicillin (AMP) 
 
2.5   Microscopy 
For 4, 6-diamidino-2-phenylindole (DAPI) (Life Technologies) staining, T. brucei cells were 
washed in PBS after harvesting at 1 × 106 cells/ml and concentrated by centrifuging at 5000 x 
g for 3 min. The pellet was resuspended in 50 μl of 1× PBS and smeared onto poly-L-lysine 
slides (VWR, 631-0107) and allowed it to air-dry. The adhered cells on the slides were fixed in 
ice cold methanol stored at -20 °C. The cells were then incubated with 20 μl of 10 μg/ml DAPI 
for 2 min to stain the nuclei and the mitochondrial DNA, followed by three washes with 1x 
PBS. Slides were mounted with a coverslip by application of Mowiol (6 g glycerol, 2.4 g 
Mowiol, 12 ml 0.2 M Tris, pH 8.5 (Harlow Chemical, Kent, United Kingdom) containing 4 μl p-
Phenylenediamine (PDA, Sigma) to a final concentration of 1 mg/ml. The slides were 
examined under a microscope (Leica DMR, Mannheim/Germany) using a 100× oil immersion 
objective. 
 
2.5.1   Indirect immunofluorescence assay (IFA) 
Differentiation of T. brucei cells into stumpy forms was assessed by IFA using a PAD1 antibody 
(Dean et al., 2009). A drop of blood from the tail vein of an infected mouse was smeared on 
a polysine-covered slide (VWR; 631-0107). It was then allowed to air dry and fixed in ice-cold 
methanol at least overnight. The fixed slides were rehydrated in 1x PBS for 5 mins in a glass 







in a humidity chamber. Slides were washed once in PBS then incubated with 50 μl of α-PAD1 
antibody (courtesy of Professor Keith Matthews) diluted in 2% BSA in PBS, 1:1000 for 1 hr at 
37 °C in a humidity chamber. Slides were washed three times in PBS, incubated with 
secondary antibody diluted in 2% BSA PBS (anti-rabbit Alexa Fluor 488 goat anti-rabbit IgG ref 
A11008; lot 1408830 1:500).  
The slides were then washed once in PBS for 10 min and slides stained with 50 µl of 10 µg/ml 
DAPI in PBS for 2 min in the dark to highlight the nuclei and kinetoplast of the cells.  
The slides were mounted with Mowiol containing 2.5% DABCO (1, 4-diazabicyclo [2.2.2] 
octane) and analysed on a Zeiss Axioskop 2 plus or Zeiss Axio Imager Z2 and images captured 
on QCapture Suite Plus Software (version 3.1.3.10, https://www.qimaging.com). Cropping of 
images and adjustment of contrast and brightness were done using ImageJ software 
(Schneider et al., 2012). 
 
2.6   RNA Sample Preparation 
To ensure a completely sterile and RNase-free working area for RNA work, benches and 
pipettes were cleaned thoroughly with 70% ethanol and RNase ZAP (Ambion), and filter tips 
were used to reduce RNase contamination. RNA samples were prepared from 30 ml of 
logarithmically growing cell culture to obtain at least 1 x 107 cells. The cells were centrifuged 
at 800 x g for 10 min and the cell pellet was resuspended in 600 µl RLT buffer from a QIAGEN 
RNeasy Mini Kit (74106) supplemented with 10 µl -mercaptoethanol/ml to lyse the cells. The 
lysate was then stored at -80 °C until processing. Upon thawing, the lysate was homogenised 
by vortexing at full speed for 1 minute. The RNA was then extracted using QIAGEN RNeasy 
Mini Kit, which uses an RNeasy spin column, according to manufacturer’s instructions. RNA 
was eluted into 30 µl of water. DNase treatment was added after RNA extraction using an 
Ambion TURBO DNA-free kit (Applied Biosystems AM1907) according to manufacturers’ 
instructions. RNA was stored at -80 °C. Repetitive freeze-thaw of samples was avoided and 







2.7   Nano Agilent analysis of RNA  
The integrity of the DNase-treated RNA was assessed using the Agilent Bioanalyzer nanochip 
kit. Briefly, the chip priming station was set to ‘C’, and an RNA Nano chip was positioned in 
the station. 1 µl Nano dye concentrate was mixed with 65 µl of spin filtered (1500 x g for 10 
minutes) Nano gel matrix, and vortexed thoroughly. 9 µl was pipetted into the ‘G’ well for the 
RNA Nano chip and was dispensed by pressing down of the plunger for 30 seconds.  
9 µl of the gel-dye mix was then pipetted into the two wells above well ‘G’, 5 µl Nano marker 
was pipetted into all remaining wells and 1 µl heat-denatured RNA ladder (70 °C for 2 minutes) 
was pipetted into the ladder well. 1 µl of each sample was loaded into each of the sample 
wells before the chip was vortexed for 60 seconds at 2400 rpm. The chip was inserted into 
the Agilent 2100 Bioanalyzer to start the run.  
 
2.8   Reverse transcription of T. b. brucei RNA  
Reverse transcription was performed using SuperScript III (Life Technologies) protocol. The 
reaction was set up using 500 ng RNA and 11 µl dH2O was mixed with 1 µl of 10 mM dNTPs 
and 1 µl of 200 ng/µl random hexamer primers (NEB). The sample mixture was incubated at 
65 °C for 5 min and then put on ice for at least 1 min. This was followed by adding 4 µl of 5x 
first strand buffer, 1 µl of 0.1 M DTT, 1 µl RNaseOUT (40 units/µl) (Invitrogen) and either 1 µl 
Superscript III Reverse Transcriptase (+RT) or 1 µl dH2O (-RT). The reaction condition used 
was 25 °C 5 min, 50 °C 60 min and 70 °C 15 min. After the stated incubations, 1 µl RNase H 
(NEB) was added, and the mixture incubated at 37 °C for 20 min to remove RNA. The 
temperature was increased to 90 °C for 10 min to stop the reaction.  
 
2.9   Parasite quantification by quantitative PCR (qPCR) 
To quantify parasites, 25 mg of tissue was weighed into a 1.5 ml tube. The Nzytech kit 







using Nanodrop ND-1000 (Thermo Scientific). The Tachyon ROX SYBR 2X Master Mix dTTP 
blue (UF-RSMT-B0101, Neurogenetic) was used for the qPCR estimation with T. brucei 18S 
rDNA primers (Appendix A). Reactions were carried out in a Stephone™ Real-Time PCR 
machine (4376600, Applied Biosystems). To each well of a 96 well plate the following 
components were added and mixed: 10 µl 2 x SYBR Green PCR Master Mix, 8 µl 1.5 µM primer 
mix, and 2.0 µl diluted DNA. Template DNA was diluted 1:10 for investigating gene and 1:50 
for internal control. Each reaction was done in triplicate.  
Thermocycler condition used was: 50 °C 2 min, 95 °C 10 min, [95 °C 15 s, 60 °C 1 min] x 40. A 
melt curve was added to the end of PCR reaction to ensure that there was only one 
amplification product. Melt curve stage: 95 °C 15 s, 60 °C 1 min, 95 °C 15 s. Results were 
analysed via the CT method (Carnes and Stuart, 2007). The data was analysed using the ABI 
Stephone software version 2.  
 
2.10  Quantitative reverse transcriptase PCR (qRT -PCR)  
The quality of the RNA was checked on the Agilent 2100 Bioanalyzer (see Section 2.7) and the 
RNA quantified with Qubit fluorometer (Q32857, Invitrogen). Quantitative PCR reactions 
were performed in a total volume of 20 μl, with the same protocol and reagent, equipment 
and calculation described in Section 2.9. Primers used are listed in Appendix A. The cDNA was 
1:10 for investigating genes and 1:50 for the GPI8, a stable housekeeping transcript was used 
as endogenous loading control. Mock reverse transcribed RNA (‘-RT cDNA’) was used as a 
negative control with each primer set. The internal reference used was the WT/WTγ or WT 










2.11  Northern blot 
2.11.1 Probe preparation  
Riboprobes were prepared by performing standard PCR (see Section 2.4.1) on COX VI 
pBluescript sk+ plasmid to amplify COX VI gene using M13 forward and reverse primers. DNA 
was purified using Qiagen column and estimated DNA was used to prepare riboprobes 
following manufacturer’s protocol (Roche). DNA was then purified before the riboprobe 
reaction was set up using DIG RNA labelling Kit (SP6/T7) (Roche). The reaction was set up 
using 1 µg of DNA and incubated with 2 µl of 10x NTP labelling mixture (10 mM ATP, 10 mM 
CTP, 10m MGTP, 6.5 mM UTP, 3.5 mM DIG-11_UTP, pH 7.5), 5 mM DTT, 20 units RNase 
inhibitor to prevent RNA degradation during the reaction, 1x transcription buffer and 40 units 
of T7 RNA polymerase. The reaction was incubated at 37 °C for 3 hr, after which 20 U of DNase 
1, RNase-free was added, and followed by further incubation for 15 min at 37 °C. The reaction 
was stopped by adding 2 µl of 200 mM ethylenediaminotetraacetic acid (EDTA), pH 8.0. The 
probe was then precipitated with 100 mM LiCI and three volumes of cold 100% ethanol at -
80 °C for 1 hr. The sample was centrifuged at 12,000 x g for 15 min, and the pellet was washed 
once with 70% ethanol and allowed to air dry after discarding the supernatant. The pellet was 
resuspended in 50 µl of nuclease-free water supplemented with 20 U RNase inhibitor (Thermo 
Fisher Scientific, UK). The ESAG9 (Tb927.5.4620) riboprobe was a kind gift from Dr Eva Rico, 
(former postdoc in Keith Matthews lab). 
 
2.11.2  RNA gel preparation and running method 
RNA agarose gels were prepared by dissolving 1.8 g of agarose in 130.5 ml of distilled water 
and microwaved. 15 ml of 10 x MOPS (23.13 g MOPS, 10 ml of 2.5M sodium-Acetate (pH 7.0), 
10 ml of 0.5 M EDTA in 500 ml; autoclaved) was added to make 1x MOPS final concentration 
and swirled when cooled. Additionally, 4.5 ml of 37% formaldehyde was added in the 
chemical hood before the gel was cast and left to set in the hood. An equal quantity of 1 µg 
RNA from each sample in a volume less than 6 µl was added to 9 µl formamide, 3 µl of 37% 







heated to 65 °C for 5 min to remove any secondary structure. The samples were loaded into 
the agarose gel and run at 150 Volts in 1x MOPS running buffer for 90 min. The gel was stained 
with 20 µl of 10 mg/ml ethidium bromide in 200 ml of 1x MOPS for 15 min with shaking to 
check for equal loading. The gel was then de-stained by washing at least twice in purite water 
for 30 min with shaking. The gel was then visualised and photographed using a Syngene G:box 
UV transilluminator (Syngene United Kingdom). This allowed visualisation of the ribosomal 
RNA within the samples, allowing the identification of under or overloaded lanes.  
 
2.11.3  Northern blot setup 
Northern blotting was performed using capillary transfer onto a positively charged nylon 
membrane. A plastic tray was filled with 10x saline-sodium citrate (SSC) up to about 2 cm the 
height of the plastic tray. A sandwich box was placed upside down in the tray and a square 
plastic, same size as that used to cast the RNA agarose gel was then placed on the sandwich 
box. A piece of chromatography paper (Fisher CHR200) pre-wet in 10x SSC (1.5 M NaCl, 150 
mM tri-sodium citrate) was placed over the gel tray and down into the 10x SSC in the plastic 
tray to create a wick for buffer transfer.  
The RNA agarose gel was then placed upside down onto the chromatography paper and 
clingfilm wrapped around the gel and over the plastic tray to prevent evaporation to the 
environment. A piece of positively charged nylon membrane (Roche 11 417 240 001) pre-wet 
in 10x SSC was placed on top of the gel and this was rolled flat using a 10 ml serological pipette 
to remove any bubbles between the gel and the membrane. The membrane was handled 
using plastic tweezers. Two pieces of chromatography paper, pre-wet in 2x SSC were placed 
on top of the membrane making sure all bubbles were removed. A pile of paper towels, four 
inches thick were placed on top of two pieces of paper and a large area flat piece of plastic 
placed on top to hold the heavyweight catalogue. The blot was left to transfer overnight and 
next day, nylon membrane was taken from the setup and allowed to dry. The RNA was UV 
cross-linked to the membrane using a UV cross-linker CL-508 (0.120 joules, 254 nm) (Uvitec 







2.11.4  Hybridization of the blot  
The membrane was pre-hybridised in 10 ml of pre-warmed hybridisation buffer in a 
hybridisation tube at 68 °C for 1 hour in a hybridisation oven (Techne Hybridiser HB-1D) with 
rotation. To 100 µl of hybridisation buffer, 2 µl of riboprobe was added and heated at 99 °C 
for 5 min. The heated probe in the buffer was added to 7 ml of hybridisation buffer pre-
warmed to 68 °C. The pre-hybridisation buffer was removed and the probe in the 
hybridisation buffer added to the membrane. The membrane was then hybridised overnight 
at 65 °C with rotation. 
 
2.11.5 Detection of mRNA in Samples  
After an overnight hybridisation, the blot was washed at 68 °C twice in 100 ml of 2x SSC with 
0.1% SDS for 30 min and then once in 100 ml 0.5x SSC with 0.1% SDS for 30 min.  
The membrane was removed from the hybridisation tube and subsequent steps performed 
in sandwich boxes. The membrane was rinsed in 100 ml of RNA wash buffer (1x maleic acid 
with 0.3% Tween 20) for 1 minute at room temperature. The membrane was then blocked in 
50 ml Maleic Acid buffer (100 mM maleic acid, 150 mM NaCl, pH 7.5) with 1% DIG blocking 
reagent (Roche 11 096 176 001) for 1 hour at room temperature with shaking. After pouring 
off the blocking solution, the membrane was then incubated in 50 ml of Maleic Acid buffer 
with 1% DIG block and 1.5 U of Anti-DIG (Anti-Digoxigenin-AP Fab Fragments Roche 11 093 
274 910) for 30 min at room temperature with shaking. The membrane was washed again 
three times in RNA wash buffer for 10 min before being incubated in 50 ml of RNA detection 
buffer (100 mM Tris HCl and 100 mM NaCl; pH 9.5) for 2 min, both at room temperature. The 
membrane was placed in a sleeve of heat sealable polyethylene (Bag W) and 10 µl of 25 mM 
CDP-Star Chemiluminescence substrate (Roche 11 685 627 001) in 1 ml of RNA detection 
buffer was applied evenly over the surface and left for 2 min. The Bag W was closed over the 
membrane and excess CDP-Star was removed using paper towels to drive the solution out 
from between the sleeve of Bag W. The sleeve was then sealed with a Hulme Martin Impulse 







the membrane in an X-ray cassette in the dark. Once in a dark room, an Amersham Hyper film 
ECL (GE Healthcare, UK) was placed in the cassette on top of the membrane and exposed for 
1 min initially and the film developed in a Compact X2 X-ray processor. Further films were 
exposed for either a longer or shorter duration depending on the result from the first 
exposure.  
 
2.12  Western blot analysis 
Sodium dodecyl sulphate–polyacrylamide gel electrophoresis (SDS–PAGE) and 
immunoblotting were performed as described earlier (Tasker et al., 2000, Breidbach et al., 
2000). Monoclonal antibodies used were: T. brucei procyclin (purchased from Cedarlane, 
Canada), PAD1 (courtesy of Professor Keith Matthews), anti-PNT1 (a kind gift from Jeremy 
Mottram, University of York, United Kingdom) (Grewal et al., 2016) and UBP1 antibody 
(donated by Alejandro Cassola’s laboratory; Argentina) (Cassola et al., 2015). Anti-elongation 
factor 1-alpha antibody (Merck Millipore; 05-235) at a 1:7000 dilution was used as loading 
control. To prepare whole cell protein samples for analysis, 2 × 106 cells were pelleted, washed 
in 1x PBS and resuspended in 10 μl of 2x sodium dodecyl sulphate (SDS) sample buffer (4% 
SDS, 20% glycerol, 120 mM Tris-HCl, pH 6.8, 0.2% bromophenol blue, 200 mM DTT). These 
extracts were then resolved on a precast NuPAGE 4-12% Bis-Tris Gel (Novex Life 
Technologies), run at 150 V with 500 ml ice-cold 1x MOPS SDS running buffer (25 ml 20 x 
MOPS SDS running buffer + 475 ml d H2O) (Invitrogen), using 1 L ice-cold 1x transfer buffer 
(200 ml methanol, 700 ml purite water and 100 ml of 10x transfer buffer (390 mM glycine, 
480 mM Tris, 0.36% SDS), and run at 90 V for 90 min. This was followed by blocking with 5% 
w/v skimmed milk in 1x Tris- Buffered Saline Tween (TBST) (10 mM Tris-HCl,150 mM NaCl and 
0.05% Tween-20) for 1 hr at room temperature. The membranes were then incubated with 
primary antibody at dilutions of 1: 1000 for PAD1, 1:3000 for EP procyclin, 1:1000 for PNT1 or 
1:500 for UBP1 in 5% skimmed milk outlined above. The incubation was done overnight at 4 
°C under shaking. Membranes were then washed thrice for 10 min each in 0.05% TBST. Both 







Dylight 800, Thermo Scientific) secondary antibodies were diluted 1:7,500 and incubated 1 h 
at room temperature. Secondary antibodies were diluted in 50% PBS and 50% Licor blocking 
buffer.  
The PNT1 secondary antibody was anti-chicken diluted in 1:2000 in 5% skimmed milk. Washes 
were repeated after secondary labelling, washed three times for 10 min each in TBST, and 
then placed in 1× Tris- Buffered Saline (TBS) (NaCl-81.8 g, Tris- 12.1g in 1L litre dH2O) prior to 
developing. Membranes were imaged using a Licor Odyssey CLx scanner. 
 
2.13  Southern blotting 
Probes were designed and produced to detect the NUKM (Tb927.11.1320) or NUBM 
(Tb927.5.450) coding sequence (to confirm presence or absence of the gene) and NUBM 5’ 
or NUKM 5′ intergenic region (to confirm the correct integration of constructs). Probes were 
prepared using the DIG High Prime DNA labelling and detection starter kit II (Roche; 
11585614910). For each sample, 1 µg of a double-stranded DNA template produced by either 
PCR or restriction digestion, according to the manufacturer’s instructions.  
For each sample, 1 µg of gDNA was digested with pst1 restriction enzyme (Promega; R6111) 
for a minimum of three hours at 37 °C and run on a 1% (w/v) agarose gel at 20 V overnight. 
The gel was soaked in Depurination Solution (0.25 M HCl) for 15 min with agitation. It was 
then denatured using a denaturation solution (1.5 M NaCl/0.5 M NaOH) 2 times, 15 mins each 
with agitation and then neutralised using neutralization solution (1M Tris and 1.5M NaCl; pH 
7.4) before the DNA was transferred to a nylon membrane (Amersham Hybond-XL, GE 
Healthcare Bio-Sciences Corp., Piscataway, NJ, USA) overnight. The membrane was removed 
the next day and cross-linked using a UV cross-linker CL-508 (0.120 joules, 254nm) (Uvitec 
Ltd, UK). 
Hybridization was carried out overnight at 44 °C for the 5’ NUKM or 48 °C for 5’ NUBM 
intergenic region probe respectively. To probe for NUKM gene, the hybridization temperature 
was 48 °C and that of NUBM was 48 °C. The DIG-labelled DNA probe was added to DIG Easy 







After 16 hr of incubation, the membrane was washed twice for 5 mins with 2x SSC / 0.1% SDS 
at room temperature, and then twice for 15 mins with pre-warmed 0.5x SSC/0.1% SDS at 65 
°C. The membrane was rinsed in maleic acid buffer with 0.3% Tween 20 for one min at room 
temperature. The membrane was blocked in 1% DIG block (Roche) in the maleic acid buffer 
for one hour at room temperature with agitation and then incubated with Anti Digoxigenin-
AP Fab Fragments (Roche) in 1% DIG block/maleic acid buffer for 30 mins. Maleic acid buffer 
with 0.3% Tween 20 was used to wash the membrane three times for 10 mins. The blot was 
soaked in the detection buffer (100 mM Tris pH 9.5, 100 mM NaCl) for two mins and then 
placed between two sheets of polyethylene followed by addition of 10 µl of 25 mM CDP-Star 
chemiluminescent substrate (Roche, 11685627001) diluted 1:100 in the detection buffer for 
two mins. Excess substrate was removed, and the polythene sealed using a heat sealer before 
incubation at 37 °C for 15 mins. The blot was then exposed to X-ray film and developed as 
described (Section 2.11.5). 
 
2.14  Bioinformatics 
2.14.1  RNA-Seq analysis: 
For RNA-Seq (Wang et al., 2009) analysis, mice were infected with two pleomorphic T. brucei 
AnTat1.1 90:13 cell lines. An akinetoplastic (AK) cell line expressing ATPase subunit L262Pγ 
that had lost all mitochondrial DNA spontaneously and a WTγ cell line with complete kDNA 
but otherwise being isogenic. Slender cells were harvested on day four post-infection whereas 
short stumpy forms were harvested on day seven post-infection when most of the population 










Figure 2.2 Schematic diagram showing sample preparation for RNA-seq analysis.  Mice were infected 
with two pleomorphic T. brucei AnTat1.1 90:13 cell line. The akinetoplastic (AK) cell line expresses 
ATPase subunit L262Pγ that had lost all mitochondrial DNA spontaneously and the isogenic WTγ cell 
line has complete kDNA.  
  
 
The slender and stumpy characteristics of parasites were confirmed by western blot analysis 
for PAD1 (Section 2.12) and IFA for PAD1 (Section 2.5.1). Total RNA was purified from parasite 
per three replicate (Section 2.6) and analysed by RNA-sequencing. Total RNA was reverse 
transcribed (Section 2.8) and library generated using oligo dT priming containing the Illumina-
specific Read 2 linker sequence. After the first strand synthesis, the RNA was removed, and 







strand synthesis was followed by a purification step rendering the protocol compatible with 
automation. Library amplification was followed which required step sequences for cluster 
generation. Next-generation sequencing (NGS) reads were generated towards the poly(A) tail 
to directly correspond to the mRNA sequence. The presence and quantity of RNA in the 
biological samples were sequenced by Beijing Genomics Institute (BGI). High-throughput 
sequencing of cDNA libraries by the Illumina HiSeq 4000 sequencer generated compressed 
fastq files with a characteristic length of each DNA read of 100 bp. Fastq formatted sequences 
were downloaded from the BGI website. The raw sequences were quality assessed using 
FASTQC. Based on the output of the FASTQC analysis, the raw fastq sequences required no 
further pre-processing to remove contaminating primers. These files were decompressed and 
mapped to the T. b. brucei TREU927 genome and annotation, downloaded in gff format from 
ftp.sanger.ac.uk/pub/project/pathogens/gff3/CURRENT/ in February 2015. Alignments to the 
reference set were performed using bowtie2 (version 2.2.7) software, requirement for 
concordant read pair mapping was applied, and all other alignments discarded. The Sequence 
Alignment Map (SAM) files that were generated by the mapping of the DNA reads to the 
reference genome were converted to sorted and indexed Binary Alignment Map (BAM) files 
using the Samtools program. Read counts for each of the predicted protein-coding regions 
were determined. The counts data were subsequently normalized to the sample with the 
lowest number of alignments, counts converted to log2, and then quantile normalized. 
Pairwise comparisons of sample groups were performed on the normalized tag counts using 
linear modelling (Bioconductor limma package). Analyses of the RNA-Seq data were 
performed by Dr Alasdair Ivens, Director of Bioinformatics, CIIE, University of Edinburgh, 
United Kingdom. Statistical analysis of graphs was done in GraphPad Prism 7 software. In all 
cases, a p-value of less than 0.05 was significant (i.e. given the null hypothesis, the probability 







3    The consequences of kDNA loss on 
nuclear gene expression  
3.1 Background and rationale 
The regulation of mitochondrial activity in different developmental stages of trypanosomes 
requires coordination between the nucleus and kinetoplast (Schneider, 2001). An example 
of this regulation is seen with the cytochrome oxidase (COX) complex. This enzyme complex 
has ten nuclear-encoded and three kinetoplastid-encoded (COX I, II, and III) subunits. RNA 
editing of the cytochrome oxidase complex is restricted to the COX II and III subunits (Feagin 
and Stuart, 1988). The COX VI has been extensively studied compared to the other nuclear-
encoded components (Matthews and Gull, 1998). The COX VI mRNA is upregulated in 
stumpy forms and is more abundant in the procyclic forms, the stage where COX VI protein 
expression occurs (Tasker et al., 2001).  
Mitochondrial retrograde signalling is a pathway for communication from mitochondrion to 
nucleus, thereby influencing many cellular activities (Butow and Avadhani, 2004). 
Coordination between the nucleus and mitochondrial genome has been studied in 
organisms such as yeast, mammals and plants. In yeast, mitochondrial dysfunction causes 
the nucleus to modulate gene expression to compensate for the defect (Knorre et al., 2016). 
Though successful completion of the life cycle of T. brucei depends on stringent regulation 
of mitochondrial activity, it is not known if similar signalling pathways exist in these 
parasites. 
Analysis of the genome sequence of T. brucei genome projected over 9000 predicted 
genes; 1700 were specific to T. brucei with about 900 being pseudogenes (Berriman et 
al., 2005).  
Little is known about global changes at the transcriptional level (Matthews et al., 2004; 
Wheeler et al., 2011), even though the transcriptome of bloodstream and insect procyclic 







developmentally regulated have been attributed to differences in mRNA stability (Clayton 
and Shapira, 2007). Various techniques have been used to assess gene expression in the 
different life cycle stages of trypanosome parasites, including microarray analysis, 
nimbelgen profiling and massively parallel signature sequencing (MPSS) (Harbers and 
Carninci, 2005; Reinartz et al., 2002). Nevertheless, these techniques have limitations which 
hinder detailed and accurate study aimed at fully understanding the transcriptome of 
trypanosome parasites. The RNA-Seq technology has being used to provide extensive 
knowledge on parasite biology and host interactions (Geiger et al., 2011). Moreover, RNA-
Seq can be used to elucidate the precise sequence of nucleotide transcripts and their relative 
abundance within a biological sample (Fiebig et al., 2015). 
The coordination of cell differentiation and gene regulation between the nuclear and 
mitochondrial genome in T. brucei has been studied. For example, the ability of bloodstream 
form parasites devoid of a mitochondrial genome to differentiate into procyclic forms has 
been determined (Timms et al., 2002). Reduction in the copy number of the nuclear-encoded 
COX VI transcript by RNAi showed that neither the other COX mRNAs encoded by the nucleus 
nor the mitochondrion were altered (Timms et al., 2002). This knock-down experimental 
procedure was carried out to determine whether the loss of a nuclear-encoded subunit 
transcript would influence the regulation of the kinetoplast-encoded subunits of the same 
enzyme complex. However, the study did not demonstrate coordinated regulation between 
the nucleus and mitochondrion during differentiation (Timms et al., 2002). In this thesis, the 
ability of akinetoplastic stumpy cells to upregulate COX VI mRNA following differentiation 
was investigated.  
Specifically, the RNA-Seq technology was used to obtain in vivo transcriptome data of 
akinetoplastic (AK) and wild type (WT) T. brucei cell lines before and after differentiation 
from slender to stumpy forms. Comparison of the transcriptome data from these two cell 
lines was used to obtain an overview of differentially expressed genes in the bloodstream 









3.1.1   Hypotheses 
1. The lack of a mitochondrial genome results in changes in nuclear gene expression in 
T. brucei, similar to retrograde signalling in organisms like yeast. 
2. The transcriptome of wild type and akinetoplastic cell lines of T. brucei changes 
during differentiation from slender to stumpy forms. 
 
 
3.2   Result 
3.2.1   Akinetoplastic cells express stumpy differentiation markers  
The PAD1 (Dean et al., 2009) and ESAG9 (Monk et al., 2013) proteins have previously been 
shown to be markers for stumpy forms of T. brucei. Wild type (WT) procyclic, WT/WTγ (WTγ) 
and WT/L262Pγ (kDNA0) (aAK) cell lines were used for the RNA analysis to probe for these 
stumpy markers in differentiated cells. The akinetoplastic slender cells were made kDNA 
independent by the introduction of L262P gamma mutation (See Section 2.1.1 and Table 
2.1). The WT/L262Pγ cell line was treated with acriflavine to obtain two akinetoplastic 
clones; the acriflavine dye concentrates within the kinetoplast to inhibit kDNA synthesis 
(Dean et al., 2013). The L262Pγ mutation was shown to render the bloodstream slender 
forms of T. brucei to be independent of the kDNA (Dean et al., 2013). To obtain an isogenic 
control, the wild type version (WTγ) was also introduced into the parental strain and was 
identified as the WT/WTγ strain (Dewar et al., 2018).  
The isogenic WT/WTγ strain and the akinetoplastic WT/L262Pγ strain were both generated 
by Caroline Dewar (Dewar et al., 2018). For this current study, the isogenic WT/WTγ strain 
and the akinetoplastic WT/L262Pγ strain were used for identification of the PAD1 and ESAG9 
markers following differentiation of slender to stumpy forms, in vivo.  
The isogenic WT/WTγ strain (simply referred to as WTγ) and two akinetoplastic clones 







stumpy forms. These stumpy forms were further induced to differentiate to procyclic forms 
via the addition of 6 mM cis-aconitate (Czichos et al., 1986) and incubated at 27 °C.  
The parental EATRO 1125 wild type strain and the isogenic wild type strain procyclic forms 
were grown in vitro. Prior to performing a Northern blot assay, ESAG9 and PAD1 riboprobes 
were prepared according to manufacturer’s protocol (see Section 2.11.1) and run on 1% 
agarose gel to determine their sizes (Figure 3.1). The sizes between 400 and 1000 bp 
obtained were satisfactory to proceed to probe for PAD1 and ESAG9. 
   
  
 
Figure 3.1 Determination of sizes of the COX VI, ESAG9 and PAD1 riboprobes using agarose gel 
electrophoresis. The molecular weight of the DNA ladder shown as 1000, 3000  and 9000 are in bp. 








RNA that were extracted from the stumpy and slender forms of the two aAk, as well as the 
isogenic WTγ clone and the parental EATRO 1125 strain (WT) were used for Northern blot 
assay for identification of the presence of the PAD1 and ESAG9 markers.  To generate stumpy 
or slender forms of T. brucei, MF1 mice were infected with the above-named cell lines via IP 
injection. Accurate measures of parasitaemia level and morphology during infection was 
recorded from wet blood smears for each cell line. Cells were harvested 4 days post infection 
(dpi), when morphologically slender cells dominated, and 7 dpi, when the population of cells 
were scored as being predominantly stumpy. RNA was also extracted from procyclic forms 
of the parental wild type strain (WT) and the isogenic wild type strain (WTγ). The procyclic 
RNA samples were extracted from cultured cells.  The procyclics and slender cells were both 
used as negative controls, as these PCF samples were not expected to express the PAD1 and 
ESAG9 markers. Following Northern blotting, the membranes were first hybridized with the 
PAD1 riboprobe to detect the presence of PAD1 mRNA. Thereafter, the detection of ESAG9 
mRNA using the ESAG9 riboprobe was also tested. As shown in Figure 3.2, there was 
increased expression of the PAD1 and ESAG9 mRNAs in the stumpy forms (SS) of the two 
aAk clones and the WTγ (SS) clone relative to the slender forms (SL) of the same clones. 
These observations supports recent findings demonstrating the differentiation of slender 





















Figure 3.2. Detection of PAD1 and ESAG9 markers in stumpy forms of wild type and akinetoplastic 
cell lines of T. brucei. The PAD1 and ESAG9 riboprobes were used for the Northern blot assay. The 
PAD1 Northern blot is shown as the two upper images and the ESAG9 Northern blot is shown as the 
two lower images. PAD1 Northern blot: Lanes 2, 4 and 6 represent stumpy form (SS) samples for aAk 
and WTγ clones while lanes 3, 5 and 7 represent slender form (SL) samples of these clones. Single-
stranded RNA (ssRNA) ladder is in lane 1 while the wild type procyclic samples are in lanes 8 and 9. 
ESAG9 Northern blot: Lane 1, 3 and 5 represent stumpy form samples for WTγ and aAK clones while 
lanes 2, 4 and 6 represent slender form samples of these cones. Lanes 7 and 8 represent the wild 
type procyclic samples. 
 
 
3.3   Nuclearly-encoded cytochrome oxidase is upregulated in 
differentiated T. brucei cells  
The RNA samples that were isolated from the two aAk, the WTγ clone and the parental 
EATRO 1125 strain (WT) were also used for determining the expression of cytochrome 
oxidase (COX VI) mRNA using the COX VI riboprobe (see Section 2.11.1). The main objective 
was to ascertain whether the absence of mitochondrial DNA in T. brucei affects the 







The data shown in Figure 3.3 indicate that there was higher expression of COX VI mRNA in 
the WTγ stumpy, procyclic forms (WT and WTγ) and aAK stumpy cell lines relative to the 
slender forms. The high expression of COX VI mRNA in the procyclic forms is expected, as 
previous study has shown that the COX VI mRNA and protein levels are enriched upon 
transformation of the bloodstream form of T. brucei to the insect form (Tasker et al., 2001). 
Interestingly, the expression of COX VI mRNA in aAK clone 2 stumpy form was lower than 
that of aAK clone 1 and WTγ stumpy form. The low expression of COX VI mRNA in one of the 
aAk clones may be due to clonal variation, although this cell line was found to express high 
levels of ESAG9 and PAD1 mRNA during stumpy development (Figure 3.2).  
The upregulation of COX VI expression have been reported in stumpy cells (Tasker et al., 
2001). The authors found that during the differentiation of stumpy forms to procyclic forms 
in T. brucei, there is an initial upregulation of COX VI expression, which is later translated to 
proteins. The data shown in the present study indicates that the level of mRNA expression 
in the stumpy form of wild type strain was similar to the stumpy form of the aAK clone 1 cell 
line, which suggests that the absence of kDNA did not alter the expression of the nuclear-
encoded COX VI gene.  
This observation might correlate with data from Timms and colleagues (Timms et al., 2002), 
where it was found that knockdown of COX VI mRNA in differentiating parasites did not 
affect mRNA levels of mitochondrially-encoded constituents of the same enzyme complex 









Figure 3.3 Detection of COX VI mRNA expression at the various stages of the life cycle of T. brucei.  
The COX VI riboprobe was used for the northern blot assay. The stumpy form samples for WTγ and 
aAK clones 1 and 2 are represented by lanes 1, 3 and 5. The slender form samples for WTγ and aAK 

















3.3.1   Akinetoplastic stumpy cells cannot differentiate into procyclic 
forms 
To investigate the presence of the procyclic marker EP procyclin on the differentiated cell 
lines, a Western blot assay was performed using the EP procyclin antibody to identify the 
presence of the procyclic marker, EP procyclin, on akinetoplastic T. brucei cell lines following 
differentiation of stumpy forms. Stumpy forms of the T. brucei cells were harvested from 
infected mice, purified by DE52 chromatography and allowed to differentiate to procyclic 
(Section 2.1.4). The elongation factor 1 (EF1; Millipore, CA) was used as a loading control 
(Rosenberry et al., 1989).  
It was observed that the akinetoplastic stumpy forms were unable to differentiate to late 
procyclic forms, as cell death was recorded approximately 48 hours after the initiation of 
differentiation. The data shown in Figure 3.4 indicate that only kDNA-containing procyclic 
forms (WT- and WTγ-differentiated procyclic forms) showed detectable protein band for EP 
procyclin on the Western blot. As was expected, the expression of EP procyclin was not 
detected for the bloodstream forms of T. brucei. 
This observation has already been reported by Dr. Caroline Dewar (PhD thesis, 2015) and 
also supports previous published data (Timms et al., 2002). Collectively, these data provide 
evidence for the requirement of kDNA-encoded gene products in procyclic development. 
Moreover, the data indicates that the L262P mutation cannot compensate for the 
requirement of kDNA during differentiation of bloodstream forms of T. brucei to procyclic 
(except where a compensatory mutation has been introduced). The checkpoint is 
independent on regulation of the initial differentiation from slender to stumpy but is 












Figure 3.4 Detection of EP procyclin in the procyclic forms of T. brucei. Upper gel: Western blot 
detection of EP procyclin in wild type and akinetoplastic cell lines of T. brucei. Lower gel: Detection 
of elongation Factor 1 (EF1), which was used as a loading control. The EP procyclin protein runs at 














3.4   Validation of RNA samples prior to RNA-Seq analysis 
As previously reported, akinetoplastic stumpy cells lack a membrane potential and have a 
reduced lifespan in vitro and in mice (Dewar et al., 2018). The loss of membrane potential 
might have led to the occurrence of programmed cell death, which could be attributed to 
the limited life span of stumpy cells (Duszenko et al., 2006). These observations raised the 
question on how stumpy forms generate mitochondrial ATP and Δψm, and whether the 
akinetoplastic cells also differ from WT at the gene level which may modulate gene 
expression during differentiation. The transcriptomics analysis that is described in this thesis 
was performed to provide insight into these unanswered questions. To compare the nuclear 
transcriptome of a wild type strain with an AK mutant, before and after differentiation from 
the slender to stumpy, mice were infected with two pleomorphic T. brucei EATRO 1125 
(AnTat1.1 90:13) cell lines. One of the cell lines has one allele of the nuclear-encoded F1FO-
ATPase subunit γ replaced with L262P mutation, WT/L262Pγ (kDNA0) (AK). This AK cell line 
lost all mitochondrial DNA spontaneously. The other cell line is an isogenic control (WT/WTγ) 
(WTγ) whose L262Pγ allele was replaced by wild type (WT) ATPase subunit γ. Stumpy 
characteristics of each cell line were confirmed by indirect immunofluorescence staining for 
PAD1, a marker expressed on the cell surface of stumpy cells. PAD1 expression was seen in 
AK and WTγ stumpy cells (Figure 3.5). This provided further evidence that kDNA is not 
required for differentiation to stumpy (Dewar et al., 2018). The IFA results for PAD1 
detection in the other biological replicates for AK and WTγ are shown in Appendix C. 
Total RNA was purified from parasites during their biological progression from slender to 
stumpy forms. RNA was extracted from three mice for WTγ slender and stumpy, four 
individual samples for WT/L262Pγ AK stumpy and three samples for WT/L262Pγ AK slender 
and were analysed by RNA-seq. This allowed biological variability to be assessed and tested 
statistically. The integrity of the DNase-treated RNA was assessed using the Agilent RNA 
6000 Nano chip on 2100 Agilent bioanalyser. 
The expression of PAD1 in Figure 3.5 combined with morphological analysis, confirmed that 
















Figure 3.5 Immunofluorescence staining of PAD1 on stumpy forms of T. brucei. Both WTγ and AK expressed the PAD1 surface protein marker, labelled 







The minimal or no expression for PAD1, and the analysis of morphology also indicated that 
slender populations were obtained for the RNA-Seq analysis. Both stumpy and slender RNA 










Figure 3.6 Assessing the purity and integrity of RNA samples prior to RNA-seq analysis. The upper 
gel image shows six samples: three RNA samples extracted from three mice infected with T. brucei   
parasites and harvested on day 4 when parasites were predominantly slender forms, and the 
remaining three RNA samples were extracted from three mice infected with T. brucei parasites 
harvested on day 7 post-infection with cell population being predominantly stumpy forms. The lower 
gel image shows integrity profile of RNA samples from  three slender forms and four stumpy forms 















3.5 Validation of transcriptome datasets 
To validate dataset for analysis of mRNAs that are regulated during differentiation events, 
sequence reads of 100–125 bp were aligned to the T. brucei reference genome to reveal 
families of related genes. Requirement for concordant read pair mapping to more than one 
locus included and all discordant alignments were discarded. In addition, all reads mapped 
to more than one position on the T. brucei reference genome were discarded. Results were 
then normalised to the sample with the lowest number of alignments, counts converted to 
log2 and quantile normalised for linear model fitting purpose. A pairwise comparison of 
sample groups was performed on the normalised counts (See Section 2.14.1). 
The counts were converted to log2, and the quantile was normalised for linear model fitting 
purposes. Alignments of sequence reads to the T. brucei reference genome were performed 
using bowtie 2. Data from Eleanor Silvester’s thesis (2016) was used as a reference; she had 
previously performed a similar analysis using the slender and the stumpy forms of 
pleomorphic T. brucei EATRO 1125 cell line without any genetic manipulation. 
For simplicity purposes, the reference samples would be referred to as REF SL or REF SS, 
whereas the samples generated from the present study would be designated as WTγ SL or 
WTγ SS for the isogenic control cell lines and AK SL and AK SS for the akinetoplastic cell lines. 
These six main groups of datasets (REF SL, REF SS, WTγ SL, WTγ SS, AK SL and AK SS) were 
used to generate 15 pairwise comparisons. A total of 19 samples were analysed (with 
assistance from Dr Alasdair Ivens, Director of Bioinformatics, Centre for Immunity, Infection 
and Evolution (CIIE) University of Edinburgh). All 19 samples passed the quality control 
analysis using FASTQC. A total of 15 multi-factor comparisons were performed using 
empirical Bayesian approaches; REF SL was compared to either REF SS or WTγ SS; WTγ SL 
was compared to AK SL; REF SS was compared to either WTγ SS or AK SS; and all other 









To further find out if the genes expressed in the RNA datasets obtained have similar 
transcript profile clustering or are unrelated, Principal Component Analysis (PCA) was 
performed. This is a technique used to emphasize variation and bring out strong patterns in 
a dataset. There were six distinct groups of samples, generally behaving similarly with 
profiles within each sample being in concordance with each other. The PC1 represents the 
biggest variation in the datasets which clearly separates stumpy cells from slender forms 
with 35% proportion of variance. From the score plot, the PC2 shows separation between 
two similar datasets which shows less variation of 22% whiles the least variable was seen in 
PC3 with 9.5% variation (Figure 3.7).  
The first three axes accounted for cumulative proportion of 35%, 57% and 67% of overall 
genetic variance in the six groups. The cumulative proportion for PC2 and PC3 are inverse of 
the proportion of variance. Both the two-dimension (2D) and three- dimension (3D) score 
plots convey the same information.  
This analysis confirmed that genes expressed in either slender or stumpy forms of both the 
REF and the WTγ cell lines were similar (See Table 3.1 and 3.2). In addition to the PCA, the 
datasets were analysed for the expression profile of known transcripts predicted to exhibit 
differential regulation during the development from slender to stumpy forms. The WTγ 
datasets were compared to the reference dataset using stringent threshold parameters 
(adjusted p-value of < 0.05 for comparison and fold change > 1). Consistent with what was 
expected, the stumpy form cell lines expressed significantly more mRNA for PAD1 transcripts 
(Tb927.7.5930 ), a cell surface protein involved in regulating developmental processes (Dean 
et al., 2009) and ESAG9 (Tb927.5.4620), a post transcriptional regulator of gene expression 






















Figure 3.7 Principal component analysis (PCA) of stumpy and slender forms of WT and AK samples 
of T. brucei. REF SS is represented in blue, WTγ SS in pink. The points with similar colours represent 
the number of sample replicates used. REF SL (yellow), WTγ SL is shown in green. The numbers after 
each letter are indicative of the replicates used for the analysis. Both two-dimensional (upper image) 
and three-dimensional relationships for the 19 samples on PCA score plot show similar level of 









The presence of abundant EP1 and GPEET procyclins was seen in stumpy cells. The procyclic 
form in the tsetse midgut has glycoprotein coat GPEET that is normally expressed 3 days 
after infection of the vector which is replaced by glycosylated EP procyclins by day 7 of 
infection (Acosta-Serrano et al., 2001; Vassella et al., 2001a, 2000). Also, among the 
upregulated transcripts in stumpy cells was Nek1/NIMA-related kinase which has a 
serine/threonine kinase activity. This kinase has been identified by (Nett et al., 2009), where 
they analysed cytosolic bloodstream form of T. brucei kinome and identified three members 
of the NEK kinase group out of 44 phosphorylated protein kinases. Purine nucleobase 
transporters has been reported to be encoded by multiple isogenes and their mRNAs are up-
regulated in procyclics (Henriques et al., 2003). 
The abundant expression of procyclin mRNAs in the stumpy form showed that these cells 
were pre-adapting for differentiation at the mRNA level as procyclins are the most abundant 
procyclic-specific transcripts and proteins (Roditi et al., 1998). Genes specifically elevated in 
stumpy forms are summarised in Table 3.1. The WTγ cells showed decreased expression of 
NEK1, Purine nucleoside transporter NT10, EP1 and GPEET when compared to the reference 
stumpy sample (REF). Though both REF and WTγ stumpy forms were morphologically similar, 
the difference in expression of stumpy specific stage transcript make the WTγ less stumpy 
compared to the REF. 
Down regulated transcripts in stumpy cells are those known to have increased expression in 
slender forms. Transcription factor II Human (TFIIH, Tb927.1.1080) which is essential in 
trypanosome RNA maturation was decreased in stumpy cells (Lee et al., 2009). Likewise, the 
RNA-binding protein (RBP7) has been shown to be required for quorum sensing and 
promoting cell-cycle arrest when overexpressed (Mony et al., 2014) (see Table 3.2). The 
elevation of these transcripts in the REF stumpy compared to the WTγ stumpy cells may 
indicate that the REF SS cells were more enriched for stumpy forms than the WTγ samples. 
However, the histone transcript (Tb927.10.10580) and mRNAs for paraflagellar rod (PFR) 
and structural components of the cell (Tb927.8.1550) were decreased in the stumpy forms 







The data showed that genes differentially expressed between slender or stumpy forms of 
WTγ were also differentially expressed in the REF samples, even though most of the 
expression differences were more pronounced in the REF datasets than WTγ. Likewise, the 







Table 3.1 Selection of proteins showing greater than 1 fold differential change in WTγ and REF stumpy cell lines with p value of <0.05. The 
transcripts are denoted by (+) for increased or (-) for decreased. The fold change is shown as FC.  Stumpy specific genes were more enriched in REF 








Table 3.2 Downregulated genes in WTγ and REF stumpy cells. Both WTγ stumpy and REF stumpy cells showed decreased level of expression of 









3.6   Comparison of mRNA expression between WTγ and AK strains 
The rationale was to test whether cells differentiating in either WTγ or REF background 
regulate similar genes expressed between REF slender and WTγ slender cells. The pairwise 
comparison dataset of REF slender relative to WTγ slender was analysed. Transcripts 
significantly regulated at adjusted p-value of < 0.05 with fold change greater than 2 gave 150 
genes to be enriched in slender cells. The expression level of these transcripts is illustrated 
in a volcano plot (Figure 3.8).  
A summary on gene list in Table 3.3 illustrates enriched transcripts in REF slender relative to 
WTγ slender showing 40 most enriched genes ordered by their relative fold change, superior 
to 2-fold change and p value of <0.05. Most of these upregulated genes were hypothetical 
proteins. Interestingly, RNA-binding protein, UBP1 (Tb927.11.500; 74-fold) which 
participates in RNA degradation and maintaining the integrity and stability of RNA in T. cruzi  
(Cassola et al., 2015) was identified. The remaining were transcripts encoding glycolytic 
enzymes or transporters for either glucose or hexose (Table 3.3), suggesting increased 
dependence on glucose as an energy source in the slender forms. The THT1 hexose 
transporter is known to be highly expressed in slender forms (Bringaud and Baltz, 1993) and 
glyceraldehyde-3-phosphate dehydrogenase (Tb927.6.4300) both showing 2.1-fold increase 
in REF slender compared to WTγ slender. Likewise, histones (Tb927.5.4200, 3-fold increased) 
and paraflagellar rod (Tb927.3.4330, 2.5-fold) increased were observed to be enriched in 
REF slender sample. Histone and PFR has been reported to be enriched in slender cells of T. 









Figure 3.8 A volcano plot showing genes that are differentially expressed in REF slender (SL) cells 
versus WTγ slender forms. Positive values represent genes that were enriched in SL cells while the 
negative values signify down-regulated genes. The genes that clustered around zero were without 
any difference in expression. The Y-axis is the log 10 adjusted p value while the x-axis denotes the log2 
fold change. The vertical red dotted line is the 2 FC cut off for genes considered as significant with p 
value of <0.05. on horizontal red line. The genes within the two vertical red dotted lines are 
coregulated and the ones that fall outside the lines are either upregulated for positive values or 











Table 3.3 Illustrates enriched transcripts in REF slender relative to WTγ slender. The list shows 40 
most enriched genes ordered by their relative fold change, superior to 2-fold change and p value of 
<0.05. Most of these upregulated genes were hypothetical proteins. 
 
Gene ID Description logFC FC 
Tb927.11.500 RNA-binding protein, UBP1 7 128 
Tb927.11.130 expression site-associated gene 9 
(ESAG9), 
6.2 74 
Tb927.11.110 expression site-associated gene 9 
(ESAG9), 
5.5 45 
Tb927.9.380 expression site-associated gene 3 
(ESAG3), 
5 32 
Tb927.6.5490 expression site-associated gene 3 
(ESAG3), 
5 32 
Tb927.9.16880 expression site-associated gene 3 
(ESAG3), 
4.2 18 
Tb927.11.20150 expression site-associated gene 3 
(ESAG3), 
4.1 17 
Tb927.5.5230 expression site-associated gene 
(ESAG3), 
4.1 17 
Tb927.6.500 gene related to expression site-
associated gene 
3.3 10 
Tb927.11.530 RNA-binding protein, putative 3.3 10 
Tb927.6.470 gene related to expression site-
associated gene 
3.1 9 
Tb927.5.4660 expression site-associated gene 3 
(ESAG3), 
3 8 
Tb11.v5.0297 variant surface protein, putative 2.9 7 
Tb927.3.250 expression site-associated gene 3 
(ESAG3), 
2.9 7 
Tb927.1.20 expression site-associated gene 3 
(ESAG3), 
2.8 7 
Tb11.15.0008 expression site-associated gene 3 
(ESAG3), 
2.8 7 
Tb927.6.540 gene related to expression site-
associated gene 
2.7 6 
Tb11.v5.0850 hypothetical protein conserved 2.6 6 
Tb927.8.450 expression site-associated gene 3 
(ESAG3), 
2.6 6 









Tb927.11.19800 hypothetical protein 2.5 6 
Tb927.4.1910 hypothetical protein conserved 2.4 5 
Tb927.9.16700 expression site-associated gene 3 
(ESAG3), 
2.3 5 
Tb11.v5.0752 expression site-associated gene 3 
(ESAG3) 
2.2 5 
Tb927.10.14540 hypothetical protein 2 4 
Tb927.9.4080 hypothetical protein conserved 1.9 4 
Tb927.11.6600 hypothetical protein conserved 1.9 4 
Tb927.8.910 hypothetical protein conserved 1.9 4 
Tb927.7.2420 glycogen synthase kinase-3 alpha, 
putative 
1.8 3 
Tb927.10.14550 ATP-dependent DEAD/H RNA 
helicase, putative 
1.8 3 
Tb927.10.5150 zinc finger protein family member, 
putative 
1.8 3 
Tb927.9.620 expression site-associated gene 3 
(ESAG3), 
1.8 3 
Tb927.11.1880 histone H1, putative 1.7 3 
Tb927.11.6890 DNA repair and recombination 
helicase protein 
1.6 3 
Tb927.11.14220 hypothetical protein conserved 1.6 3 
Tb11.v5.0537 polyubiquitin, putative 1.5 3 
Tb927.3.1910 hypothetical protein conserved 1.5 3 



















3.7   Evidence for retrograde signalling? 
A three-way comparison using 3 groups of datasets comprising slender to stumpy 
differentiation in REF, WTγ and AK cells will be instrumental in ascertaining whether a 
correlation between the two WT datasets exists. Moreover, the comparison would provide 
relevant information as to whether any upregulated genes were unique to each dataset and 
thereby linked to the genetic background of each cell line. Following the comparison, it was 
observed that many transcripts were unique and not shared, however, PCA analysis in 
indicates overall relatedness of samples.  
Of the four hundred and seventeen transcripts enriched in REF SL forms when compared to 
REF SS forms, 146 genes were uniquely expressed in REF slender. Examples of such genes 
included expression site-associated gene 3 (ESAG3) (Tb927.9.16880; 15-fold), flagellar 
protein PF16 (Tb927.1.2670; 3.2-fold), beta tubulin (Tb927.1.241; 4-fold) and histone H4 
(Tb927.5.4220; 4-fold). The rest were glycosomal glycerol kinase (Tb927.9.12550; 2.8-fold) 
and enzymes involved in glycerol metabolism and known to be located in the glycosome 
(Hart et al., 1984), and procyclin-associated gene 2 (Tb11.v5.1027; 2-fold). All these 
transcripts that have been reported to be upregulated in slender forms. Approximately, two-
third of the transcripts encoded hypothetical proteins. A summary of the unique and shared 
genes is illustrated in a 3-way Venn diagram in Figure 3.9.  
Fifty-one distinct genes were unique to WTγ slender and the remaining genes were shared 
with both REF slender and AK slender. Consistent with what was  expected, WTγ SL cells 
expressed the following elevated genes: RBP32 (Tb927.9.4560; 3 fold), adenosine 
transporter (Tb927.2.6220; 2.8 -fold) which is an amino acid transporter (AAT6) also involved 
in eflornithine uptake and that has been shown to be detected only in slender forms (Carter 
and Fairlamb, 1993; Sanchez et al., 2002), retrotransposon hot spot protein 7 (RHS7) 
(Tb927.7.2030; 2.5 fold), a purine nucleoside transporter (Tb927.6.220; 2.1 fold) which is 
detected in both bloodstream and procyclic life cycle stages (Sanchez et al., 2002), GPI 







(Tb927.9.16010; 2 -fold). The remaining two-third of these transcripts were hypothetical 
proteins.  
Finally, a total of 446 genes were up-regulated (≥2-fold change) in AK slender relative to AK 
stumpy. Out of these, 141 were unique to this dataset. The genes upregulated in AK SL 
included ESAG3 (Tb927.3.460; 7-fold), procyclin-associated gene 5 (PAG5) protein 
(Tb927.10.10230; 3.7- fold), retrotransposon hot spot protein 3 (RHS3) (Tb927.4.280; 3.7-
fold), BARP protein (Tb927.9.15550; 2.6-fold), flagellar protofilament ribbon protein 
(Tb927.8.4640; 2.5-fold), TFIIF-stimulated CTD phosphatase (Tb927.10.14270; 2.3 -fold) and 









Figure 3.9 A 3-way Venn diagram illustrating distribution of unique and shared genes among 
slender AK, slender REF and slender WTγ RNA samples. The AK genes are shown in blue, WTγ in 
yellow and REF in green. The number of genes that are uniquely expressed as well as those shared 
among the three groups are shown in the Venn diagram. This Venn was created using Venny 2.1.0. 
 
Surprisingly, only 70 genes were shared among the three datasets, accounting for 11% of 
the total transcripts upregulated in the three slender cell samples (Figure 3.9). Comparing 
the shared genes to the unique transcripts retained within the two WT datasets clearly 
showed a poor correlation between REF and WTγ cell lines. A list of the transcripts whose 
expression profiles were shared among the three datasets are shown in Table 3.4. The 
common genes that were significantly regulated among the three datasets include: ESAG 
transcripts (ESAG2, ESAG11), histone transcripts, mRNAs for structural components such as 







transporters, which are in agreement with previous reports (Bringaud and Baltz, 1993; 
Geiger et al., 2011; Hug et al., 1993). A third of these transcripts represented hypothetical 
proteins.  
 
Table 3.4: Significantly expressed trypanosome stage-regulated genes shared among slender AK, 
slender REF and slender WTγ. The table was generated when a three-way comparison of three 
different datasets comprising slender to stumpy differentiation in REF, WTγ and AK cells was 
performed to ascertain whether a correlation exist between REF  and WTγ datasets.The genes listed 
in the table are genes enriched in slender forms. FC represents fold change of 2 and above with p 
value of <0.05. 
Symbol Description LogFC FC 
Tb927.6.500 gene related to expression site-associated gene 3.8 13.9 
Tb927.6.540 gene related to expression site-associated gene 3.7 13 
Tb927.11.14840 chromosomal passenger protein 3.3 9.8 
Tb927.10.10210 procyclin-associated gene 4 (PAG4) protein 2.5 5.7 
Tb927.4.2740 hypothetical protein conserved 2.5 5.7 
Tb927.7.610 mitochondrial DNA ligase homolog, LIG k-alpha 2.4 5.3 
Tb927.8.2280 hypothetical protein conserved 2.4 5.3 
Tb927.10.8440 glucose transporter 1B 2.3 4.9 
Tb927.11.6550 PUF nine target 1 2.3 4.9 
Tb927.11.890 hypothetical protein conserved 2.3 4.9 
Tb927.9.1340 Nucleoporin 2.3 4.9 
Tb11.v5.0308 THT1 - hexose transporter, putative 2.2 4.6 
Tb927.10.8460 glucose transporter, putative 2.2 4.6 
Tb11.v5.0676 expression site-associated gene 2 (ESAG2) 2.1 4.3 







Tb927.3.3270 ATP-dependent phosphofructokinase 2.1 4.3 
Tb927.7.2830 histone H2A, putative 2 4 
Tb11.v5.0531 fructose-bisphosphate aldolase, glycosomal, 1.9 3.7 
Tb927.10.5620 fructose-bisphosphate aldolase, glycosomal 1.9 3.7 
Tb927.3.2580 hypothetical protein conserved 1.9 3.7 
Tb927.6.210 leucine-rich repeat protein 1 (LRRP1), 1.9 3.7 
Tb927.3.2500 hypothetical protein 1.8 3.5 
Tb927.7.2920 histone H2A, putative 1.8 3.5 
Tb927.8.2270 hypothetical protein conserved 1.8 3.5 
Tb927.8.5340 hypothetical protein 1.8 3.5 
Tb927.8.6240 STOP axonemal protein 1.8 3.5 
Tb11.v5.0307 THT1 - hexose transporter, putative 1.7 3.2 
Tb927.1.2050 hypothetical protein, unlikely 1.7 3.2 
Tb927.1.3830 glucose-6-phosphate isomerase, glycosomal 1.7 3.2 
Tb927.10.12820 hypothetical protein conserved 1.7 3.2 
Tb927.10.14160 aquaporin 3, putative 1.7 3.2 
Tb927.11.11980 corset-associated protein 15 1.7 3.2 
Tb927.3.2530 expression site-associated gene 11 (ESAG11), 1.7 3.2 
Tb927.9.15770 hypothetical protein conserved 1.7 3.2 
Tb927.9.6290 AK1 1.7 3.2 
Tb11.v5.0330 THT1 - hexose transporter, putative 1.6 3 
Tb927.10.13930 phosphatidic acid phosphatase, putative 1.6 3 
Tb927.6.350 hypothetical protein conserved 1.6 3 







Tb927.9.7400 expression site-associated gene 11 (ESAG11) 1.6 3 
Tb927.9.8190 hypothetical protein conserved 1.6 3 
Tb11.01.6240 expression site-associated gene 2 (ESAG2) 1.5 2.8 
Tb11.01.6241 expression site-associated gene (ESAG) protein, 1.5 2.8 
Tb927.8.2070 hypothetical protein conserved 1.5 2.8 
Tb927.8.2260 hypothetical protein conserved 1.5 2.8 
Tb927.2.5660 adenylate kinase, putative 1.4 2.6 
Tb927.3.2590 hypothetical protein 1.4 2.6 
Tb927.6.3180 hypothetical protein conserved 1.3 2.5 
Tb927.9.11580 glycosomal membrane protein 1.3 2.5 




3.8 Differential gene expression in slender WTγ versus stumpy  
WTγ  
To determine differences in gene expression between slender to stumpy specifically in the 
AK and WTγ cell line, I first compared genes differentially expressed between slender and 
stumpy cells in WTγ cells. Out of 2010 genes which were significantly differentially expressed 
(1001 up-regulated and 1009 down-regulated), 246 genes were identified as differentially 
regulated with a 2-fold increase between slender forms and stumpy forms with a p value < 









Figure 3.10 Volcano plot showing genes that were differentially expressed in WTγ slender cells 
relative to WTγ stumpy forms. The genes that grouped around zero were co-regulated. The Y-axis is 
the log 10 adjusted p value while the x-axis denotes the log2 fold change. The vertical red dotted line 
is the 2 FC cut off for genes considered as significant with p value of <0.05. on horizontal red line. 
The genes within the two vertical red dotted lines are coregulated and the ones that falls outside the 
lines are either upregulated for positive values or downregulated for negative values. 
 
One-third of the 246 selected transcripts encoded predicted hypothetical proteins. The 
analysis also revealed that transcripts encoding glycosomal proteins, such as fructose-
bisphosphate aldolase (Tb927.10.5620), were among the 246 selected genes. It has 
previously been reported that the expression of fructose-bisphosphate aldolase is at least 
six times higher in bloodstream trypanosomes compared to procyclic forms (Hug et al., 
1993). Another study also demonstrated that the aldolase was decreased within 24 hours 
after differentiation to stumpy in T. brucei cells (2009) and this data confirmed the trend, 
with an upregulation of 3.7 FC in WTγ slender forms with respect to WTγ stumpy forms 







(Tb927.6.4280), which is known to be upregulated in slender and downregulated in stumpy 
forms (Queiroz et al., 2009), and pyruvate kinase (Tb927.10.14140) were both increased by 
4.6-fold in WTγ slender (Table 3.5). The PNT1 protein (Tb927.11.6550), which is required for 
kDNA maintenance, was also upregulated by 3-fold in WTγ slender compared to WTγ 
stumpy. I noticed as a trend that genes that were upregulated in WTγ slender were also 
upregulated in REF slender, but expression differences were more pronounced in the REF 
slender cells. A complete list of the genes is attached as electronic files. 
 
 
Table 3.5 List of top 50 upregulated transcripts expressed in WTγ slender compared to WTγ 
stumpy with p value of <0.05 and a fold change of 2 and above. 
Symbol Description logFC FC 
Tb927.5.4000 hypothetical protein  3.60 12.1 
Tb927.10.7650 hypothetical protein 3.30 9.8 
Tb927.10.7150 hypothetical protein 3.00 8.0 
Tb927.1.2020 hypothetical protein 2.40 5.3 
Tb927.9.13190 hypothetical protein, unlikely 2.40 5.3 
Tb927.11.18280 ESAG7 (expression site associated protein 
7), 
2.30 4.9 
Tb927.10.14140 pyruvate kinase 1 2.20 4.6 
Tb11.v5.0605 pyruvate kinase 1, putative 2.20 4.6 
Tb927.6.4280 glyceraldehyde 3-phosphate 
dehydrogenase, 
2.20 4.6 
Tb927.6.4300 glyceraldehyde 3-phosphate 
dehydrogenase, 
2.10 4.3 







Tb927.1.3330 hypothetical protein, 2.10 4.3 
Tb927.11.9000 cation transporter, putative 2.00 4.0 
Tb927.4.3280 expression site-associated gene 2 
(ESAG2) 
2.00 4.0 
Tb11.v5.0531 fructose-bisphosphate aldolase, 
glycosomal, 
1.90 3.7 
Tb927.10.5620 fructose-bisphosphate aldolase, 
glycosomal 
1.90 3.7 
Tb927.9.7840 hypothetical protein,  1.90 3.7 
Tb11.v5.0514 cation transporter, putative 1.90 3.7 
Tb927.9.7950 hypothetical protein 1.90 3.7 
Tb927.1.3720 hypothetical protein,  1.90 3.7 
Tb927.8.5340 hypothetical protein 1.80 3.5 
Tb927.2.1470 hypothetical protein conserved 1.80 3.5 
Tb927.10.7170 hypothetical protein 1.80 3.5 
Tb927.11.2400 hypothetical protein conserved 1.70 3.2 
Tb927.10.8440 glucose transporter 1B 1.70 3.2 
Tb927.11.9380 hypothetical protein 1.70 3.2 
Tb11.v5.0307 THT1 - hexose transporter, putative 1.70 3.2 
Tb927.7.1960 retrotransposon hot spot protein 7 
(RHS7), 
1.70 3.2 
Tb927.6.810 hypothetical protein 1.70 3.2 
Tb927.4.3290 hypothetical protein conserved 1.70 3.2 
Tb927.3.3430 hypothetical protein conserved 1.70 3.2 







Tb927.11.6550 PUF nine target 1 1.60 3.0 
Tb927.9.4560 RBP32 1.60 3.0 
Tb927.6.350 hypothetical protein conserved 1.60 3.0 
Tb927.8.2280 hypothetical protein conserved 1.60 3.0 
Tb927.1.2050 hypothetical protein, 1.60 3.0 
Tb11.v5.0330 THT1 - hexose transporter, putative 1.60 3.0 
Tb927.7.2010 retrotransposon hot spot protein 7 
(RHS7), 
1.60 3.0 
Tb927.10.10210 procyclin-associated gene 4 (PAG4) 
protein 
1.60 3.0 
Tb927.7.2020 retrotransposon hot spot protein 7 
(RHS7), 
1.60 3.0 
Tb927.11.11990 hypothetical protein 1.60 3.0 
Tb927.9.13160 hypothetical protein 1.60 3.0 
Tb927.9.7860 hypothetical protein conserved 1.60 3.0 
Tb927.9.4830 hypothetical protein 1.60 3.0 
Tb927.6.210 leucine-rich repeat protein 1 (LRRP1), 1.60 3.0 
Tb927.10.12820 hypothetical protein conserved 1.50 2.8 
Tb927.7.610 mitochondrial DNA ligase homolog, LIG k-
alpha 
1.50 2.8 
Tb927.11.11980 corset-associated protein 15 1.50 2.8 










I further compared the transcript levels of genes expressed within stumpy cells generated 
from AK and WTγ pleomorphic trypanosomes. Specifically, I examined whether 
differentiation to stumpy forms in an akinetoplastic background influences gene expression 
and whether any identified difference can be attributed to the absence of the kinetoplast. 
The same procedure of sorting significant genes with an adjusted p-value of <0.05 was used 
for this analysis. The data analysis revealed that 405 gene features were statistically 
significant, consisting of 234 genes with increased expression and 171 down-regulated genes 
in AK stumpy compared to WTγ stumpy. More stringent analysis revealed that 34 genes were 
differentially expressed (either upregulated or downregulated) with a fold change of 2 in AK 
stumpy samples (Table 3.6). 
 
Table 3.6 List of expression transcripts in akinetoplasti (AK) stumpy  cells .Genes were sorted by p 
value of <  0.05 and a fold change (FC) of 2 and above. The (+) are enrichment in AK stumpy whiles (-
) indicates decreased expression. Stringent analysis revealed that 34 genes were differentially 
expressed (either upregulated or downregulated). 
Symbol Description Log FC FC 
Tb927.11.500 RNA-binding protein, UBP1 +6.20 +73.5 
Tb927.9.7950 hypothetical protein +2.80 +7.0 
Tb927.1.3770 hypothetical protein, unlikely +1.70 +3.2 
Tb927.8.200 UDP-Gal or UDP-GlcNAc-dependent +1.60 +3.0 
Tb927.9.11200 hypothetical protein +1.60 +3.0 
Tb927.9.3220 hypothetical protein +1.50 +2.8 
Tb927.10.8340 hypothetical protein +1.40 +2.6 
Tb927.2.5720 hypothetical protein +1.40 +2.6 
Tb927.11.17880 expression site-associated gene 9 
(ESAG9) 
+1.40 +2.6 
Tb927.9.7340 expression site-associated gene 9 
(ESAG9) 
+1.20 +2.3 







Tb927.9.15980 nucleoside transporter  +1.00 +2.0 
Tb927.10.6430 hypothetical protein +1.00 +2.0 
Tb927.11.14840 chromosomal passenger protein -1.00 -2.0 
Tb927.8.1640 MSP-B, putative -1.00 -2.0 
Tb927.8.1620 MSP-B, putative -1.00 -2.0 
Tb927.8.1630 MSP-B, putative -1.00 -2.0 
Tb927.11.3390 hypothetical protein -1.00 -2.0 
Tb927.9.7550 adenylosuccinate lyase, putative -1.10 -2.1 
Tb927.10.15060 hypothetical protein -1.10 -2.1 
Tb927.8.5340 hypothetical protein -1.20 -2.3 
Tb927.7.130 expression site-associated gene 3 
(ESAG3) 
-1.30 -2.5 
Tb927.11.7820 endonuclease/exonuclease/phosphatase -1.40 -2.6 
Tb927.6.510 procyclic form specific polypeptide A-
alpha 
-1.40 -2.6 
Tb927.6.480 procyclic form specific polypeptide A-
beta 
-1.50 -2.8 
Tb927.9.4160 hypothetical protein -1.60 -3.0 
Tb927.9.4180 hypothetical protein -1.70 -3.2 
Tb927.9.15970 hypothetical protein -1.70 -3.2 
Tb927.6.520 procyclic form specific polypeptide A-
beta 
-1.70 -3.2 
Tb927.8.480 phosphatidic acid phosphatase protein -2.10 -4.3 
Tb927.10.10250 EP2 procyclin -2.20 -4.6 
Tb927.9.16070 hypothetical protein -3.60 -12.1 
Tb927.3.290 expression site-associated gene 3 
(ESAG3) 
-4.40 -21.1 









Genes that were highly expressed in AK stumpy relative to WTγ stumpy samples included a 
predicted RNA-binding protein, UBP1 (Tb927.11.500; 74-fold) which participates in RNA 
degradation and maintenance of the integrity and stability of RNA in T. cruzi (Cassola et al., 
2015), and a UDP-GlcNAc dependent-protein (Tb927.8.200 3-fold increase). Another 
transcript which was enriched and was consistent with cells being quiescent was the 
expression site-associated gene 9 (ESAG9) (Tb927.9.7340; 2.3-fold). This observation is in 
agreement with data from a previous study indicating that the gene is upregulated in stumpy 
forms (Monk et al., 2013). A third of the remaining transcripts were hypothetical proteins. A 









Figure 3.11 Volcano plot representing 405 genes that were either upregulated or downregulated 
in stumpy AK cells. Positive values signify upregulated genes while negative values represent 
downregulated genes in AK SS. The genes that grouped around zero were co-regulated. The Y-axis is 
the log10 adjusted p value while the axis denotes the log2 fold change. The vertical red dotted line is 
the 2 FC cut off for genes considered as significant with p value of <0.05 (Horizontal red line). The 
genes within the two vertical red dotted lines are coregulated and the ones that fall outside the lines 













Further analysis investigated if there were differences in transcript expression between AK 
stumpy in REF stumpy cells and WTγ stumpy cells. To achieve this objective, the abundance 
of AK stumpy transcripts was compared to the WTγ and REF stumpy datasets. One hundred 
and seventy-five unique genes were statistically differentially expressed in AK when 
compared to the reference cell line and 22 unique genes were found when compared to 
WTγ cells. However, comparing the common differences between two datasets revealed 13 
genes to be regulated and shared among the two datasets Figure 3.12.  
 
 
Figure 3.12 Venn diagram showing robust gene expression in stumpy cells. The number of genes 
expressed in AK SS and REF SS cells are shown in blue whereas those expressed in AK SS and in WTγ 
SS cells shown in yellow. The 13 genes that are common to both are shown in light brown. The unique 
genes for both datasets are indicated,22 genes represented AK stumpy in WTγ cell lines and 175 











The analysis from two independent biological replicates (REF and WTγ) showed genes that 
were uniquely expressed to each dataset. Examples from the 22 genes expressed only in the 
AK stumpy cells versus the WTγ stumpy cells were RNA-binding protein, UBP1 (Tb927.11.500 
74-fold increase), ESAG9 (Tb927.11.17880, 2.6-fold increase), nucleoside transporter 1 
(Tb927.9.15980, 2-fold increase) and hypothetical protein (Tb927.9.7950, 7-fold increase, 
Tb927.2.5720, 2.6-fold increase and Tb927.1.910, 2-fold increase). 
Among the 13 genes were UDP-Gal or UDP-GlcNAc-dependent (Tb927.8.200), hypothetical 
proteins (Tb927.10.8340 and, Tb927.10.6430), ESAG9 (Tb927.9.7340), which is expressed in 
stumpy cells (Monk et al., 2013), GPEET2 procyclin precursor (Tb927.6.510) and EP2 
procyclin (Tb927.10.10250), which is upregulated in stumpy form (Matthews and Gull, 
1998). These transcripts were more pronounced in REF stumpy cells compared to that of 
WTγ stumpy. This suggests that the WTγ cells were less stumpy than those used to produce 
the REF stumpy RNA samples and thus not expressing transcripts to the same level. 
However, the expression of EP3-2 procyclin (Tb927.6.520) was enriched in AK stumpy 
generated from WTγ cells. These transcripts are summarized in Table 3.7. 
 
Table3.7 A list of genes with increased mRNA levels in stumpy cells of T. brucei. The list shows 
enrichment or downregulation of genes in AK stumpy cells compared to either WTγ or REF stumpy 
cells. The genes were sorted by p value of < 0.05 and a fold change (FC) of 2 and above. 
  
 AK SS vs WTγ SS  AK SS vs REF SS  
Gene ID Description logFC FC logFC FC  
Tb927.1.3770 hypothetical protein, unlikely 1.70 3.2 2.20 4.6  
Tb927.8.200 UDP-Gal or UDP-GlcNAc-dependent 1.60 3.0 1.60 3.0  
Tb927.9.11200 hypothetical protein, unlikely 1.60 3.0 1.20 2.3  
Tb927.9.3220 hypothetical protein, unlikely 1.50 2.8 1.90 3.7  
Tb927.10.8340 hypothetical protein 1.40 2.6 2.10 4.3  
Tb927.9.7340 expression site-associated gene 9 (ESAG9) 1.20 2.3 1.20 2.3  







Tb927.9.7550 adenyl succinate lyase, putative -1.10 -2.1 -1.40 -2.6  
Tb927.11.7820 endonuclease/exonuclease/phosphatase,  -1.40 -2.6 -1.70 -3.2  
Tb927.6.510 procyclic form specific polypeptide A -1.40 -2.6 -1.60 -3.0  
Tb927.6.480 procyclic form specific polypeptide A -1.50 -2.8 -1.50 -2.8  
Tb927.6.520 procyclic form specific polypeptide A -1.70 -3.2 -1.50 -2.8  
Tb927.10.10250 EP2 procyclin -2.20 -4.6 -2.30 -4.9  
 
 
There were likewise genes that were uniquely expressed in AK cells generated in a WT 
background. The number of regulated mRNAs that were found was higher than that found 
to be expressed in the WTγ cells. A total of 175 transcripts were differentially expressed 
between the AK stumpy and REF stumpy dataset. Among the differential expression 
transcripts were expression site-associated gene 3 (ESAG3) (Tb927.9.16260, 3-fold increase), 
hypothetical protein (Tb927.9.9930, 2.4-fold increase), SLACS reverse transcriptase 
(Tb927.9.14660, 2.2-fold increase) and two-thirds of the transcripts were hypothetical 
proteins. Surprisingly, UBP1 was also upregulated in AK stumpy cells compared with WTγ 
cell, as well as being upregulated in AK slender when compared to WTγ slender. Studies has 
shown that UBP1 depletion in bloodstream form by RNAi was simultaneous with UBP2. 
Moreover, UBP1 was undetectable by Western blotting in several cell lines (Hartmann et al., 
2007). One possible explanation of UBP1 in AK samples could be a retrograde response 
which generates upregulation of UBP1 in both the AK slender and stumpy cell lines. 
However, the difference in UBP1 expression was only detected in WTγ and not REF cells, 
suggestion that that the culturing and genetic manipulation of WTγ may have led to the loss 










3.9   Validation of RNA-Seq data for differentially expressed genes 
 
Data obtained from this study has shed light on the genes that are enriched in stumpy forms 
or commonly shared in T. brucei cells differentiating from slender to stumpy forms. 
Particularly intriguing is the presence of UBP1 both significantly upregulated in AK slender 
(56-fold) and AK stumpy (74-fold) when compared with the same life stages in WTγ cell line. 
 The upregulation of this gene in both AK slender and AK stumpy cells was suggestive of 
retrograde signalling existing in T. brucei as this gene is expressed in the AK cells and not the 
WTγ cells. To confirm this, gene expression profile, complementary DNA (cDNA) was 
prepared from slender and stumpy RNA samples of AK and WTγ and quantitative reverse 
transcriptase PCR (qRT-PCR) performed (Section 2.10).  
Figure 3.13 shows UBP1 expression was pronounced in only the AK samples, contrasting with 
the low expression seen in WTγ cells. GPI8 was used as constitutively expressed 
housekeeping gene to normalise the samples. 
Qualitative investigation of UBP1 revealed that its elevated expression in AK samples was 

















Figure 3.13 Gene expression analysis by qRT-PCR for AK and WTγ samples. The Expression of UBP1 
was enriched in both AK slender and AK stumpy forms, shown in yellow and blue respectively. Both 
slender and stumpy forms of WTγ have no detectable UBP1 expression. The expression of UBP1 in 
the other cell lines was normalized using WTγ SL as reference sample. The Y axis represents the log10 




I further investigated this gene in monomorphic cell lines incapable of differentiating to 
stumpy and procyclic. The monomorphic cells used were previously listed in Table 2.1 of 
Chapter 2. In this analysis, the UBP1 mRNA was still highly expressed in the AK cell line, but 
this was at level similar to that seen in the monomorphic cell lines (Figure 3.14). Next, the 
mutated and acriflavine treated monomorphic cell lines were used to test if UBP1 was highly 









Figure 3.14 Comparison of UBP1 expression in pleomorphic and monomorphic AK and WTγ cell 
lines. UBP1 was highly expressed in pleomorphic AK SL with no significant change between 
monomorphic AK and WTγ cells. Expression levels of UBP1 in the other cell lines were normalized 
using WTγ SL as reference sample The Y axis represents the log10 relative quantification values 













In T. brucei, there are approximately 70 different proteins having at least one RNA 
Recognition Motif (RRM) of which some are essential for normal growth in at least one life-
cycle stage (Alsford et al., 2011; Wurst et al., 2009). UBP1 and UBP2, are known to be similar 
proteins with a single RRM domain (Hartmann et al., 2007) and both are recognised by the 
same antibody, generated against the T. cruzi protein but also able to recognise T. brucei 
UBP1 and UBP2 (Hartmann et al., 2007). It was important therefore to determine if the 
elevate UBP1 signal observed was caused by UBP1, UBP2 or both genes. 
Firstly, I did a BLAST search to align both UBP1 and UBP2 from T. brucei to identify conserved 
regions, allowing the design of primers outside to specifically target UBP2. Primers specific 
for UBP2 were designed within the red regions for specificity (Figure 3.15). Using these 
primers revealed that the UBP2 signal generated by qRT-PCR did not correspond to the UBP1 
data. Instead, analysis of the expression profile of UBP2 transcripts revealed there was low 
level expression of the gene across all the cell lines, including AK slender cells which 



















Figure 3.15 A BLAST result of aligned UBP1 and UBP2 coding sequence. The conserved region for 










Figure 3.16 UBP2 expression in pleomorphic and monomorphic AK and WT cell lines. The UBP2 
expression was downregulated in both pleomorphic and monomorphic cell lines regardless of the 
presence of the kinetoplast. The Y axis represents the log10 relative quantification values and the X-
axis is the individual samples investigated. The expression levels of UBP2 in the other cell lines were 
normalized using WTγ SL as reference sample. 
 
After getting these results, I performed a similar analysis to probe for UBP1 expression levels 
using the parental cell lines from which the AK clone was generated, to test if the UBP1 levels 
were similar there. The cell lines used were the parental pleomorphic cell line T. brucei 
EATRO 1125 AnTat 1.1 90:13 (REF), the isogenic control line (WT/WTγ) (WTγ), the same 
parental cell line with the L262P mutation with intact KDNA (WT/L262Pγ kDNA+) or devoid 
of kinetoplast (WT/L262Pγ (kDNA0). The results revealed UBP1 to be downregulated in all 







 The upregulation of UBP1 was in AK slender and AK stumpy in WTγ cells but not in the REF 
slender or stumpy samples (Figure 3.13). This suggested that UBP1 is at unusually low level 
in WTγ cell lines comparted to all other lines tested, including the AK cells, and thus the high 
expression of UBP1 in AK cells was not due to retrograde signalling. The loss of UBP1 
expression may have resulted from passaging processes and other manipulations of the WTγ 
line.  
 
Figure 3.17 qRT-PCR result for UBP1 expression in bloodstream form pleomorphic T. brucei EATRO 
1125 cell lines. The expression of UBP1 was downregulated across all cells. The Y- axis represents the 
log10 relative quantification values and the X-axis is the individual samples investigated. Expression 












3.10  UBP1 protein expression in T. brucei  
To analyse the expression of TbUBP1 protein, I performed a western blot and probed the 
membrane with a TcUBP1 polyclonal antibody. This antibody was raised against 
recombinant TcUBP1 as an immunogen (D’Orso and Frasch, 2001). The use of the T. cruzi 
antibody is possible against T. brucei extracts, because the UBP1 and 2 sequences are well 
conserved between the species. The samples analysed were AK slender and AK stumpy cells, 
WTγ slender and WTγ stumpy cells, and samples from two parental cell lines—T. brucei 
EATRO 1125 (AnTat1.1 90:13) (REF1), and T. brucei EATRO 1125 (AnTat1.1) (REF2). EATRO 
1125.  
As controls for antibody specificity, samples from TbUBP1/2 RNAi bloodstream and procyclic 
cell lines were used, since RNAi induction in these cell lines would result in decreased 
expression of both proteins in procyclic forms of the parasite and an absence of UBP1 in 
bloodstream form (Hartmann et al., 2007). The cell lysates were denatured using SDS-gel 
electrophoresis and blotted (see Section 2.12), prior to detection using polyclonal antiserum 
to TcUBP1. The result is shown in Figure 3.18, with the predicted molecular weights of 
TbUBP2 to be 19.5 kDa and that of TbUBP1 to be 24.3 kDa. As expected, the antibody 
recognized both UBP1 and UBP2, generating a corresponding double band for both. In 
addition to the expected bands are non-specific bands that run at 50 kDa UBP2 was 
expressed in the AK slender, AK stumpy as well as WTγ slender and stumpy but not UBP1 
(Figure 3.18, upper blot). The two pleomorphic T. brucei EATRO 1125 however showed both 
UBP1 and UBP2 expression. As expected, the RNAi bloodstream samples showed reduced 
expression of the protein upon induction. The procyclic protein samples neither showed 
reduction upon the induction of RNAi. These findings support to the data obtained by 
Hartmann et al. (2007) where they showed an absence of UBP1 in bloodstream form cell 
lines even though they express UBP2, except for T. brucei EATRO 1125 AnTat 1.1 and T. 








In contrast, procyclic T. brucei EATRO 1125 AnTat1.1, T. brucei 247, T. brucei TREU927/4 and 
T. brucei 427 strains all expressed both UBP1 and UBP2. (Hartmann et al., 2007). The 
expression of UBP2 was much more pronounced in both AK slender and WTγ slender than 
their stumpy counterparts. The data suggests that UBP1 proteins are not expressed in 
bloodstream form T. brucei. 
 
Figure 3.18 TbUBP1/2 protein expression in T. brucei. Western blot using extracts of different 
trypanosome strains and the anti-TcUBP1 antibody. Upper gel detects UBP1 and 2 in 2 x 106 cells/ml 
for each named cell line. Images were developed with Odyssey CLx imaging system. The positions of 
molecular mass markers are indicated with expected sizes for UBP1 (30 kDA) and UBP2 (~20 kDa) in 









3.10.1 Validation of differential gene expression in akinetoplastic cell 
lines by qRT-PCR 
As documented earlier, the elevated transcript level of UBP1 in AK slender and AK stumpy 
cells was suggestive of retrograde signalling occurring in T. brucei. However, hypothesis was 
found to be incorrect, with instead UBP1 being lost in WTγ cells and not because of the 
absence of kinetoplast causing upregulation of this transcript as a compensatory response. 
Beyond UBP1, however, akinetoplastic cells have shown the upregulation of certain other 
transcripts that were statistically significantly more expressed in both AK slender and AK 
stumpy forms in comparison to WTγ slender and WTγ stumpy cells. Among these genes were 
PNT1, a cysteine peptidase (Tb927.11.6550 1.7-fold increase in AK slender important for 
kDNA maintenance (Grewal et al., 2016). PNT1 is regulated during the cell cycle where it 
mostly peaks at S-phase (Archer et al., 2009). Studies have shown over-expression of PNT1 
to be associated with kinetoplast-related defects, such as the presence of  mislocated 
kinetoplasts (Archer et al., 2009). Since this gene is known for kinetoplast maintenance, its 
potential upregulation in akinetoplastic cells compared to WTγ was of interest to pursue. 
For example, the absence of kDNA in the akinetoplastic cells could possibly convey the loss 
of kDNA information from the mitochondrion to the nucleus to elicit the upregulation of this 
gene to compensate for the loss. In addition to PNT1, two hypothetical proteins 
(Tb927.10.8340, 2.6 -fold increase and Tb927.10.6430, 2-fold increase) also showed 
differences in expression between AK stumpy and WTγ stumpy. These hypothetical proteins, 
unfortunately, have no data on their cellular localisation, structural analysis and functional 
prediction. Nonetheless, I analysed these transcripts by qRT-PCR to experimentally confirm 
the expression profile of these three genes. The results obtained by qRT-PCR reproduced the 
higher expression of PNT1 in AK slender as compared to WTγ slender as seen by RNA-Seq 
(Figure 3.19).  
Thus, the expression in AK slender was higher than in WTγ slender with p value of 0.016 (*) 
even though the difference was not as pronounced as found by the RNA-Seq data. In 







whereas the expression of WTγ slender cells versus WTγ stumpy cells showed 
downregulation of PNT1 in stumpy forms with p value <0.0001 (****), this being consistent 
with the RNA-Seq data. 
I further analysed the expression of PNT1 at the protein level, using slender and stumpy 
samples as well as two PNT1 RNAi knock down samples. As expected, the RNAi samples 
showed reduced expression of the protein upon induction but there was little or no 
difference between slender and stumpy cells despite the differences seen at the RNA level 
earlier. The expression of PNT1 at the protein level also varied across different cell lines 
(Figure 3.20). 
 
Figure 3.19. Detection of PNT1 in slender and stumpy T. brucei by qRT-PCR assay. The expression 
of PNT1 is lower in SS forms with respect to SL forms. The Y axis represents the % relative 
quantification values and the X-axis is the individual samples investigated. Asterisks indicate level of 
statistical significance between the compared cells. The expression levels of PNT1 was first 









I further analysed the expression of PNT1 at the protein level, using slender and stumpy 
samples as well as two PNT1 RNAi knock down samples. As expected, the RNAi samples 
showed reduced expression of the protein upon induction but there was little or no 
difference between slender and stumpy cells despite the differences seen at the RNA level 
earlier. The expression of PNT1 at the protein level also varied across different cell lines 
(Figure 3.20). 
 
Figure 3.20 Western blot of PNT1 expresison. The position of the PNT1 bands corresponds to 60kDa 
for each sample. Lanes were loaded with 2x106 cells/ml for each SL or SS cells for the first eight wells 
and the last 4 wells to the right are the RNAi control samples. The Upper panel was probed with PNT1 








3.10.2 Validation of hypothetical proteins (Tb927.10.6430 and 
Tb927.10.8340) 
Strongly regulated genes in AK stumpy relative to WTγ stumpy included hypothetical 
proteins Tb 927.10.6430 and Tb927.10.8340. A BLAST search gave no useful information on 
these genes, and no orthologs are reported for these genes. Also, there was not any 
information on any interPro domains, cellular location, functional prediction nor proteomic 
profile. Nonetheless, I performed qRT-PCR on these uncharacterised transcripts to 
determine the validity of the RNA-Seq data. My results showed that cDNAs generated by RT-
PCR reproduced the highly expressed transcripts revealed in the RNA-Seq data (Figure 3.21 
and Figure 3.22). 
 Thus, the expression of Tb927.10.8340 in AK stumpy relative to WTγ stumpy was-2-fold 
upregulated with p value of < 0.006 (**). In contrast, the gene was 7.3-fold decreased in AK 
slender when compared to AK stumpy with p value of <0.0001 (****). Similarly, this gene in 
WTγ slender was 6-fold decreased in comparison with WTγ slender with p value of <0.0001 
(****). There was no significant difference in Tb927.10.8340 expression between the AK 









Figure 3.21 Experimental validation of the transcripts for uncharacterised hypothetical proteins in 
T. brucei. Relative quantification expressed in percentage on the Y-axis for Tb927.10.8340. The 
asterisk reflects the magnitude of significant difference between each paired comparison. The 
expression was downregulated in SL forms compared to SS forms. The Y axis represents the 
percentage relative quantification values and the X-axis is the samples investigated. The expression 
levels of the hypothetical gene were first normalised with GPI8 and then all samples normalised using 
WTγ SL as reference sample.  
 
The hypothetical gene Tb927.10.6430 expression was upregulated in AK stumpy compared 
to WTγ stumpy by 2.6- fold with p value of 0.042 (*). By comparison with AK slender, the 
transcript was 6.9-fold decreased in AK slender forms relative to AK stumpy with p value of 
<0.0001 (****).  
WTγ slender levels of Tb927.10.6430 were 5.7-fold downregulated when compared to WTγ 
stumpy with p value of <0.0001 (****). There was no significant difference in the expression 







The intriguing observation of the three genes mentioned earlier to be upregulated in AK 
slender and stumpy relative to WTγ cells is suggestive of retrograde response influencing 
gene expression and other cellular activities in the absence of mitochondrion.  
 
Figure 3.22 Estimation of Tb927.10.6430 mRNA abundance by qRT-PCR.  AK SS shows increased 
expression of the transcript relative to WTγ SS and decreased levels of the transcript in SL cells. The 
relative abundance of transcript expressed as a percentage is plotted on the Y axis and X-axis shows 
the SL and SS cells investigated. The expression levels of the hypothetical gene were first normalised 











3.11  Discussion  
3.11.1 Nuclear gene expression is not affected by absence of 
kinetoplast in T. brucei stumpy forms 
Differentiation of African trypanosomes involves developmental regulation of mitochondrial 
activity which requires regulation of the nuclear genome and the kinetoplast. Thus, the 
mechanisms that control the nuclear and mitochondrial genomes are vital to understanding 
the control of metabolic development. Successful progression through the life cycle stages 
of T. brucei involves modulation of gene expression, as well as immunological, metabolic and 
morphological changes (discussed in Section 1.2.6). As previously reported, the 
developmental regulation of mitochondrial activity requires coordination between the 
nucleus and kinetoplast (Schneider, 2001). Hence this study used the nuclearly encoded 
subunit of cytochrome oxidase COX VI, which has been extensively studied (Matthews and 
Gull, 1998), to investigate whether absence of the kinetoplast influences the regulation of 
nuclear gene expression. Data obtained from this study showed that the absence of 
kinetoplast did not influence nuclear expression of COX VI mRNA. 
Although similar studies have examined the regulation of nuclear and mitochondrial 
components of the cytochrome oxidase complex during differentiation between 
bloodstream form and procyclic form, they were unable to establish clonal lines of 
dyskinetoplastid bloodstream form either by acriflavine treatment or RNA interference 
ablation of mitochondrial topoisomerase II. However, an akinetoplastic cell line used to 
investigate communication between the nucleus and kinetoplast during differentiation 
between slender and stumpy showed that transition to stumpy forms was independent of 
the presence of the mitochondrial genome (Dewar et al., 2018). Indeed, PAD1 staining (Dean 
et al., 2009) and the increased expression of the ESAG9 differentiation marker (Monk et al., 
2013), in akinetoplastic cell lines, confirmed this observation in the present study.  
However, the akinetoplastic stumpy cells described by Dewar et al., (2018) lacked 
membrane potential and had a reduced lifespan in vitro and in vivo. These cells showed 







The authors showed that akinetoplastic stumpy cells died quicker than WT stumpy cells with 
intact kinetoplast (Dewar et al., 2018). Stumpy forms can utilise both glucose and α-
ketoglutarate as carbon sources for mitochondrial substrate phosphorylation in vitro 
(Bienen et al., 1993).  
As reported previously (Timms et al., 2002), COX VI mRNA depletion had no effect on 
morphological development to stumpy forms, indicating no requirement for an intact 
cytochrome oxidase complex during early differentiation events. Moreover, analysis of the 
relative transcript levels of the kinetoplast-encoded components of the COX complex 
demonstrated that these were independent of the level of nuclear encoded COX VI (Timms 
et al., 2002). In the present study, the expression profile of COX VI in slender, stumpy and 
procyclic forms confirmed that stumpy and procyclic forms express higher amount of COX 
VI mRNA relative to slender cells. This observation corroborates a study which showed that 
the abundance of COX VI mRNA is stage-regulated and more abundant in procyclic (Tasker 
et al., 2001). Coordination between the nucleus and mitochondrial genome has been studied 
in organisms such as yeast, mammals and plants (Kleine and Leister, 2016).  
However, yeast cells with defects in the mitochondrial genome (rho mutants) showed 
altered transcription of class I and II RNA of nuclear genes because these strains had lost the 
ability to carry out mitochondrial protein synthesis, and thus lacked most of the 
mitochondrial transcripts found in respiratory competent cells (Parikh et al., 1987). The class 
I transcription has been shown to be conserved in T. brucei, which utilizes RNA pol I for both 
rRNA synthesis and transcription of the major surface antigens, procyclin and VSG 
(Schimanski et al., 2004). Likewise, the mitochondrial unfolded protein response (UPRmt), 
conveys information on the functional status of the mitochondrion to the nucleus, thereby 
modulating expression of nuclear genes  (Kleine and Leister, 2016; Knorre et al., 2016; 
Qureshi et al., 2017). The unfolded protein response (UPR) is induced when the quality 
control machinery of the cell is overloaded with unfolded proteins. The mitochondrial ABC 
transporter HAF-1 modulates the nuclear accumulation transcription factor ATFS-1, a key 
regulator of the UPRmt. ATFS is a basic-leucine zipper (bZip) transcription factor, which 







of oxidative stress (Nargund et al., 2012). Under physiological conditions, ATFS-1 localises in 
the mitochondrion for degradation by proteases. However, in the presence of mitochondrial 
dysfunction, ATFS-1 accumulates in the nucleus to restore mitochondrial function by the 
induction of mitochondrial proteases and ROS detoxifying genes as well as metabolic 
regulators to compensate for the defect (Nargund et al., 2012). Trypanosomes lack 
conventional transcription regulation, and thus, lack most of the UPR machinery present in 
other eukaryotes (Michaeli, 2015). 
In summary, this study was unable to establish that the absence of mitochondrial genome 
elicits response from nucleus to compensate for the defect, as reported in yeast. 
 
3.11.2 Effect of differentiation on abundance of transcripts. 
Regulation of gene expression throughout the cell cycle has been addressed in several 
organisms like bacteria, budding yeast, mouse, trypanosomes and human cells (Chávez et 
al., 2017), both at the level of individual genes as well as in a genome-wide manner. Many 
of the regulated mRNAs described so far have known functions, and/or had previously 
shown preferential expression in either slender, stumpy or procyclic forms. Thus, this study 
also compared global changes in the transcriptomes of WTγ and AK T. brucei during 
differentiation from slender to stumpy. The goal was to have a comprehensive view of the 
potential effects of mitochondrial dysfunction on nuclear gene expression in these parasites. 
Expression of known stage-regulated genes were detected during analysis of the data 
obtained from the present study, thereby validating of the dataset. A novelty, however, was 
the downregulation of some hypothetical proteins in WTγ, which were much less expressed 
in AK cells compared to WTγ. RNA-Seq was performed on biological replicates of slender and 
stumpy samples from akinetoplastic and wild type cells. 
This is the first datasets for akinetoplastic slender and stumpy bloodstream forms compared 
to wild type slender and stumpy forms. The UDP-Gal is annotated as pseudogene on 
TriTrypDB and mentioned to have a UDP-glycosyltransferase activity. This gene is a cell 







they represent a considerable parasite-specific innovation, which has differentiated 
independently in the distinct trypanosomatid lineages (Silva Pereira and Jackson, 2018). 
Thus, future work is recommended to investigate the upregulation of this gene in AK stumpy 
cells. The hypothetical proteins enriched in stumpy AK cells have no available data on their 
cellular localisation, structure and functional prediction.  
This study suggests that the absence of the mitochondrial genome has an unexpectedly less 
dramatic effect on the levels of nuclearly-encoded mRNA in bloodstream forms (slender and 
stumpy) of T. brucei. It can be postulated that the difference in gene expression is due to 
stress response. 
In addition to these comparisons, I examined slender AK cells differentiating to stumpy 
forms, to identify common or enriched genes between slender and stumpy forms in the AK 
cells. Genes identified were mostly annotated as ‘pseudogene’, or ‘hypothetical unlikely’. 
Among these were transcripts encoding glycolytic enzymes and the THT1 hexose transporter 
(Tb11.v5.0307, 5.3-fold increase). The THT1-encoded transport system for glucose is life-
cycle stage dependent with bloodstream expressing 40-fold more THT1 than THT2 which is 
detectable in procyclic (Bringaud and Baltz, 1993). Other differentially expressed genes 
included DNA ligase LIG k alpha (Tb927.7.610, 9.2-fold increase) and PNT1 (Tb927.11.6550 
5.7-fold), a cysteine peptidase required for kDNA maintenance (Grewal et al., 2016), which 
was more highly expressed in AK slender forms than in WTγ slender. Studies that have 
depleted PNT1 by RNAi in the bloodstream form T. brucei have shown this gene to be 
essential both in vitro culture and in vivo, with the induced cells being enriched for 
accumulated cells without a kinetoplast, confirming the role of PNT1 in kDNA maintenance. 
(Grewal et al., 2016). 
To focus on identification of differences in gene expression in cells differentiating from 
slender to stumpy, the genes implicated in glycolytic process have also been reported in 
different species of trypanosomes. In T. cruzi, histones have been reported to be enriched 
in blood form (Chávez et al., 2017). Likewise, ESAG3 and enzymes involves in glycolysis such 
as glyceraldehyde 3 phosphate have been reported to be enriched in blood form of T. theleri 







histones, fructose bisphosphate, aldolase and glyceraldehyde 3 phosphate in bloodstream 
form relative to epimastigote and metacyclic stages. The upregulation of similar scripts has 
been reported in the RNA-Seq dataset. 
Further to the transcripts expressed in slender and stumpy cells, the study also compared 
transcript levels of genes expressed in the stumpy forms generated from different genetic 
backgrounds. As expected, TbPIP39, dihydrolipoyl dehydrogenase and EP1 procyclin were 
detected, thereby confirming differentiation of the stumpy forms of the AK cell line. 
Surprisingly, UBP1 was also upregulated in AK stumpy cells compared with WTγ cell, as well 
as being upregulated in AK slender when compared to WTγ slender. A possible explanation 
for the difference in UBP1 expression detected in WTγ and not REF cells, may be due to 
culturing and genetic manipulation of WTγ, rather than a retrograde response caused by loss 
of the kinetoplast.  
Undoubtedly, the data obtained in this Chapter has provided insights on the possible 
occurrence of a retrograde response, even though the transcriptomic studies suggest that 
the absence of the mitochondrial genome has a limited effect on the levels of nuclearly 
encoded mRNAs in bloodstream form of T. brucei. 
 
3.11.3 qRT-PCR validation of differentially expressed genes 
corroborated transcript profile 
After validating the observed dynamic mRNA changes during differentiation from slender to 
stumpy forms, transcripts that were enriched in akinetoplastic cells were validated by qRT-
PCR. The genes validated were PNT1 and two hypothetical proteins (Tb927.10.8340 and 
Tb927.10.6430) which showed differences in expression between AK stumpy and WTγ 
stumpy. The results obtained by qRT-PCR reproduced the higher expression of PNT1 in AK 
slender as compared to WTγ slender as seen by RNA-Seq (Figure 3.19.) Consistent with 
observation, the two hypothetical proteins were highly expressed in AK stumpy cell relative 
to WTγ stumpy form (Figure 3.21 and Figure 3.22). All together, these data support the 








3.12  Outlook 
In this chapter, data obtained from this study demonstrated that the absence of kinetoplast 
had minimal effect on gene expression. Even though enriched transcripts were obtained for 
stumpy akinetoplast cell, the study was unable to perform in-depth investigation of the 
hypothetical proteins and the UDP-Gal protein. Hopefully, future analysis of these proteins 
will discover the biological function of these genes. A possible approach is to either 
knockdown or overexpress these proteins to ascertain their effect on the parasite. The 
minimal difference in mRNA expression in akinetoplastic and wild type stumpy cells could 
be because of the few numbers of sample replicate used for this study. A previous study 
which was conducted to ascertain  how many biological replicates are needed to ensure valid 
biological interpretation of RNA -seq data or which statistical tools are best for analysing the 
data suggested that at least 6 biological replicates are required to enable identification of 
significantly  and differentially expressed genes for all fold changes (Schurch et al., 2016).  
This data suggests a repeat of transcriptome comparison between akinetoplastic procyclic 
and wild type at early differentiation time point as akinetoplastic cells cannot establish late 

















4    Assessing the effects of 
mitochondrial dysfunction on 
differentiation of bloodstream T. 
brucei 
4.1 Background and rationale 
The mitochondrion plays important roles in the life cycle of T. brucei, with its activity 
changing across the various stages of the parasite’s life cycle (Priest and Hajduk, 1994). 
Complex I (NADH:ubiquinone oxidoreductase) is the primary electron entry point in the 
mitochondrial electron transport chain which pumps proton into the mitochondrial inner 
membrane to produce ATP (Hirst, 2005). In addition to its role of being a coenzyme used in 
electron transport chain, NADH is also involved in generating acetyl-CoA which enters the 
citric acid cycle (Figure 4.1). As bloodstream form of the parasites in adipose tissue showed 
upregulation in the beta-oxidation pathway (Trindade et al., 2016), it is likely that there is 
increase demand for NADH dehydrogenase activity to generate energy.  
RNAi knockdown of three core subunits of complex I (NUBM, NUKM, NUEM) revealed no 
growth defect in procyclic forms, in vitro, neither was there an effect on Δψm (Verner et al., 
2). However, these cell lines had a 20% reduction of total mitochondrial NADH oxidation 
activity. A recent study which used knockout of two core subunits of complex I (NUBM and 
NUKM) has suggested that complex I may be implicated in energy transduction in 
akinetoplastic stumpy cells, thereby resulting in shorter life span (Dewar et al., 2018). There 
are no reports on the life span of stumpy cells in other hosts; the effect of parasite 
distribution on the life span of stumpy cells in different tissues is also unknown (Trindade et 
al., 2016). An alternative NADH dehydrogenase with rotenone-insensitive NADH oxidation 







facilitate rapid growth of procyclic forms when the activity of complex I limits growth and 




Figure 4.1 The beta oxidation metabolic pathway. The oxidation reaction occurs on the β carbon of 
an acyl-CoA molecule and breaks the fatty acid chain into two α and three β carbon atoms. The 
reaction generates FADH2, NADH and acyl CoA. The acyl CoA dehydrogenase removes two hydrogen 
from the α and β carbon atoms. Enoyl-CoA hydratase catalyses the second step, which is hydration 
of the fatty acid. Hydroxyacyl-CoA dehydrogenase removes the hydrogen in the hydroxyl group to 
produce  NADH + and ketoacyl-CoA thiolase catalyses the thiolytic cleavage. The NADH and FADH2 
molecules produced by both fatty acid β-oxidation and the TCA cycle are used by the electron 
transport chain to produce ATP. The NADH molecule produced by this metabolic pathway is indicated 








However, T. brucei NDH2 has been suggested to be oriented towards the intermembrane 
space and hence, is unable to compensate for the loss of complex I; oxygen consumption 
was detected when NADH was applied externally to digitonin-permeabilised procyclic cells 
(Verner et al., 2013). The lack of permeability of mitochondrial membrane to NADH suggest 
that NDH2 is situated within the mitochondrial membrane and is oriented towards the 
cytosol. If this is correct, it would be highly questionable whether NDH2 is capable of 
compensating for loss of complex I activity. Studies have shown that depletion of NDH2 by 
RNAi knockdown affects parasite growth and decreases Δψm in procyclic forms (Verner et 
al., 2013). Assessing the effects of mitochondrial dysfunction on nuclear gene expression 
(discussed in Chapter 3 of this thesis) has been followed up by investigating the effect of 
absence of kDNA on temporal and spatial differentiation of bloodstream form of T. brucei. 
Attempts to generate complex I null mutants and akinetoplastic cell lines are two different 
means of assessing the effect of mitochondrial dysfunction. Recent work has shown 
adipose tissue as a third major reservoir for T. brucei, aside the colonisation of blood in 
early infection and later crossing the blood-brain barrier (BBB) in mammalian hosts 
(Trindade et al., 2016). These parasites also reside in the lymphatic system, interstitial spaces 
of organs, choroid plexuses and meninges of the brain (Kennedy, 2013). Studies describing 
tropism of the skin have also shown that T. brucei is found near the subcutaneous adipocytes 
(Caljon et al., 2016; Capewell et al., 2016). Previous studies have showed that parasites from 
adipose, heart, and brain tissues can re-invade the bloodstream to establish new infection 
(Trindade et al., 2016).  
The adipose tissue form (ATF) of T. brucei differs from the bloodstream form and the 
procyclic form because the ATF utilise fatty acids as an external carbon source, which would 
be in contrast to usage of glucose and proline as major carbon sources by bloodstream and 
procyclic forms, respectively (Szöör et al., 2014). These predictions were suggested by 
transcriptomic analysis, where upregulated genes in ATF included putative fatty acid β-
oxidation enzymes such as carnitine-acyltransferases, which is responsible for mitochondrial 







the mitochondrion of ATFs, the same study also reported that these parasites were able to 
utilize exogenous myristate and formed β-oxidation intermediates. The beta oxidation may 
require increase demand for NADH, which may be the role of complex I, eventually 
generating energy for ATF of the parasite. 
 
4.1.1 Hypotheses 
The Vassella research group has reported that HMI-9-based medium containing 
methylcellulose allowed several pleomorphic T. b. brucei strains to proliferate without 
growth arrest (Vassella et al., 2001b). Growth-arrested populations can also be established 
by culturing slender forms of T. brucei  in methylcellulose medium without dilution for 48 
hours to allow accumulation of SIF and subsequent stumpy formation (Zimmermann et al., 
2017). This technique was used in the present study for differentiation of complex I null 
mutants and the WT EATRO to stumpy forms, in vitro. This chapter investigated the following 
hypotheses: 
1.  Complex I play an important role in stumpy forms and/or in cells residing in adipose 
tissue.  
2.  Complex I may be required for viability of T. brucei stumpy cells. 
 
4.2   Results 
4.2.1   Complex I null mutant in bloodstream form trypanosome. 
To generate functional cI null mutants in pleomorphic T. brucei, EATRO 1125 strain AnTat 
1.1 cells (Engstler and Boshart, 2004) were grown in HMI-9 medium containing 1.1% (w/v) 
methylcellulose, supplemented with 20% (v/v) foetal calf serum (FCS) and 5% serum plus 
(Section 2.1.2). As targets for generating functional cI null mutants, core subunits NUBM and 
NUKM were chosen. NUBM and NUKM are found within the hydrophilic part of the cIα 
subcomplex and forms part of the four-core complex I nuclearly encoded proteins. The 
flavoprotein NUBM is the first protein to receive electrons from NADH, whereas the iron-







ubiquinone. The homologous recombination strategy chosen to generate blood form cell 
lines lacking the NUBM or NUKM genes is depicted in Figure 4.2 and follows a general 
approach originally described by Wirtz et al. (1999). Approximately 500 bp of the 5′ and 3′ 
intergenic regions from NUKM and NUBM were amplified using the primers listed in 
Appendix A. These sequences were then inserted upstream and downstream, respectively, 
of cassettes encoding either  T7 RNA polymerase (T7RNAP) and neomycin resistance 
(NEO) genes (pTbNUBM-KO1 and pTbNUKM-KO1, to replace the first allele) or Tet repressor 
(TETR) and hygromycin resistance (HYG) genes (pTbNUBM-KO2 and pTbNUKM-KO2, to 
replace the second allele). Single knock out (SKONEO) cell lines were generated with 
pTbNUBM-KO1 and pTbNUKM-KO1 and used to generate double knockout (DKO) null 
mutants (Δnubm::NEO/Δnubm::HYG and Δnukm::NEO/Δnukm::HYG) by replacing the 
second allele with pTbNUBM-KO2 and pTbNUKM-KO2 (Figure 4.2). Hence, the DKO null 
mutants were resistant to both NEO and HYG. This study used published constructs 
described by Surve et al.(2012). Also, conditional knockout (CKO) cell lines for NUBM and 
NUKM used in this study were kind gift from Sachin Surve (Seattle Biomedical Research 
Institute, Seattle, Washington, USA). These were cell lines generated in the study conducted 
by Surve et al. (2012).  
After transfection and selection (See Section 2.1.2), the resulting blood form lines were 
analyzed by PCR (testing for correct integration of the knockout constructs and absence of 
the coding sequence). The locations of primers used for the confirmation of KO cells are  
shown in Figure 4.3 C and D. For confirmation of correct 5’ end integration of constructs, 
forward primers (Primer 1) were used that corresponded to 5’ intergenic regions upstream 
of the sequences used to generate the KO constructs; reverse primers (Primer 2) 
corresponded to sequence within the T7RNAP gene. Likewise, correct 3’ end integration was 
tested with PCR primers that corresponded to a region within the NEO gene (Primer 3) and 










Figure 4.2 Deletion of complex I subunits. Schematic illustration of NUBM and NUKM loci and 
constructs used for gene deletion by homologous recombination. Each construct contains 3’ and 5′ 
intergenic regions from either the NUBM or NUKM gene and an antibiotic-resistance gene (Surve et 
al., 2012). The first alleles of both NUKM and NUBM were replaced by a G418/neomycin resistance 
(NEO), while the second allele was replaced by hygromycin resistance (HYG) cassette. Knockout 
constructs were generated as described by (Ochatt et al., 1999).  
 
 
A 980-bp fragment from the F1FO-ATPase subunit γ was amplified to control for presence of 
gDNA in each sample. For detection of correct integration of the construct into the EATRO 
1125 AnTat 1.1 genome, primers were designed to target 3’ and 5’ intergenic regions and 
within T7RNAP and TETR genes of constructs. Correct integration of the construct to replace 
one NUBM allele would be expected to yield band sizes of 1120 bp and 1200 bp for 5’ and 
3’ end integrations, respectively (A). Analysis of a putative nukm SKO cell line by PCR gave 







To this end, the putative SKO clones were transfected with the constructs containing the 
NEO and T7 RNAP (for PCR confirmation) cassette, flanked by NUBM or NUKM upstream and 
downstream regions (Figure 4.2 C and D). The location of annealing primers is indicated for 















Figure 4.3 Assessment of correct replacement of one NUBM allele (panel A) or NUKM allele (panel 
B) with the NEO and T7 RNA pol cassette. Primers were designed and used to test integration of the 
pTbNUBM-KO1 and pTbNUKM-KO1 constructs into the EATRO 1125 AnTat 1.1 strain to generate 
NUBM (A) and NUKM (B) SKO cell lines, respectively. The images show the amplification products for 
each cell line after agarose gel electrophoresis. The ATPase γ subunit was amplified to confirm 
presence of gDNA in the samples. (A) DNA band sizes of 1120 bp and 1200 bp indicate correct 5’ and 
3’ end integration, respectively, of the construct into the NUBM locus. (B) DNA band sizes expected 
for correct integration of construct were 971 bp and 1154 bp which corresponded to 5’and 3’ end 
integration. (C) Location of primers for amplifying 5’ and 3’ integration of construct on NUBM locus. 









For NUBM, seven G418/hygromycin resistant clones were selected and analysed in a duplex 
PCR for the NUBM and ATPase subunit γ coding sequence (CDS). Assessment of deletion of 
NUBM alleles in the seven selected clones was done by PCR. The parental WT AnTaT 1.1 
strain was used as control. The expected sizes for the NUBM and ATPase subunit γ 
amplification products were 1488 bp and 980bp, respectively. Clone A and B were 
transfectants with NUBM CDS still present after second round attempt to generate NUBM 
double knockout clones. The remaining five DKO clones (1-5) had the NUBM gene succesfully 
deleted. The parental WT cell line served as positive control, where the expected fragment 
size of 1488 bp was amplified (Figure 4.4). However, only two clones were able to grow 
























Figure 4.4 Assessment of deletion of NUBM alleles in the seven selected clones by PCR. The 
parental WT AnTaT 1.1 strain was used as control. The expected sizes for the NUBM and ATPase 
subunit γ amplification products were 1488 bp and 980bp, respectively. Clone A and B were 
transfectants with NUBM CDS still present after second round attempt to generate NUBM double 
knockout clones. The remaining five DKO clones (1-5) had the NUBM gene succesfully deleted. The 
parental WT cell line served as positive control, where the expected fragment size of 1488 bp was 
amplified. The water control confirmed absence of T. brucei DNA contamination in the PCR master 
mixture. The 1-kb DNA ladder was used to extrapolate the sizes of the PCR products. 
 
 
For NUKM, fourteen clones were resistant to G418/hygromycin drugs. Successful deletion 
of both alleles was assessed by a PCR reaction specific for the CDS of NUKM, carried out as 







control (as described in Section 2.4.1). All fourteen antibiotic resistant clones for NUKM 
could be confirmed for absence of gene (Figure 4.5).  
 
 
Figure 4.5 Confirmation of deletion of both NUKM genes by PCR.  NUKM CDS-specific primers were 
used to enable confirmation of the presence or absence of the gene in the parental and antibiotic 
resistantclones, respectively. All 14 clones analysed showed successful deletion of both NUKM 
alleles. The parental cell line showed the expected size of 612 bp for the NUKM amplicon. The ATPase 
subunit γ gene was used as positive control in the same reaction. The water control  which served as 
negative showed no amplicon, indicating the absence of contamination of the PCR master mixture.  
 
 
4.2.2   Southern blot analysis confirmed complex I double knockout clones 
Following PCR analysis, Southern blot analysis was performed to validate the absence of 
either the NUBM or NUKM gene in the selected clones. The presence of PstI endonuclease 







of a ∼ 3.0 kb fragment in PstI-digested genomic DNA that can be detected by Southern 




Figure 4.6 A Schematic representation of the NUKM locus on chromosome 11 of the T. b. brucei 
TREU927 genome, before and after integration of KO constructs.  The PstI fragment detected by 
the NUKM 5’-UTR probe (and, in case of the WT, by the CDS probe) is highlighted in blue. A DNA 
band size of 2959 bp is expected for the WT NUKM locus. Successful replacement with the 
T7RNAP/NEO and TETR/HYG cassettes in the DKO clones is expected to result in detection of PstI 
DNA fragments of 4579 bp and 1974 bp with the same probe. The NUKM 5’ and 3’ intergenic region 
is highlighted in pink and grey on the middle and bottom maps, respectively. Abbreviations: ALD- 
Aldolase, ACT- Actin, NLS- Nuclear localization signals , PARP- procyclic acidic repetitive protein, 
SAS- splice acceptor site and HYG- Hygromycin. 
 
Hybridising a blot of PstI-digested genomic DNA with the NUKM CDS probe showed the ∼3.0 







band was absent in the putative DKO clones, but, surprisingly, also in the SKO and CKO cell 
lines (Figure 4.7, left panel). The absence of NUKM gene in the SKO cell could be that the 
remaining DNA sequence of NUKM is below detection level with this technique. The 
detection of NUKM in WT with two alleles showed weak signal. The CKO cell may not have 
the gene present in the genome even outside the rDNA locus. For presence of both 5’ UTR 
in the SKO could be a possible contamination of SKO DNA by the other samples. When 
probed with the 5’-UTR probe, DKO and CKO cell lines showed band sizes of ~2 kbp and ~4.5 
kbp, consistent with correct integration of both constructs (Figure 4.7, right panel). Again, 
the SKO cell line showed the same result as the DKO cell lines, which was unexpected. The 
WT AnTat1.1 parent cell line showed once again only the expected ∼3.0 kbp band. 
Altogether, the Southern analysis further validated the deletion of both alleles of the NUKM 
gene in the four clones investigated. 
 
Figure 4.7 Assessment of deletion of NUKM alleles in four clones by Southern analysis. Southern 
blot analysis of PstI-digested genomic DNA (1 μg) from Δnukm::NEO/Δnukm::HYG (DKO NUKM) (4 
clones) Δnukm/NUKM (SKO); inducible NUKM cell line (CKO NUKM) and wild-type trypanosomes 
(AnTat 1.1) and using a probe against the CDS (left panel with each number corresponding to samples 
investigated) and 5′-UTR (right panel) of NUKM. The size (kb) migration of marker DNAs are indicated. 
Blot hybridised with NUKM gene probe gave ∼3.0 kbp for presence of gene in the wild type AnTaT 
1.1 control cell line and absent in the DKO clones in left panel. DKO cell lines show sizes for both 
construct integration when probed with 5’ NUKM UTR DNA probe (1971 bp and 4579 bp) on the right 
blot. Same size of ∼3.0 kbp was obtained for WT when probed with 5’ NUKM UTR DNA probe. The 










Similarly, putative NUBM DKO mutants were subjected to Southern analysis using a probe 
for the NUBM 5′-UTR (results with a CDS probe were of poor quality, data not shown). 
Probing PstI-digested genomic WT T. brucei DNA with was predicted to result in a 5.1 kbp 
band (Figure 4.8, top map), whereas ~4.4 kbp and ~2.3 kbp bands were expected for DKO 
clones (Figure 4.8, middle and bottom maps). 
 
 
Figure 4.8 A schematic representation of the NUBM locus on chromosome 5 of the T. b. brucei 
TREU927 genome, before and after integration of KO constructs. The PstI fragment detected by the 
NUBM 5’-UTR probe (and, in case of the WT, by the CDS probe) is highlighted in blue. A DNA band 
size of 5099 bp is expected for the WT NUBM locus. Successful replacement with the T7RNAP/NEO 
and TETR/HYG cassettes in the DKO clones is expected to result in detection of two PstI DNA 
fragments (4425 bp and 2276 bp) with the same probe. The  NUKM 5’ and 3’ intergenic region is 
highlighted in blue and gray/green on the middle and bottom maps, respectively. Abbreviations:: 
ALD- Aldolase, ACT- Actin, NLS- Nuclear localization signals , PARP- procyclic acidic repetitive protein, 









Only PstI-digested genomic DNA of the WT AnTat 1.1 strain gave a DNA band size of ∼5 kb 
when probed with the NUBM 5’-UTR (Figure 4.9). For the DKO cell lines, DNA bands of 
∼ 4.4 kb and ∼ 2.3 kb confirmed successful replacement of the NUBM alleles with the 
T7RNAP/NEO and TETR/HYG cassettes (Figure 4.9). The blot also showed DNA bands 
between 2 kb and 4 kb, as well as below 1 kb, some of which were present in all cell lines, 
suggesting non-specific hybridisation. Overall, the Southern analysis confirmed the Δnubm 
genotype of two putative DKO clones tested. 
 
 
Figure 4.9 Detection of deletion of both alleles of the NUBM gene using Southern blotting. Genomic 
DNA was digested with the PstI enzyme. Specific probes were used for hybridization under the same 
conditions used initially for the detection of NUKM. Two DKO of NUBM clones 
(Δnubm::NEO/Δnubm::HYG, Lanes 1 and 3), WT control EATRO 1125 AnTat 1.1 (Lane 2), CKO NUBM 
(ΔnubmI::NEO/Δnubm::HYG, Lane 4) cell lines. Non-specific bands are shown on the blot between 
2kb and 4kb and well as below 1kb, albeit, all expected band sizes were detected for NUBM CDS 
(5099 bp) in WT and 4425 bp for 5’ UTR target region when replaced with pTbKO1 construct. The 









4.2.3  Stumpy cells generated in methylcellulose  
The ability of NUKM and NUBM null mutants to differentiate, as well as the parental cell line, 
in methylcellulose was investigated. Prior to the start of this study, I cultivated EATRO 1125 
strain AnTat1.1 in HMI-9 based medium supplemented with 20% (v/v) foetal calf serum, 5% 
serum plus, and 1.1% (w/v) methylcellulose as described (Vassella et al., 2001b). The 
pleomorphic cell line was used because they possess the ability to undergo full 
developmental stages and hence was suitable for analyses of trypanosome differentiation 
(M. Engstler and Boshart, 2004; Fenn and Matthews, 2007). This cell line was a kind gift from 
Professor Markus Engstler laboratory (Department of Cell and Developmental Biology, 
Biocenter, University of Würzburg, Germany). To generate density-induced stumpy 
parasites, slender cells at a seeding density of 5 x 105 cells/ml were left in culture without 
dilution for 48 hours. This procedure allowed the build-up of SIF and led to stumpy formation 
(Zimmermann et al., 2017). After 48 hours incubation at 37 °C, a pH change was observed 
via detection of an orange-yellowish colour. Cell death was also detected in a sub-population 
of cells for both WT and null mutant, even though majority of the cells were viable. 
Microscopic examination of culture revealed cell crenation, and debris. These observations 
suggested that timing of the experiment was critical because when cells were incubated 
beyond 48 hours, most of the cells, if not all, became inviable. A total of two clones were 
differentiated for NUBM mutant lines and fourteen clones for NUKM mutant cells. The 
differentiated stumpy forms showed the characteristic morphological change from long 
slender shape to short stumpy, and expressed the protein associated with differentiation 
(PAD1 surface marker; Figure 4.10 (Dean et al., 2009), which was detected by 








Figure 4.10 Expression of PAD1 by methylcellulose differentiated stumpy cells of T. brucei. The 
analyses were conducted with methylcellulose-induced stumpy cells for WT AnTat 1.1, NUKM DKO 
clone 1, and NUBM DKO clone 1 lines. Stumpy formation was initiated after slender cells were seeded 
at a density of 5x 105 cells/ml and left undiluted in HMI-9 medium with 1.1% (w/v) methylcellulose 
supplemented with 20% (v/v) foetal calf serum (FCS) and 5% serum plus for 48 hours. The 
differentiated stumpy cells were then harvested by diluting the viscous medium (1:4 dilution) with 
trypanosome diluting buffer (TDB), spun down to discard supernatant and spread remaining cells on 
microscopic slides for air drying. The WT and mutant stumpy trypanosome cells displayed a 
homogenous cytoplasmic PAD1 signal (green) as revealed by immunofluorescence. Nuclear (N) and 
mitochondrial DNA (K) were stained with DAPI (white). The phase image shows stumpy morphology 










4.2.4   Complex I null mutant cells can differentiate to procyclic forms 
The development of stumpy cells to procyclic forms is accompanied by replacement of cell 
surface VSG with EP-procyclin coat (a form of procyclin rich in glutamate and proline repeats) 
(Matthews and Gull, 1994b). To investigate whether cI null mutants cells were able to 
differentiate to procyclic forms, they were exposed to cis-aconitate and a temperature shift 
to 27 °C (Section 2.1.4) (Rolin et al., 1998). To monitor differentiation, expression of EP 
procyclin protein, a marker of differentiation (Acosta-Serrano et al., 2001), was analysed by 
immunoblotting with a EP antibody. In vitro differentiated trypanosomes show procyclin 
coat is gained after 2 hours, after replacing the VSG coat (Matthews, 1999). This is the reason 
for testing this protein in the differentiated cell lines. As shown in Figure 4.11, both WT and 
null mutant procyclic cells were able to express EP procyclin. Expression of EP in the single 
knockout cell line was not abundant in comparison to the null mutants. EF1 was used as a 










   
Figure 4.11 Expression of stage-specific marker by differentiating trypanosomes.  Methylcellulose-
induced stumpy trypanosomes were exposed to cis-aconitate to facilitate differentiation into 
procyclic forms. Aliquots of procyclic differentiated cells of WT EATRO 1125 (AnTaT 1.1 strain), DKO, 
SKO were analysed by SDS-PAGE and immunoblotting 72 hours post induction of differentiation by 
adding cis-aconitate and placing cultures at 27 °C. Undifferentiated BSF was used as negative control 
and PF strain 29-13 as positive control. All cell lines expressed EP procyclin except the BSF slender 
sample. The 33-kDa EP protein is shown in green and the 53-kDa elongation factor (EF-1α) (Grewal 
et al., 2016), which was used as a loading control, is shown in red. As a negative control, bloodtream 















4.2.5   Growth analyses of complex I null procyclic T. brucei mutants 
This study has shown the ability to generate and propagate NUBM DKO and NUKM DKO cell 
lines in HMI-9 supplemented with 1.1% methylcellulose and induce stumpy formation in 
these cell lines. To generate the null mutant in EATRO AnTat 1.1, the cells were cultivated in 
medium described in Section 2.1.3. After transfection, selected clones were able to grow in 
normal HMI-9 without the methylcellulose. Unfortunately, comparative growth analysis of 
WT and NUBM DKO versus NUKM DKO in HMI-9 medium was not performed.  
The in vitro differentiation to procyclic form was generated as described (Section 2.1.4). 
NUBM DKO procyclic cells and the differentiated parental EATRO 1125 AnTat1.1 procyclic 
cells were grown in SDM-79 medium for two weeks before performing the growth analyses. 
One WT AnTat 1.1 and two distinct clones of the nukm null mutant procyclic cells were 
investigated. Each cell line had two replicates of cell culture. In SDM-79 medium, NUBM DKO 
cells grew marginally slower compared to WT when cultured under the same conditions for 
two weeks (Figure 4.12). The generation time for WT AnTat 1.1 was 10.5 hrs and that of 
NUBM clone 1 and 2 was 14.04 and 19.4 hrs respectively. Hence, the data shown Figure 4.12 
represent the growth analyses of only WT and NUBM procyclic in vitro. The results show 
growth defect in NUBM procyclic cells when compared to the parental cell line WT AnTaT 








Figure 4.12  Growth analysis of complex I mutant procyclic form upon triggering differentiation 
with cis-aconitate. Growth analyses of WT and NUBM mutant procyclic clone 1 and 2 cultivated in 
vitro, are shown. Both WT and null mutant PCF were maintained at 2 x 106 daily after each cell count.  
Parasite densities were measured daily and then passaged by adjusting density to 2 × 106 cells/ml in 
fresh medium. The population growth was then calculated as cell density multiplied by the 
cumulative dilution factors. The cumulative growth curves after normalization for dilution at each 
subculture of WT and cI null mutant NUBM differentiated PCF cells were determined over a period 
of two weeks in SDM-79. WT is shown in lilac, NUBM PCF clone 1 and 2 in orange and green, 
respectively. 
 
4.2.6   Virulence of NUBM and NUKM DKO parasites in mice 
To test the ability of the NUBM and NUKM DKO cell lines to differentiate into stumpy cells 
in mice, three different treatments were administered to three different groups of 10-week 
old male MF1 mice. These mice were infected intraperitoneally with 2000 cells of EATRO 
1125 AnTat 1.1 cell line or NUBM DKO clone 1 and 2 or NUKM DKO clone 1 and 2.  
These cells were resuspended in HMI-9 prior to mice inoculation. The parasitaemia and 
survival of these mice were monitored daily until day 6. Mice infected with WT parasites and 
NUBM or NUKM DKO cells reached parasitaemia of 108 and > 108 /ml of blood respectively 







differentiated to stumpy forms. Pleomorphic cells differentiate in a density-dependent 
manner from the proliferative slender form, through an intermediate stage, to the non-
proliferative then to fly-infective stumpy stage form (MacGregor et al., 2013).  
These stumpy forms are visible between day 4–6 post infection with parasitaemia plateaus 
at about day 5–7 post infection with >80% cell population exhibiting morphological stumpy 
forms (MacGregor et al., 2013), but that was not the case of these cell lines. The 
hyperparasitaemia observed in DKO clones resulted in the death of one out of the two NUKM 
DKO clone 1 infected mice. Collectively, the hyperparasitaemia observed in mice infected 
with either WT or DKO T. brucei suggest that these trypanosomes have lost pleomorphism. 
 
Figure 4.13 Parasitaemia profile of T. brucei infection. WT and NUBM and NUKM cells were used to 
inoculate 10 weeks MFI male mice with 2 × 103 trypanosomes. Parasite levels were monitored from 
day 3 till day 6 post-infection. Two mice were used per each clone of cell line. By day 6. WT (A) 
parasitaemia had reached 1x 108, whiles NUBM (B) and NUKM (C) cells showed uncontrollable 
growth of ~3 x 108 and ~4 x 108 parasites/ ml of blood respectively. The Y-axis is log10 parasite count 
per ml of blood and X-axis is number of days post-infection. One mouse infected with NUKM clone 1 








4.2.7   Confirmation of pleomorphic trypanosome strain EATRO 1125 
AnTat1.1 
The cell line obtained from Professor Markus Engstler’s laboratory in Würzburg only showed 
30% stumpy cells after 6 days post-infection to differentiate to stumpy forms. Pleomorphism 
is the ability of T. brucei slender forms to differentiate to stumpy forms with >80% of cell 
population in a mouse model. To generate new cI null mutant in a pleomorphic T. brucei 
background, different batches of stabilates of EATRO 1125 AnTat1.1 were obtained from the 
same laboratory, which originated from the Matthews laboratory (University of Edinburgh, 
United Kingdom). These batches of samples were validated to confirm that they were true 
pleomorphic cell lines. The data shown in Figure 4.14 demonstrate that these cell lines 
differentiated to stumpy forms in mice on day 6 post-infection and expressed PAD1 (Dean 
et al., 2009) when analysed by immunoblotting. Analysis of cell morphology also revealed 
that cells were stumpy-shaped when differentiated in mice (Figure 4.14) and this compares 
with the cell shape reported previously (Matthews et al., 2015). 
 
Figure 4.14 Confirmation of pleomorphic T. brucei cell line. EATRO 1125 serodeme AnTat1.1 
differentiated to stumpy morphology as shown in the brightfield microscopy picture (left panel). 
Blood was harvested, and lysates from purified trypanosomes were fractionated by SDS-PAGE and 
analysed by immunoblotting (right panel) with antibodies against PAD1 (green signal) and EF-1α as 
loading control (red signal). For each sample, 2 x106 cells were loaded. Two control cell lines (stumpy 
control and AnTat1.1 BSF) were run alongside the sample of interest. The negative control, AnTat1.1 
BSF (lane 2) showed no expression for PAD1, whereas the positive AnTat1.1 stumpy cell lines (lane 1 
and 3) expressed PAD1. EF1 was used as a loading control. Western Images were developed with 








4.2.8 Generation of complex I null mutant in pleomorphic T. brucei  
Having confirmed that the new batch of EATRO 1125 AnTat1.1 efficiently differentiates into 
stumpy cells during a mouse infection, these cells were used in a new attempt to generate 
NUKM null mutants in a truly pleomorphic background. In parallel, it was attempted to 
establish NUKM null mutants in the EATRO 1125 AnTat1.1 90:13 cell line, a well-established 
model for differentiation studies as it is particularly amenable to the generation of 
transgenic cell lines (MacGregor et al., 2013). The slender AnTat1.1 parasite was cultured in 
HMI-9 medium. The slender AnTat1.1 parasite was cultured in HMI-9 medium as described 
in Section 2.1.3.  The medium used for culturing the slender forms of EATRO 1125 (AnTat1.1 
90:13) cells is also described in Section 2.1.1.  
These trypanosome cultures were kept at densities below 5 x 105 cells/ml to prevent cells 
from differentiating to the stumpy stage. The plasmids used to attempt deletion of both 
alleles of NUKM in EATRO 1125 AnTat1.1 have been described in Section 4.21 and by Surve 
et al (2012) and are listed in Table 2.2. In two separate attempts of transfection with 
pTbNUBM-KO1 and pTbNUKM-KO1, 74 putative NUBM SKO and 63 NUKM SKO clones were 
generated. Analysis of 15 transfectants each for NUBM and NUKM by PCR gave no amplicon 
and thus integration of construct to delete gene was unsuccessful. A summary of the 
transfections that were performed, the type of cell line used, the number of selected clones 
from each round of transfection and the validation method for the selected clones are 






























NUBM SKO 74 PCR 
Tested 15, none gave 
an amplicon. ATPase 






NUKM SKO 63 PCR 
Tested 15, none gave 
an amplicon. ATPase 




The selectable marker genes in plasmids pTbNUKM-KO1 (G418 resistance) and pTbNUKM-
KO2 (hygromycin resistance) are already present in cell line EATRO 1125 AnTat1.1 90:13. 
Two synthetic constructs were designed because the AnTat 1.1 90:13 has neomycin and 
hygromycin to maintain the expression of T7-polymerase and the tetracycline repressor.  
These selectable markers and genes are also present in two existing constructs (pTbNUKM-
KO1 and pTbNUKM-KO2). 
 Consequently, the two synthetic constructs (containing blasticidin and phleomycin 
resistance genes as selectable markers) were used in attempt to delete the NUKM gene. The 
constructs were designed such that one had the distal end of NUKM UTRs and the other had 
the proximal end closer to the coding sequence of the NUKM gene (Appendix B). Here, ~300 
nucleotide targeting sequences were used to provide greater recombination frequency, and 
thus an efficient transfection (Merritt and Stuart, 2013).  
Successful integration of both constructs would result in deletion of both alleles of the 
NUKM gene. Three independent transfections with construct pEX-K4-NUKM-1 gave 25 
putative SKO clones that grew stably in blasticidin (Table 4.2). The gDNA was of sufficient 







clones by PCR for integration of pEX-K4 NUKM-1 revealed that, two samples had 5’ 
integration with one additionally showing integration at 3’end (Figure 4.15). The 5’ and 3’ 
replacement by pEX-K4 plasmid expected size is 2459 bp, whiles the 5’ end integration 
fragment size is 1519 bp and that of 3’ end integration is 1186 bp. As shown on the linear 

















Figure 4.15 Confirmation of correct integration of construct by PCR and gel electrophoresis. Primers 
were designed to amplify the NUKM 5’ and 3’ UTR loci in WT (control) and to confirm the integration 
of construct with either 5’ end or 3’ end of NUKM in SKO lines. The parental cell line showed no 
amplicon, as expected for construct integration but the 2459 bp size was expected to serve as control 
for the 5’ to 3’ ends of the UTR loci on the EATRO 1125 genome. Two clones (1 and 4) showed 
successful integration of 3’ end in one allele of the NUKM gene. Clone 4 then gave the correct size of 
1519 bp for 5’ end integration of the construct. The water control showed no amplicon, indicating 








Mouse infections showed that neither of these two SKO clones were able to efficiently 
differentiate into stumpy forms in mice (data not shown). This suggests that the attempt to 
delete cI subunit hinders differentiation ability of pleomorphic cell line. The other clones 
either gave no amplicon with PCR or incorrect sizes from what was expected for correct 
integration (data not shown). Attempts to delete the second allele of NUKM in this NUKM 
SKO clone with plasmid pEX-K4-NUKM-2 were unsuccessful (Table 4.2). Efforts to start 
NUKM gene deletion in the parental cell line with plasmid pEX-K4-NUKM-2 resulted in sixty 
viable clones, 19 clones tested for absence of the NUKM gene by PCR analysis gave 
inconclusive results (Table 4.2). Thus, all efforts to generate NUBM or NUKM null mutants in 
parasites that are competent for efficient stumpy differentiation in mice have been 
unsuccessful. A summary of cell line used, the number of selected clones and validation 
methods is presented in Table 4.2. 
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20. Only 15 




Six clones gave band 
sizes close to size of 
5' to 3' NUKM UTR 
integration. Two out 
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4.2.9 The T. brucei NUKM null mutant shows decreased fitness in fat 
As described before (Section 4.2.6) the T. brucei EATRO 1125 AnTat1.1 cell line (Würzburg 
strain) and NUBM or NUKM null mutant cell lines derived from it did not efficiently 
differentiate into stumpy forms in vivo at peak parasitaemia (i.e. after six days post 
infection), although individual cells exhibited morphological characteristics of short stumpy 
forms and also expressed PAD1, a stumpy marker (see Figure 4.10). All cell lines were 
virulent in mice with hyperparasitaemia. Thus, parasite grew faster with change in parasite 
density with time in infections such that the parasite level exceeded >108 trypanosomes/ml 
which overwhelmed the host. 
The absence of cI subunit NUBM or NUKM in T. brucei bloodstream form may render the 
knockout (KO) cells incapable of activating complex I of the respiratory chain for the 
parasites to survive in adipose tissue. This was done because it has been published that the 
adipose tissue is a niche for T. brucei, and these adipose tissue forms are capable of 
replicating within the fat (Trindade et al., 2016). The rationale here was to use null mutant 
to test if complex I is required for survival in adipose tissue. Because these KO cells were 
unable to fully differentiate in mice (Section 4.2.6), only first peak of parasitaemia was 
considered and tested. This is in contrast to what was done in the study conducted by 
Trindade et al (2016), where parasitaemia was monitored until day 28 post-infection. The 
AnTat1.1 WT parental and NUBM and NUKM null mutant cells were used to inoculate three 
groups (one with WT, one with NUBM and one with NUKM) of 10-weeks old female C57BL/6J 
mice and monitored levels of parasitaemia in various tissues, including the ability of these 







post-infection and drop on day 6 even though it could not differentiate into stumpy form. 
The parasitaemia pattern with this same cell line gave a different profile when infection was 
done in MF1 mice strain. As shown in Figure 4.13, parasitaemia was 108 trypanosomes/ml 
by day 6 post-infection and mice had to be euthanised.  
The KO clones parasitaemia depicted that of monomorphic cell line where there was rapid 
parasite growth by day 5 post-infection with >3 x 108 parasites/ ml of blood and continued 
increasing in parasite number without differentiating to stumpy forms (Figure 4.16). The 
hyperparasitaemia observed for these cell lines is the consequence of their inability to 
differentiate to stumpy, as shown in Section 4.2.6. NUKM KO cells were most virulent among 
the three cell lines as mice infected by these cell lines started dying by day 6 post-infection.  
This study was done in collaboration with the Figueiredo laboratory in Lisbon, some of the 
animal experiments were carried out by that laboratory by the help of Tiago Rebelo who 
helped in generating some of the data in this section. 
Both WT and DKO cells peaked on day 5 but parasitaemia level reduced on day 6 for WT 
infection. Having established the parasitaemia profile of these cell lines, organs harvested 
on day 6 post-infection from WT and NUBM infected mice were used for qPCR analysis. 
However, a new infection was set up for WT and NUKM and organs of infected mice with 
these cell lines were harvested on day 5 post-infection to assess the ability of these null 
mutant and parental cell line parasites to invade other tissues and organs apart from blood. 
After perfusing mice with PBS with heparin, various organs were harvested. The perfusion 
was done to remove all traces of blood from the organs to allow only observation of resident 
parasites. DNA was extracted from the samples, and parasite density quantification in the 
heart, liver, kidney and gonadal adipose tissue (AT) was performed by measuring parasite 













Figure 4.16 Growth of WT and NUBM or NUKM null mutant cell lines of T. brucei in 
immunocompetent C57BL/6J mice. Data presents individual infections (3 replicates) with the same 
WT cell line or DKO clone1.or NUBM clone 1. Panel A shows infection with NUBM and B show NUKM 
infection. The WT data are the same both panel A and B The parasitaemia in blood was fixed in 







These organs were chosen because Trindade and colleagues showed an increase in parasite 
load in most of these organs by immunohistochemical staining (Trindade et al., 2016). High 
parasite density was observed in the heart, liver and kidney, respectively, with statistical 
significance of differences indicated by asterisks: * p ≤ 0.05 and  ** p ≤ 0.01 p values s in the 
organs infected with NUBM KO cells compared to the WT cell infected organs (Figure 4.17), 
where parasitaemia in blood had dropped on the day of organ harvest. In contrast, there 
was no significant difference in the total parasite numbers in the gonadal AT of both WT and 
NUBM KO cells. The density of parasites per milligram of organ or tissue was calculated as a 
ratio of parasite gDNA versus mouse gDNA in each tissue. This was done by weighing the 
tissue and used calibration curve to translate qPCR signal into numbers of parasite. 
 
Figure 4.17 Quantification of WT and NUBM DKO parasite density of different organs in mice. 
Parasite loads in organs of C57BL/6J mice were quantified by qPCR targeting trypanosome 18S rRNA 
genes (converted to parasite numbers using a calibration curve) and are given as parasites (log10) per 
mg of organ. Shown are average values from three mice per cell line, and three technical qPCR 
replicates per sample (n = 9) Error bars are standard error of the mean (SEM). The NUBM parasite 
load was significantly more than the one observed with WT parasite in heart with p-value of 0.01 (*). 
NUBM parasite load was higher than WT in the kidney and liver (* = p value of 0.027, ** = p value of 










Similarly, the parasite load in the heart, kidney and liver of mice infected with NUKM DKO 
parasites were higher compared to those infected with the WT (Figure 4.18), with statistical 
significance of differences indicated by asterisks: * p ≤ 0.05 but not as high as levels observed 
in NUBM DKO samples. The NUKM DKO cells showed ~10-fold more parasites in heart, liver 
and kidney when compared to those infected with the WT cells. Interestingly, in striking 
contrast to what was observed for blood, heart, kidney and liver, the total parasite numbers 
measured in the gonadal AT was ~4-fold lower for NUKM DKO cells compared to WT cells 
(Figure 4.18). The parasite density was calculated as mentioned earlier. 
 
 
Figure 4.18 Quantification of parasite density of different organs in mice infected with either WT 
or NUKM KO cells. Parasite loads in organs of C57BL/6J mice were quantified by qPCR targeting 
trypanosome 18S rRNA genes (converted to parasite numbers using a calibration curve) and are given 
as parasites (log10) per mg of organ. Shown are average values from three mice per cell line, and 
three technical qPCR replicates per sample (n = 9). Error bars are standard error of the mean (SEM). 
The NUKM parasite load was significantly more than the one observed with WT parasite in kidney 
with p-value of 0.012 (*). There was no significant difference in heart and liver infected with either 
WT or NUKM lines. NUKM parasite load was however, lower than WT in the gonadal AT (* = p value 








This interesting observation of the difference in parasite numbers in gonadal AT relative to 
other tissues when NUKM DKO / NUBM DKO parasites were compared to WT appeared to 
support the hypothesis that cI activity may be important for efficient invasion of or survival 
in AT. It was surprising, however, that this phenotype was much more pronounced for NUKM 
null mutants than for NUMB null mutants, because both NUBM and NUKM are core subunits 
of complex cI and essential for electron transfer. Nonetheless, these observations prompted 




4.2.10 Generation of NUKM add-back cell line 
The increased parasite load in blood and organs by KO cells compared to WT cells could 
presumably be because of direct consequence of hyperparasitemia due to lack of stumpy 
differentiation. The gonadal AT did not show a similar increase in parasite load when NUBM 
DKO cells were compared with WT and was even lower in the gonadal AT of mice infected 
with NUKM DKO cells. WT parasites behaved differently in the Lisbon experiments compared 
to that conducted in Edinburgh. The parasite increased over the period of time (Figure 4.13), 
contrast to what was observed in Figure 4.16. The phenotype with NUKM null mutants was 
stronger, so I focused on these mutants for further analysis to test the hypothesis that cI 
may be important for metabolism in AT. If the hypothesis is correct, introducing a 
functional WT NUKM allele into the NUKM double knockout (DKO) mutant should restore 
the virulence. In order to generate such a cell line, the coding sequence of NUKM was 
cloned into the HindIII and BamHI sites of pHD1344tub. The NUKM gene was cloned into 
the pHD1344tub plasmid (Carnes et al., 2012), for ectopic constitutive NUKM expression 
from the tubulin locus. 
 The add-back construct was sequenced to confirm the NUKM insert, and this construct was 
used to transfect NUKM DKO clone 1. After selection of puromycin resistant parasites, 10 







size of 612 bp for the NUKM gene fragment (Figure 4.19). WT AnTat1.1 cell and the NUKM 
DKO cell line served as positive and negative PCR controls, respectively. 
 
 
Figure 4.19 PCR confirmation of NUKM add-back cell lines. Ten clones selected were tested for 
successful introduction of the NUKM gene into NUKM DKO clone 1. DNA extracted from NUKM DKO 
cells and from AnTat1.1 WT cells was used as negative and positive control, respectively. The 1-kb 
ladder was used and expected size of NUKM gene is 612 bp. 
 
 
To confirm expression of the ectopic allele, levels of NUKM mRNA were assessed by qRT-
PCR analysis in two of the add-back clones. EATRO 1125 strains AnTat1.1 and AnTat1.1 90:13 
and the parental NUKM DKO cell line were used as controls. As shown in Figure 4.20, NUKM 
mRNA expression in the add-back cell lines was ~10-fold higher in both add-back clones 
compared to the WT cell. This is presumably because the NUKM gene in the pHD1344-tub 
plasmid features a 3’ UTR from actin, a constitutively expressed housekeeping gene, and 
because that construct recombines into the stably transcribed β tubulin locus. As expected, 










Figure 4.20. Quantitative RT-PCR with T. brucei cDNA for detection of NUKM. On the Y-axis is log10 
relative quantification (RQ) plotted against the samples investigated. Three biological replicates each 
of sample were analysed. The levels of the NUKM mRNA were normalised with GPI8, and then all 
samples were normalised against WT AnTaT 1.1 90:13 as reference sample. The NUKM clone 1 was 
used as a negative control.  Each sample was three technical replicates and -R control was included. 
 
 
4.2.11 NUKM add-back does not restore a WT phenotype  
To test whether NUKM add-back cell lines can rescue the hyperparasitemia, eight-week-old 
female C57BL/6J mice were inoculated with WT cells, two NUKM add-back cell lines and two 












Blood parasitaemia was assessed daily from day three post-infection. Three mice from each 
group were sacrificed on day five post-infection as previous experiment with KO cells were 
analysed on day 5 post-infection to enable comparison with previous data. Mice were 
perfused, and the various organs harvested, while blood parasitaemia continued to be 
monitored for the other two mice in each group (Figure 4.21). WT AnTat1.1 showed a normal 
pattern of blood parasitaemia, peaking at day six and dropping afterwards. The two different 
clones for both NUKM DKO and NUKM add-back were more virulent and showed 
hyperparasitemia. Mice infected with NUKM DKO cells had to be sacrificed or died between 
day five and day seven post-infection. NUKM add-back clone 1 infected mice died between 
day six and day seven post-infection (Figure 4.21). NUKM add-back clone 2 infected mice 
had no detectable parasites as of day five post-infection. This clone was eliminated from 
parasite number quantifications in the organs. However, from day 6 post-infection, mice 









Figure 4.21. Blood parasitaemia profile of WT, NUKM DKO and NUKM add-back cell lines. The WT 
EATRO 1125 AnTat1.1 cell line, two NUKM DKO cell lines and two NUKM add-back cell lines were 
used to infect five mice each and parasite load in blood was monitored over time. WT is shown in 
blue, NUKM DKO clones 1 and 2 are shown in solid purple and dash lines respectively, and NUKM 
add-back clones 1 and 2 in solid orange and dash, respectively. The Y-axis shows the log10 of blood 
parasitaemia /ml and the X-axis represents the number of days post-infection. Three mice for each 
cell line were sacrificed on day 5 for parasite quantification in organs. In the two remaining mice 
from each group, blood parasitaemia continued to be monitored until mice had to be sacrificed 
because they showed signs of suffering. Despite best efforts, some mice died. 
 
For the organ samples from day 5, parasite quantification was performed by qPCR targeting 
trypanosome 18S DNA from heart, kidney and gonadal AT, as previously. Unpaired t test 
followed by post analysis test using ANOVA showed that AnTat 1.1 had high parasite load in 
AT when compared the NUKM clone 1, 2 and add-back clone 10 with a p value of 0.0049 
(**). The two NUKM DKO lines showed higher parasite numbers in heart (**= p value of 
0.004). There was no significant difference in parasite density in kidney infected with either 
WT, NUKM clone 1, 2 or add-back clone 1 cell line. A post hoc test was performed to know 







multiple comparison done on the kidney data showed no significant difference between WT 
in comparison with NUKM KO clones 1 and 2 nor Addback clone 1. The significant value 
indicated for heart was generated from WT comparison with NUKM clone 1 and 2. Finally, 
the significant difference obtained for gonadal AT was from WT in comparison with NUKM 
clone 1, clone 2 and Addback clone 1 as shown in Table 4.4. The NUKM add-back clone 1 
showed a similar phenotype as the NUKM DKO clones (Figure 4.22).  
 
 
Figure 4.22. Parasite density in organs determined by qPCR. Mice were infected with WT, NUKM 
DKO or NUKM add-back cell lines. Parasite loads in organs of C57BL/6J mice on day 5 post-infection 
were quantified by qPCR targeting trypanosome 18S rRNA genes (converted to parasite numbers 
using a calibration curve) and are given as parasites (log10) per mg of organ. Shown are average values 
from three mice per cell line, and three technical qPCR replicates per sample (n = 9). Error bars are 
standard error of the mean (SEM). Statistical significance of differences is indicated by asterisks: ** 













Table 4.4 A detailed information  of the post hoc pairwise comparison indicating  samples that 
accounted for significant difference found with  ANOVA as illustrated in figure 4.22 
 
 
A number of different scenarios could explain this finding. One possibility is that the 
phenotype observed for the NUKM DKO clones was unrelated to loss of NUKM (e.g. a 
random genetic change in the stumpy differentiation pathway resulting in monomorphism). 
Finally, the phenotype could be caused by NUKM deficiency, but NUKM expression levels in 
the add-back cell line might be inappropriate (for example, the qRT-PCR analysis suggested 











4.2.12 Chronic infection in mice infected with Akinetoplastic and 
isogenic control cell lines 
Previous studies done in Prof. Achim Schnaufer’s research laboratory using mouse model 
infected with akinetoplastic (AK) cell line showed that the AK line pleomorphic cell line 
EATRO 1125 (AnTat1.1 90:13) with L262P mutation in the nuclear-encoded F1 subunit γ 
permitted survival of slender bloodstream forms lacking kDNA. Nevertheless, the absence 
of mtDNA in these parasites causes an alteration in mitochondrial metabolism and a reduced 
life span (Dewar et al., 2018). The WT used here is the same parental cell line with wild type 
version (WTγ) introduced to generate an isogenic control (WT/WTγ). This is called WTγ for 
simplicity sake. To test whether cI is needed by the AK cells for longevity, AK and WTγ 
infected mice were subjected to chronic infection in mice. This will enable comparison of AK 
cells to WTγ to know whether the AK can exhibit cyclical waves of parasitaemia. The AK 
pleomorphic cell line under investigation has one allele of the nuclear-encoded F1FO-ATPase 
subunit γ replaced with an L262P mutation. The AK cells were generated by acriflavine 
treatment (Dean et al., 2013) (aAK) or spontaneously lost the kinetoplast without acriflavine 
treatment (AK). The survival of mice was monitored for 57 days. Female C57BL/6J mice were 
each inoculated with either WTγ or AK cell lines. By the 7th day following inoculation, WTγ 
started showing detectable parasitaemia contrary to early normal parasitaemia wave seen 
on day 3 post- infection in mice infected with AK cells. However, the peak was lower and 
cleared quickly compared to that usually observed for the AnTat 90:13 strain (Data not 
shown). Moreover, fluctuating parasitaemia of 106 to 107parasites/mL were detected for AK 
infected mice and 107 to 108 parasites/mL were also detected for WTγ infected mice, by day 
12 post-infection. By day 20, parasite levels dropped to 105 to 106 parasites/mL for two of 
the AK infected mice while the third mice had undetectable parasitaemia. WTγ infected mice 








One out of the three mouse in the AK group died by day 30 post-infection while all the three 
mice in the WT group were still alive at that time. Interestingly, the remaining mice in the 
AK and WTγ groups demonstrated restored rates of survival until day 57 post-infection.  
The parasitaemia profile observed in C57BL/6J mice by Dr Luisa Figueiredo‘s co-workers in 
Lisbon did not correlate with the observations from our study using the same cell lines. 
Detailed comparison between these cell lines have been conducted (Dewar et al., 2018). In 
their report, they showed that WTγ cell line had parasitaemia earlier (day 3) than AK cell line 
(day 4) and parasites declined quickly (by day 7 post- infection) than WTγ (parasitaemia 
dropped between day 7 and 8 post-infection). However, at peak parasitaemia, populations 
of both cell lines showed 80–90% stumpy cells (Dewar et al., 2018). The following factors 
may account for the difference and fluctuations in parasitaemia profile of C57BL/6J mice 
infected with either AK or WTγ cells. Firstly, the mice strain used in Lisbon is C57BL/6J and 
sex is female whereas the one I use in Edinburgh is MFI males. The second contributing factor 
could be the difference in culture medium; there is high possibility that the AK and WTγ cells 
have adapted to the MFI mice strain, hence further investigations with these two cell lines 
were carried out using the MFI mice strain.  
 
4.2.13 T. brucei akinetoplastic parasite showed preference in adipose 
tissue when compared to other organs 
The mouse infections with NUBM DKO and NUKM DKO parasites presented above (see 
Figure 4.17 and Figure 4.18) showed that parasitaemia in AT was similar or even lower 
compared to the WT control, a noteworthy contrast to the substantially higher parasite load 
in blood and other organs tested. Insertion of an ectopic NUKM gene into the NUKM DKO 
cell line did not restore the WT phenotype (see Figure 4.22), hence evidence for a potential 








To obtain further experimental evidence for or against a role of in AT parasites, the AK T. 
brucei EATRO 1125 AnTat1.1 cell line expressing L262Pγ that had spontaneously lost the 
mitochondrial genome (Dean et al., 2013), and thus lacked all eight mitochondrially-encoded 
cI subunits, was used. These subunits are critical for cI function, and analysis of an AK T. b. 
evansi cell line had in fact suggested absence of cI in the absence of kDNA (Surve et al., 2012).  
It was therefore expected that a reduced relative parasitaemia in AT should be observed for 
the AK cells if cI was important in AT parasites. To test this prediction, 10-week old female 
MF1 mice were inoculated with either the AK T. brucei L262γ cell line or the otherwise 
isogenic cell line expressing WTγ (see Section 2.1.1). The level of parasitaemia in blood was 
monitored daily, and parasite load in various organs was determined by quantifying 
trypanosome gDNA at 7 days post-infection. The organs were harvested on day 7 post-
infection due to the infection dynamics of these cell lines and parasite load in various organs 
was determined by quantifying trypanosome gDNA (mentioned in Section 4.2.12). The blood 
had a 10-fold higher parasite density in WTγ cells relative to AK L262Pγ cells on day 7 post-
infection (Figure 4.23), presumably reflecting the observation that the AK cells typically show 









Figure 4.23 Parasitaemia level in blood of WTγ and AK L262Pγ infected mice. (A) Parasitaemia 
during mouse infections with WT and AK cells was measured over time. Mice were infected at day 0, 
with three mice infected per cell line. Error bars are standard error of the mean (SEM). Tail snips 
were performed every daily from day 3 post- and cell counts were estimated from blood smears. (B). 
Parasitaemia was determined by isolating DNA from infected mouse blood on 7 dpi and performed 
qPCR targeting trypanosome 18S rRNA genes.The 18S qPCR signal was converted to parasite density 
using a calibration curve. Shown are average values from three mice per cell line, and three technical 
qPCR replicates per sample (n = 9). Error bars are standard error of the mean (SEM). The WT parasite 
load was higher than AK parasite in blood.(*** = p value of 0.0002). 
 
 
The parasite densities in solid organs were also quantified on day 7 post-infection (Figure 
4.24). The data show that, with the notable exception of the gonadal AT, parasite load was 
lower in organs from mice infected with AK T. brucei relative to the control: heart, liver and 
kidney from infections with AK parasites had a 2-to 5-fold lower parasite loads compared to 









Figure 4.24 Parasite density quantification in organs from mice infected with AK and control 
parasites at day 7 post-infection (experiment 1). Parasite loads in gonadal AT, heart, liver and kidney 
of MF1 mice were quantified by qPCR targeting trypanosome 18S rRNA genes (converted to parasite 
numbers using a calibration curve) and are given as parasites (log10) per mg of organ. Shown are 
average values from three mice per cell line, and three technical qPCR replicates per sample (n = 9). 
Error bars are standard error of the mean (SEM). Three biological replicates were run, and each 
sample had three technical replicates. The AK parasite load was significantly more important than 
the one observed with WTγ parasite in AT with p-value of 0.0189 (*). WTγ parasite load was higher 
than AK in the heart, kidney and liver (**** = p value of <0.0001, ** = p value of 0.0019). 
 
To validate the high number of AK parasites in AT relative to WTγ, the previous experiment 
was repeated using different AK and WT control cell lines, also published by Dewar et al. 
(2018). In this case, kDNA deletion from the T. brucei EATRO 1125 AnTat1.1 L262Pγ cell line 
had been achieved by acriflavine treatment (indicated by the ‘aAK’ designation below). As a 
control, different clone of the EATRO 1125 AnTat1.1 WTγ cell line was used. Each of these 







parasitaemia was monitored daily, and mice were sacrificed at day 7 post-infection for 
parasite quantification in heart, liver, kidney and AT. The organs were harvested on day 7 
post-infection due to the infection dynamics of these cell lines mentioned in Section 4.2.12. 
Tail snips were performed daily from day 3 post infection till day 7 and cell counts were 
estimated from blood smears using Rapid Matching method. Parasitaemia profile for both 
WT and aAK shown in Figure 4.25 A. Quantification of parasite load in organs gave a similar 
picture as before (Figure 4.25 B). Parasite loads of aAK parasites in liver and kidney were 
significantly lower compared to the WT control, but significantly higher in AT. A difference 



















Figure 4.25 Parasite density quantification in blood and organs from mice infected with AK and 
control parasites (experiment 2). (A) Parasitaemia during mouse infections with WT and AK cells was 
measured over time. Mice were infected at day 0, with three mice infected per cell line. Error bars 
are standard error of the mean (SEM). Tail snips were performed every daily from day 3 post- and 
cell counts were estimated from blood smears. (B) Parasite loads in gonadal AT heart, liver and 
kidney of MF1 mice were quantified by qPCR targeting trypanosome 18S rRNA genes (converted to 
parasite numbers using a calibration curve) and are given as parasites (log10) per mg of organ. Shown 
are average values from three mice per cell line, and three technical qPCR replicates per sample (n = 
9). Error bars are standard error of the mean (SEM). The WT parasite load was significantly more 
than the one observed with aAK parasite in liver and kidney with p-value of 0.002 (**). The aAK 
parasite load was higher than WT in the heart and gonadal (** = p value of 0.004, and * = p value of 
0.023) respectively. 
 
The results show that akinetoplastic cells have a niche in adipose tissue. The results obtained 
with NUBM mutant infection showed increased parasite levels in solid organs when 







adipose tissue infected with either WT or NUBM. In contrast to infection done with NUKM 
cell line, the gonadal adipose tissue had low NUKM parasite when compared to WT. 
Interestingly, when similar infection was done using akinetoplastic cell line, the parasites 
showed preference to gonadal adipose tissue than the other organs. The aAK parasites were 
able to differentiate like the WT in both in blood and in adipose tissue (Figure 4.26). On day 
4 post- infection, blood smear was taken to get a control of slender forms of both cell lines. 
On day 7 post-infection, blood and fat were collected, and parasites isolated. The presence 
of slender and stumpy parasites is shown by phase contrast image and DAPI stained images 
show presence and absence of kinetoplast (Figure 4.26). 
 
 
Figure 4.26 Micrographs showing parasite differentiation in blood. Images are representative of all 
three mice infected with either WT or aAK cells. Phase contrast DAPI images are shown. Scale bar, 5 
µm is indicated on phase contrast image. 
 
 
Data obtained from Figure 4.24 and Figure 4.25 showed high number of AK cells in AT when 
quantified by qPCR. Here, WT and aAK parasites harvested from AT on day 7 were examined 







However, difference in experiments with NUKM/NUBM null mutants and that of data 
generated using akinetoplastic cell line, does not support an important role of cI in AT. 
. 
 
Figure 4.27. Micrographs showing presence of stumpy forms in adipose tissue. Representative 
images of parasites isolated on day 7 post-infection from gonadal AT from mice infected with aAK T. 
brucei (left) and WT control parasites (right). Absence or presence of kDNA was assessed by DAPI 
staining. Upper images show merged phase contrast and DAPI staining, and bottom images show 
DAPI staining alone. Scale bar, 5µm indicated on phase contrast image. 
 
 
4.2.14 T. brucei akinetoplastic cell showed preference for adipose 
tissue 
Because aAK parasite levels were higher than WT in AT in independent infections, a co-
infection of WT and aAK was carried out to investigate the apparent relative preference of 
AK T. brucei for AT more directly. Already, this akinetoplastic cell line has shown to 
proliferate and differentiate in blood and AT (see Figure 4.26 and Figure 4.27) respectively. 







parasitaemia and morphology were monitored from day 3 post-infection. Blood smears 
were taken daily from day 3 to day 6 post-infection and parasitaemia was judged by eye, 
based on the Rapid Matching method (Herbert and Lumsden, 1976). On day 6, parasitaemia 
had reached 5 x 108 cells/ml (Figure 4.28) which was higher as compared to average 
parasitaemia levels of the three mice with parasite count of 1.89 x 108 cells/ml and 9.4 x 107 
cells/ml observed on day 7 post-infection for WT and aAK T. brucei, respectively, in the single 
infection experiments (see Figure 4.25). 
 
 
Figure 4.28 Parasiteamia in mice infected with WT and akinetoplastic T. brucei cell lines. Mice were 
infected at day 0, with both WT and akinetoplastic cell line and parasite numbers monitored from 
day 3 post-infcetion till day 6. Three mice were inoculated in this experiment. Error bars are standard 
error of the mean (SEM). Tail snips were performed day 3 to day 6 post infection and cell counts 
were estimated from blood smears. 
 
At day 6, mice were sacrificed, and AT parasites collected and fixed for microscopy. From 
the blood smears, it was observed that WT parasites came up earlier than aAK parasites, 
with peaks at day 6 vs. day 5 post-infection. The morphology of selected parasites is 







were seen (Figures 4.29 and 4.30).  The aAK parasite (without kinetoplast) were observed 
from 4 dpi. This observation is comparable to earlier experiments with the other 
akinetoplastic cell line that lost kDNA without treatment. In both experiments, the 
akinetoplastic cell lines showed delayed rise in parasitaemia but rapidly decreased and 
cleared once peak density had been reached. Similar infection dynamics have been observed 
between WT and akinetoplastic cells (Dewar et al., 2018). 
 
 
Figure 4.29 Micrographs showing differentiation of WT and aAK cells from slender to stumpy in 
blood from a co-infected mouse. The images are morphology of selected parasites WT and aAK cells 
were inoculated into mice, and blood smears were taken daily after day 3 post-infection until day 6. 
Exclusively slender cells were observed on days 3 and 4, with differentiation starting on day 5 and 
stumpy forms being observed on day 6 post-infection. Upper panels = merged phase contrast and 
DAPI images. Lower panels = DAPI stained image alone. Scale bar, 5µm. shown in phase contrast 
images.  
 
As shown in Figure 4.29, differentiation from slender to stumpy was observed in blood from 
day 5 post infection with WT and aAK cell line. WT parasites were first seen on day 3 post-
infection followed by aAK parasites on day 4 post-infection. Parasitaemia increased over the 







on DAPI stain of fixed smeared blood to differentiate AT (without kDNA) from WT (with 
kDNA). Parasite differentiation during infection was assessed by determining manually 
proportions of stumpy, intermediate, and slender cells on days 3-6 post-infection for blood 
and on day 6 only (the day mice were sacrificed) for AT. Differentiation was assessed based 
solely on morphology, as for this experiment it was not possible to use PAD1 staining (Dean 
et al., 2009) to confirm stumpy forms due to technical problems. The changes in parasite 
morphology observed for both blood and AT compartments were similar for AK and WT 
control T. brucei, and comparable to what has been described (Trindade et al., 2016).  
The average percentage counts for stumpy, intermediate and slender form parasites in 
blood on day 6 were 80%, 7% an11%, respectively, for WT cells, and 77%, 11% and 10%, 
respectively, for aAK. In AT, percentages of stumpy, intermediate and slender of were 20%, 
15% and 65%, respectively, for WT, and 15%, 10% and 75%, respectively, for aAK parasites 
(Figure 4.27) shows a representative micrograph image. The percentage count in blood and 


















Table 4.5  A summary of percentage score for stumpy, intermediate and slender forms of T. brucei 
in blood and adipose tissue on day 7 post infection. Infected with three replicate samples of either 









Thus, on day 6, AT parasites contained a lower percentage of stumpy forms than blood, 
similar to what has been described in other studies for skin and gonadal AT (Capewell et al., 
2016; Trindade et al., 2016). Parasitaemia in blood for WT cells increased much earlier, and 
to higher numbers, than for aAK cells (Figure 4.30). 
Figure 4.31 shows stumpy forms of WT and aAK in coinfection experiment. The morphology 
of stumpy cells in adipose tissue corresponding to the morphology of stumpy forms found 
in blood (see Figure 4.29). However, the relative distribution of these parasites differs from 
blood. Parasitaemia in AT was judged by eye, based on the Rapid Matching method (Herbert 
and Lumsden, 1976) and, thus, parasite score count was done to score for each cell line. 

























Figure 4.30 Blood parasitaemia profile of WT and aAK T. brucei cell lines in a coinfection experiment 
in mice. Mice were inoculated via IP injection with WT and aAK T. brucei cells and parasites collected 
from day 3 post infection till day 6. (A) Tail snips were performed from day 3 post-infection and cell 
counts estimated from blood smears. WT parasites was seen in mice by day 3 post-infection whiles 
aAK parasitaemia was seen from day 4 post-infection. (B) Parasites were counted by semi-
quantitative scoring (Capewell et al., 2016) on the entire blood smear, and relative numbers of WT 
and aAK parasites are given for each day. The values represented are the means of the percentage 











Figure 4.31 AnTat1.1 90:13 cells with and without kDNA are able to differentiate to the stumpy 
form in AT. Both WT and aAK cells were used to inoculate mice in a coinfection experiment, and AT 
parasites were harvested after mice were sacrificed on day 6 post-infection. AT parasites were fixed, 
and micrographs taken for phase contrast (top) and DAPI images (bottom). Arrows indicate an aAK 
















Figure 4.32 Relative levels of parasitaemia of WT and aAK T. brucei cells in AT of co-infected mice. 
Both WT and aAK cells were used to inoculate 10-week-old female MF1 mice in a coinfection 
experiment. AT parasites were harvested after mice were sacrificed on day 6 post infection, fixed, 
and DAPI stained micrographs used to count relative numbers of WT and AK parasites. The parasite 
count was assessed by semi-quantitative scoring. The values represented are the means of the 
percentage from the three infected mice. The scoring was performed blinded and independently for 
consistency and accuracy and also to prevent bias. Morphology was scored by three individuals, 








4.3.1 T. brucei cI mutants and akinetoplastic cells infiltrated solid organs 
and adipose tissue 
Organisms such as viruses (e.g. HIV) (Damouche et al., 2015), parasites (T. brucei) (Capewell 
et al., 2016; Trindade et al., 2016) and bacteria (Mycobacterium tuberculosis) (Neyrolles et 
al., 2006) have been reported to reside in adipose tissue (AT). T. brucei accumulates in blood, 
solid organs, CNS, adipose tissue and skin, and it has been recently shown that the parasites 
also accumulate in testis, infiltrates inflammatory cell and cause severe tissue damage which 
triggers strong immune response (Carvalho et al., 2018). RNA Seq analysis has shown T. 
brucei adipose tissue form parasites (ATF) to upregulate genes that encode enoyl-CoA 
hydratase and 3-ketoacyl-CoA thiolase which forms part of the β-oxidation cycle (Trindade 
et al., 2016). Additionally, acyl-CoA synthases and carnitine-acyltransferases were also 
upregulated (Trindade et al., 2016). This catabolic pathway produces NADH and would be 
expected to put more demand on systems for NADH oxidation, such as cI. Thus, we 
hypothesise that cI is important for efficient energy production in AT. However, this 
hypothesis can only be tested with cI mutants in a pleomorphic background. Unfortunately, 
mutants generated in this study did not differentiate in mice, so experiments performed 
could only look at the first peak of parasitaemia. To test this hypothesis, mice were infected 
with T. brucei parasites that are null for NUKM and NUBM, subunits expected to be critical 
for cI activity (Zhu et al., 2016) Here, data reported in this chapter show that T. brucei NUBM 
and NUKM null mutant were both found in AT during the first peak of parasitaemia. Even 
though both mutants were virulent, with evident hyperparasitaemia in blood and other 
organs, NUBM mutant showed no significant difference in AT parasitaemia when compared 
to WT cells. Interestingly, the NUKM showed less parasitaemia in AT when compared to the 
WT. The reasons for difference in preference for AT between the two main core subunits of 
cI was unknown.  
The NUBM parasitaemia in AT was less than what was observed for blood and other organs 
which supported the decision to focus on NUKM mutants with stronger phenotype (Figure 







the NUKM null mutant lines, with high parasite numbers in solid organs and less in AT when 
compared to a control cell line (Figure 4.22). Trypanosomes have been described previously 
in organs such as liver, spleen, AT, kidney and heart (Kennedy, 2004; Trindade et al., 2016). 
However, there is no investigation on survival nor invasion of T. brucei parasites that are null 
for NUKM and NUBM subunits in these organs. In summary, the data show that NUKM null 
mutant can survive in AT and solid organs such as heart, liver and kidney. 
 
4.3.2 T. brucei akinetoplastic cells show relative increase in AT over blood 
Another hypothesis of this study is to test whether cI is required for full viability of stumpy 
cells. Could this be a consequence of upregulation of NADH producing activities in stumpy 
form mitochondria? The hypothesis is supported by the observation of a shorter lifespan of 
akinetoplastic stumpy cells observed by Dewar et al. (2018), and that inhibiting cV (another 
activity that depend on kDNA-encoded genes) pharmacologically did not reduce the lifespan 
(cIII and cIV are not expressed, so are unlikely to be responsible). Addressing this question 
would have required the generation of cI deficient mutants in a pleomorphic background, 
which was not achieved. Nonetheless, these cell lines were used to inoculate mice to test 
whether they can infect adipose tissue and differentiate to stumpy forms. In separate 
infections, the parasite load of AK cells was typically lower in blood and solid organs but 
higher in gonadal AT, compared to control parasites (Figure 4.24; Figure 4.25). A co-infection 
experiment showed WT parasites accumulating in both blood and AT during the first peak 
of parasitaemia, whereas AK parasites came up on day 4 post infection and dropped by day 
6. The smaller number of parasites could be a competitive situation where the AK forms 
were losing out or were not as viable as WT. However, it was intriguing to note that the AK 
cell line had a relative preference for AT, with a shift from 6% of parasites in the blood being 
AK, to 35% in AT (Figure 4.32).  
The relative accumulation of the AK cells in AT could be due to several reasons: AT serves as 
a protective environment to evade immune response. This is supported by recent studies 
where they saw no parasites in the lumen of intact epididymal ducts or seminiferous tubules 







parasite differentiation may be delayed and the affinity for fatty tissue could be upregulating 
other mitochondrial NADH dehydrogenase activities, such as NDH2.  
To investigate whether AK cells differentiate to stumpy forms in AT, mice were co-infected 
with AK and WT cells and parasitaemia and differentiation was monitored. Cells were 
harvested on day 6 post-infection due to increased number of parasites present in mice. 
However, most of the cells in the blood had differentiated to stumpy forms. Although the 
results obtained here showed about a fourth of number of stumpy found in blood, the 
morphology and percentage number of stumpy in these null mutant are similar to what has 
been reported (Trindade et al., 2016). The parasites in blood expressed high levels of GFP 
(86%) and that in fat was around 21% GFP positive. (Trindade et al., 2016). These stumpy 
percentages are like what was in this study, where stumpy forms found in blood was 80% on 
the average for WT and 75% for mutant cell line and around 18% for what was observed in 
AT. In summary, data obtained in this chapter present evidence that AK trypanosomes have 
a relative preference for AT and can differentiate into the transmission competent stumpy 
stage trypanosome. However, to understand the apparently preferential tropism of AK T. 
brucei parasites for AT, further studies are necessary to elucidate the mechanisms these 
parasites use to adapt in adipose tissue during T. brucei infection. 
This study is the first to investigate the ability of T. brucei cells that are complex I deficient, 
either due to specific deletions of nuclear genes or due to akinetoplastidy, to reside in AT 
and to differentiate from the dividing slender trypanosomes to non-dividing stumpy forms 
in AT. Additionally, these parasites have shown to infect other solid organs.  
Even though the hypothesis that cI is important in AT could not be tested due to inability to 
generate cI null mutant in pleomorphic background, the ability of these cell lines to reside 










The AK parasite showed relative increase in AT over blood when compared to WT. It is 
possible that these parasites are evading the immune response from the blood. This 
observation may be of biological relevance. T. equiperdum, is sexually transmitted and cause 
wasting disease in equines, (Desquesnes et al., 2013). It is possible that the parasites hide in 
the gonadal adipose tissue and male reproductive organs to contribute to the wasting seen 
in infected animals and transmission. The wasting may result from breakdown of fat to 
produce glucose to maintain glucose level for metabolism in the new environment. Here, 
one could speculate that these ATF parasites possess specific receptor required for crossing 
barriers between blood and other tight control checks to evade evading immune response 
and reside in other compartments. Another question to be addressed is to find out whether 
these parasites are evenly spread across the adipocytes or have compartmentalised niche in 
stromal vascular fraction (SVF) of cells. The SVF includes preadipocytes, endothelial cells, 
adipose tissue macrophages and fibroblasts. This will help scientist to know more about 
transmission of these disease and also for accurate diagnostic techniques. 
Another outstanding question to be addressed is whether these ATF parasites contribute to 
poor drug response during treatment as the parasites are covered in the fat and resist drug 
action in infected organisms which affect drug distribution. This will help with the design of 
liposoluble compound hits to improve the poor bioavailability of drugs used to treat 
trypanosomiasis. Indeed, this study has shown that parasites were relatively abundant in AT 
compared to blood. But this raises further questions: are the parasite evading immune 
response and stay in AT for survival? Possibly hiding from drug action? Does residence in 
gonadal AT imply a potentially higher likelihood of sexual transmission? Where does the 
parasite have to reside in order to be sexually transmissible? Thus, the transmission 











4.3.3 Complex I is not important in bloodstream form T. brucei cells 
The existence and functionality of cI in T. brucei have been debated (Duarte and Tomás, 
2014; Opperdoes and Michels, 2008; Surve et al., 2012, 2017; Verner et al., 2011). 
 Recent research suggests that cI contributes around 20% of the specific NADH 
dehydrogenase (i.e. NADH:ubiquinone oxidoreductase) activity in procyclic T. brucei, even 
though cI seems not to be essential (Verner et al., 2011). However, BF null mutants of cI 
subunits showed normal growth both in vitro and in vivo (Surve et al., 2012, 2017). Here, 
it was not possible to test the hypothesis that cI has a role to play in stumpy forms of T. 
brucei due to unavailability of null mutants in a truly pleomorphic background.  
The hypothesis is supported by the observation of a shorter lifespan of akinetoplastic stumpy 
cells observed by Dewar et al., (2018). Knockout of two catalytic subunits (NUBM and 
NUKM) of cI, using the same constructs described by Surve et al., (2012), was confirmed by 
PCR.  Unfortunately, I was unable to generate cI null mutant as the T. brucei null NUBM and 
NUKM subunits of cI was not able to differentiate in vivo. The EATRO AnTat 1.1 cell line has 
been used to study slender to stumpy differentiation (Dejung et al., 2016; Naguleswaran et 
al., 2018).  
However, the parental cell line and the DKO cell lines (knockout of NUBM and NUKM) were 
unable to differentiate in mice. Since this study was unable to generate a cI null mutant, a 
possible approach to consider is the use of CRISPR Cas9 targeted gene method. The gene 
disruption of NUBM or NUKM could be achieved by using Cas9-based approach in 
pleomorphic T. brucei to generate cI null mutants. This approach of using inducible cas9 and 
guide RNAs is efficient, less time consuming and null mutant clones can be generated in a 
single transfection without selectable markers (Rico et al., 2018). 
 The data presented in this thesis confirmed that the EATRO 1125 AnTat1.1 strain with 
NUBM and NUKM knockouts differentiated to stumpy forms in vitro in methylcellulose and 
expressed PAD1. My data also showed that these methylcellulose differentiated stumpy 
underwent further differentiation to generate procyclic, which expressed EP, a 







of methylcellulose to generate stumpy cells in vitro has been confirmed (Naguleswaran et 
al., 2018). Their study validated the use of cultured bloodstream as a substitute for animal-
derived parasites using RNA-Seq analysis performed on biological replicates of culture-
derived bloodstream form and early and late procyclic of T. brucei. Their datasets expression 
profiles confirmed that genes known to be stage-regulated in the animal and insect hosts 
were also regulated in culture derived cells.  
As shown in Figure 4.11, NUBM and NUKM null mutant stumpy-like cells generated in vitro 
and induced for differentiation to PF revealed high expression of EP. Analysis of the growth 
profiles demonstrated that procyclic null mutants grew slightly slower compared with the 
parental control cell line. Under the same conditions, the WT cells differentiated to PF 
continued to grow robustly, whereas growth was slower in procyclic NUBM null mutants. 
The two independent NUBM null mutant procyclic clones showed similar growth profiles 
during the adaptation period.  
Ultimately, the growth profiles indicate that the absence of cI activity in the NUBM null 
mutant affected growth in the procyclic stage. A second attempt to generate NUBM and 
NUKM null mutants used another pleomorphic cell line (Markus Engstler and Boshart, 2004) 
that was confirmed to efficiently differentiate into stumpy forms in mice. Unfortunately, 
only SKO cells could be generated in the time permitted for this project, and these cells had 
lost pleomorphism.  
In MF1 mice, all cell lines (null mutants and parental) were largely monomorphic and 
virulent, precluding the study of any potential effects on differentiation efficiency or stumpy 
longevity. Since mutants did not differentiate in mice, the first peak of parasitaemia was 
considered in experiment with NUBM and NUKM mutant lines, which posed limitation to 
this study. One possible explanation could be that the maintenance of pleomorphism 
renders the deletion of the cI impossible. Thus, cI is essential in pleomorphic cells and 
probably for stumpy forms. This work shows that knockout NUBM and NUKM genes in the 
parental cell line was not fully pleomorphic in mice. However, these DKO cells were capable 
of differentiating to stumpy forms in methylcellulose. Finally, NUBM null mutant 







suggested to ascertain a functional role for cI in this null mutant cell. These could include 





This study is the first to investigate the effects of mitochondrial dysfunction on nuclear gene 
expression. The transcriptome of wild type and akinetoplastic cell lines of T. brucei changes 
during differentiation from slender to stumpy forms was investigated. Transcripts enriched 
in slender and stumpy stage forms were identified. A novelty, however, was the 
downregulation of some hypothetical proteins in WTγ, which were much less expressed in 
AK cells compared to WTγ. The RNA-Seq result suggests that the absence of the 
mitochondrial genome has a limited effect on the levels of nuclearly encoded messenger 
RNA needed to make proteins in bloodstream stage of T. brucei. A future work on RNA-Seq 
analysis of transcriptome comparison between akinetoplastic procyclic and WT T. brucei 
within the first few hours after inducing differentiation will provide more information on 
possible changes in gene expression between stumpy and procyclic forms of these cells. 
Since akinetoplastic procyclic forms are not viable (Caroline’s thesis), one can only check 
cells within 48 hr of differentiation. 
This study is the first to investigate the ability of T. brucei cI deficient cells - obtained either 
through deletion of specific nuclearly encoded core cI genes or via loss of kDNA to reside 
and differentiate from the dividing slender trypanosomes to non-dividing stumpy forms in 
AT. Additionally, these parasites have been shown to infect other solid organs. Though the 
AK cell lines have shown affinity for fatty tissue, this experiment must be repeated as the 
available data is not enough to make a conclusion. It would be ideal to confirm whether the 
preference for fat is a common feature of this cell line and other Trypanosoma species. The 
NUBM and NUKM mutants however did not show any preference for AT. In C57 mice, 







NUBM/NUKM mutants and parental cell line. The infection profile with the parental cell line 
followed progressive waves of parasitaemia (MacGregor et al., 2011).  
The NUBM and NUKM mutants however were virulent with hyperparasitaemia. The 
hypervirulent nature of these mutants may be due to the mutation caused by deleting these 
subunits of cI. Here, one could speculate that these ATF parasites possess specific receptor 
required for crossing barriers between blood and other tight control checks to evade evading 
immune response and reside in other compartments. It is necessary to investigate in depth 
the selective advantage of these parasites to reside in adipose tissue as this tropism may 
contribute to treatment failure in infected organisms, since the drugs of choice for 
trypanosomiasis are not liposoluble. 
Inevitably, this work leads on to questions that remain about the role of cI in the metabolism 
of ATF trypanosomes and as to whether it is important for longevity in AK cells of T. brucei. 
The data generated in this study does not support the hypothesis that cI is important for 
metabolism in AT. Thus, the phenotype observed in NUBM and NUKM mutant cells is not 
attributed to lack of complex I. In regard to the relative abundance of AK parasites in AT, a 
number of questions arose from this study. Does residence in gonadal AT imply a potentially 
higher likelihood of sexual transmission? Where does the parasite have to reside in order to 
be sexually transmissible? Could this influence the design of liposoluble drugs in the future?  
One of the main questions is why the lack of kDNA lead to preferential tropism which is 
different from WT? A metabolomics analysis of the AK and WT will give some answers to this 
question. Is it also possible that these ATF parasites are easily eliminated in blood and 
therefore are protected in the adipose tissue? A possible approach to investigate this further 
is by comparing the immune response upon infection in each tissue by FACS using antibodies 










5.1 Appendix A: List of primers in material and methods 
Table 5.1  Primers used in this study 
PRIMER NAME  SEQUENCE 
qPCR GPI8_FWD 5' CGAAGCGCATTTGGATAGC 3' 
qPCR GPI8_REV 5' AGCGCGTGATGACAGTGAAG 3' 
COX6 FWD 5' GAAGCGTGCTCTAGGACATT 3' 
COX6 REV  5' CCCTTGCGGTTTGTCTTTAC 3' 
qPCR UBP1 FWD 5' GGGTCAAGTGAATCAAGAACCC 3' 
qPCR UBP1 REV 5' CCGAAGCGCTCAAACAACTG 3' 
qPCR UBP2 FWD 5' CAACAACATTATATGATG 3' 
qPCR UBP2 REV 5' TTACTGACGGGATATCGGA 3' 
NUKM qPCR FWD 5' ATTGCAGTATGCACAAATGACTTT 3' 
NUKM qPCR REV 5' ACAATACCAAAACGATCCAAATC 3' 
ADDBACK NUKM FWD 5' TTCACAAGCTTATGCTTCGTCGCA 3' 
   ADDBACK NUKM REV 5' TGGGCAGGATCCATCTCGAACAGAA 3' 
ESAG9 FWD 5' GATCAGAGAGGGTTGGAATCTG 3' 
ESAG9 REV 5' CTGTGGCATGATCTCCTGAA 3' 
NUBM FWD 5' AGCTTATGCTCCGGCGTGTGGGTTTTCTTT 3' 
NUBM REV 5' CGTTCCAATTCCGCACGATCTTTCCGTCC 3' 
NUKM FWD 5' ATGCAAGCTTATGCTTCGTCGCACGTCG 3' 
NUKM REV 5' GCATGGATCCATCTCGAACAGAATACTTTTG 3' 
   NUBM 5’ FWD    5' ATAGCGGCCGCGTTTTGTTGTGCGGGACGAA 3' 
   NUBM 5’ REV    5' ATAACGCGTCTCGAGCTACACACAAGGTTCAATTTGA 3'  
   NUBM 3’ FWD    5' ATATCTAGAATTTAAATGGTGGTGGTGTAGTATTGAA 3'  
   NUBM 3’ REV    5' ATAAGGCCTGCGGCCGCCGGAAGTCAGCGTTAAGTTA 3'  
   NUKM 5’ FWD    5' ATAGCGGCCGCCGGCATTTCTTCGAGGCAGT 3' 
   NUKM 5’ REV    5' ATAACGCGTCTCGAGTGCAAACTATTTATCTATCCTCTTC 3' 
   NUKM 3’ FWD    5' ATATCTAGAATTTAAATGAATCATGGTACAATAGGAGTTTCT 3' 
   NUKM 3’ REV    5' ATAAGGCCTGCGGCCGCGTTGCGACCGTTACGTTTGA 3' 
   M13 FWD    5' GTAAAACGACGGCCAGT 3' 
   M13 REV    5' CAGGAAACAGCTATGAC 3' 
   PHD1344 FWD    5' TTCACCCTCATGTTCCGTCG 3' 
   PHD1344 REV    5' GAGTTCTTGCAGCTCGGTGA 3' 
   PLASMID INSERT 5' end NUKM 
DISTAL 
   5' GAATACATATTTGTTATTGATTTA 3' 
   PLASMID INSERT 3' end NUKM 
DISTAL 







   PAD1 FWD    5' GACCAAAGGAACCTTCTTCCT 3' 
   PAD1 REV    5' CACTGGCTCCCCTAAGCT 3' 
   ATP synthase FWD    5' CGGCGGCCGCATGTCAGGTAAACTTCGTCTTTACAAAG 3' 
   ATP synthase REV    5' ATAGGATCCCTACTTGGTTACTGCCCCTTCCCAG 3' 
   qPCR PNT1 FWD    5' CACCGCGGGAAACACATAAT 3' 
   qPCR PNT1 REV    5' AACGACACGGTGGAATAGGT 3' 
   qPCR HYP 6430 FWD    5' TGGAAGTTGGAGCCGTTAGT 3' 
   qPCR HYP 6430 REV    5' ATTTGTCCACGCAAGAACCC 3' 
   qPCR HYP 8340 FWD    5' TCATTCTTCCCGAGATGCGA 3' 
   qPCR HYP 8340 REV    5' TCCTTCCTTCCTTCCCTTGG 3' 
   TRYPS 18S FWD    5’ ACGGAATGGCACCACAAGAC 3’  
  TRYPS 18S REV    5’ GTCCGTTGACGGAATCAACC 3’ 
   5' INT  NUBM     5' CCCGAGCTAACGCAGCAGAT 3' 
   PLASMID T7RNAP NUBM     5' TTCGTTCTTAGCGATGTTAATC 3' 
    3' INT NUBM     5' AGAACGCGGCTACAATTAAT 3' 
   PLASMID NEO NUBM    5' CGCAGCGCATCGCCTTCTAT  3' 
   5' INT  NUKM     5' CTCGTCACGGCCGCTACCTG 3' 
   PLASMID T7RNAP NUKM     5' TTCGTTCTTAGCGATGTTAATC 3' 
    3' INT. NUKM     5'  CATACACATACGATTTAG 3' 
























Figure 5.1  A plasmid map showing pLew90 with ampicillin as bacterial resistance with hygromycin 
selectable marker. Tet repressor is driven by 10% T7 promoter with target locus of tubulin. This 















Figure 5.2   The pLew13 vector with T7 RNA polymerase and neomycin gene. The bacterial 
resistance is ampicillin and the target locus is tubulin. This plasmid served as the backbone to 















Figure 5.3 The plasmid map of pLew90 with ampicillin as bacterial resistance with hygromycin 
selectable marker. Tet repressor is driven by 10% T7 promoter with target locus of tubulin. This 



















Figure 5.4  This is a pBluescript sk+ plasmid with COXVI coding sequence. The CDS was inserted 
within the multiple cloning site flanked by M13 forward and reverse primers. The PCR product of 


















Figure 5.5  This pEX-K4 is a synthetic plasmid used for deleting complex I subunit, NUKM in T. brucei 
cell line. The selectable marker is kanamycin. The  5’ and 3’ UTR of NUKM selected were distant from 














Figure 5.6  The pEX-K4 is a synthetic plasmid used for deleting complex I subunit, NUKM in T. brucei 
cell line. The selectable marker is kanamycin. The 5’ and 3’ UTR of NUKM selected were close to the 














Figure 5.7 A pHD1344 plasmid with NUKM coding sequence replacing the CAT reporter gene. The 
PCR product NUKM was cloned into pHD1344 plasmid with puromycin resistance (PAC) selectable 


















Figure 5.7  The pGEM®-T Easy Vector Systems was used to cloning. PCR products into multiple 











































































































Figure 5.8 Immunoflourescence images for PAD1 staining in T. brucei bloodstream forms. These are the biological replicate samples used in the 
RNA-Seq analysis. Four replicate samples for stumpy AK, three for slender AK, Three each for WTγ stumpy and slender samples. Slender samples 
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